Current Build

4.3.14.422 Code System http://dicom.nema.org/resources/ontology/DCM

Vocabulary Work Group Maturity Level: 0Informative Use Context: Any

This is a code system defined at http://medical.nema.org/medical/dicom/current/output/chtml/part16/chapter_D.html .

Summary

Defining URL:http://dicom.nema.org/resources/ontology/DCM
Version:01
Name:DICOM Controlled Terminology Definitions
Title:
Definition:

DICOM Code Definitions (Coding Scheme Designator "DCM" Coding Scheme Version "01")

Committee:??
OID:1.2.840.10008.2.16.4 (for OID based terminology systems)
Copyright:These codes are excerpted from Digital Imaging and Communications in Medicine (DICOM) Standard, Part 16: Content Mapping Resource, Copyright © 2011 by the National Electrical Manufacturers Association.
Source ResourceXML / JSON

This Code system is used in the following value sets:

  • ValueSet: Audit Event ID (Event Types for Audit Events - defined by DICOM with some FHIR specific additions.)
  • ValueSet: AcquisitionModality (Transitive closure of CID 29 AcquisitionModality)
  • ValueSet: Media Type Code (Media Type Code)
  • ValueSet: Audit Event Sub-Type (More detailed code concerning the type of the audit event - defined by DICOM with some FHIR specific additions.)
  • ValueSet: ParticipationRoleType (This FHIR value set is comprised of Actor participation Type codes, which can be used to value FHIR agents, actors, and other role elements. The FHIR Actor participation type value set is based on DICOM Audit Message, C402; ASTM Standard, E1762-95 [2013]; selected codes and derived actor roles from HL7 RoleClass OID 2.16.840.1.113883.5.110; HL7 Role Code 2.16.840.1.113883.5.111, including AgentRoleType; HL7 ParticipationType OID: 2.16.840.1.113883.5.90; and HL7 ParticipationFunction codes OID: 2.16.840.1.113883.5.88. This value set includes, by reference, role codes from external code systems: NUCC Health Care Provider Taxonomy OID: 2.16.840.1.113883.6.101; North American Industry Classification System [NAICS]OID: 2.16.840.1.113883.6.85; IndustryClassificationSystem 2.16.840.1.113883.1.11.16039; and US Census Occupation Code OID: 2.16.840.1.113883.6.243 for relevant recipient or custodian codes not included in this value set. If no source is indicated in the definition comments, then these are example FHIR codes.)
  • ValueSet: AcquisitionModality (Transitive closure of CID 29 AcquisitionModality)
  • ValueSet: InstanceAvailability (Availability of the resource.)
  • ValueSet: SecurityRoleType (This example FHIR value set is comprised of example Actor Type codes, which can be used to value FHIR agents, actors, and other role elements such as those specified in financial transactions. The FHIR Actor value set is based on DICOM Audit Message, C402; ASTM Standard, E1762-95 [2013]; selected codes and derived actor roles from HL7 RoleClass OID 2.16.840.1.113883.5.110; HL7 Role Code 2.16.840.1.113883.5.111, including AgentRoleType; HL7 ParticipationType OID: 2.16.840.1.113883.5.90; and HL7 ParticipationFunction codes OID: 2.16.840.1.113883.5.88. This value set includes, by reference, role codes from external code systems: NUCC Health Care Provider Taxonomy OID: 2.16.840.1.113883.6.101; North American Industry Classification System [NAICS]OID: 2.16.840.1.113883.6.85; IndustryClassificationSystem 2.16.840.1.113883.1.11.16039; and US Census Occupation Code OID: 2.16.840.1.113883.6.243 for relevant recipient or custodian codes not included in this value set. If no source is indicated in the definition comments, then these are example FHIR codes. It can be extended with appropriate roles described by SNOMED as well as those described in the HL7 Role Based Access Control Catalog and the HL7 Healthcare (Security and Privacy) Access Control Catalog. In Role-Based Access Control (RBAC), permissions are operations on an object that a user wishes to access. Permissions are grouped into roles. A role characterizes the functions a user is allowed to perform. Roles are assigned to users. If the user's role has the appropriate permissions to access an object, then that user is granted access to the object. FHIR readily enables RBAC, as FHIR Resources are object types and the CRUDE events (the FHIR equivalent to permissions in the RBAC scheme) are operations on those objects. In Attribute-Based Access Control (ABAC), a user requests to perform operations on objects. That user's access request is granted or denied based on a set of access control policies that are specified in terms of attributes and conditions. FHIR readily enables ABAC, as instances of a Resource in FHIR (again, Resources are object types) can have attributes associated with them. These attributes include security tags, environment conditions, and a host of user and object characteristics, which are the same attributes as those used in ABAC. Attributes help define the access control policies that determine the operations a user may perform on a Resource (in FHIR) or object (in ABAC). For example, a tag (or attribute) may specify that the identified Resource (object) is not to be further disclosed without explicit consent from the patient.)

DICOM Code Definitions (Coding Scheme Designator "DCM" Coding Scheme Version "01")

Copyright Statement: These codes are excerpted from Digital Imaging and Communications in Medicine (DICOM) Standard, Part 16: Content Mapping Resource, Copyright © 2011 by the National Electrical Manufacturers Association.

Properties

CodeURLDescriptionType
statushttp://hl7.org/fhir/concept-properties#statuscode

This code system http://dicom.nema.org/resources/ontology/DCM defines the following codes:

CodeDisplayDefinitionDeprecated
ARCHIVE ArchiveArchive device
AR AutorefractionAutorefraction device
AS AngioscopyAngioscopy deviceDeprecated
AU AudioAudio object
BDUS Ultrasound Bone DensitometryUltrasound Bone Densitometry (modality)
BI Biomagnetic imagingBiomagnetic imaging device
BMD Bone Mineral DensitometryBone Mineral Densitometry by X-Ray (modality), including dual-energy X-Ray absorptiometry (DXA) and morphometric X-Ray absorptiometry (MXA)
CAD Computer Assisted Detection/DiagnosisComputer Assisted Detection/Diagnosis device
CAPTURE Image CaptureImage Capture Device, includes video capture
CD Color flow DopplerColor flow DopplerDeprecated
CF CinefluorographyCinefluorographyDeprecated
COMP Computation ServerComputation Server; includes radiotherapy planning
CP CulposcopyCulposcopyDeprecated
CR Computed RadiographyComputed Radiography device
CS CystoscopyCystoscopyDeprecated
CT Computed TomographyComputed Tomography device
DD Duplex DopplerDuplex DopplerDeprecated
DF Digital fluoroscopyDigital fluoroscopyDeprecated
DG DiaphanographyDiaphanography device
DM Digital microscopyDigital microscopyDeprecated
DOCD Document Digitizer EquipmentEquipment that digitized hardcopy documents and imported them
DS Digital Subtraction AngiographyDigital Subtraction AngiographyDeprecated
DSS Department System SchedulerDepartment System Scheduler, workflow manager; includes RIS
DX Digital RadiographyDigital Radiography device
EC EchocardiographyEchocardiographyDeprecated
ECG ElectrocardiographyElectrocardiography device
EPS Cardiac ElectrophysiologyCardiac Electrophysiology device
ES EndoscopyEndoscopy device
F FemaleFemale sex
FA Fluorescein angiographyFluorescein angiographyDeprecated
FC Female changed to MaleFemale sex changed to Male sex
FILMD Film DigitizerFilm Digitizer
FP Female PseudohermaphroditeFemale Pseudohermaphrodite
FS FundoscopyFundoscopyDeprecated
GM General MicroscopyGeneral Microscopy device
H HermaphroditeHermaphrodite
HC Hard CopyHard Copy
HD Hemodynamic WaveformHemodynamic Waveform acquisition device
IO Intra-oral RadiographyIntra-oral Radiography device
IVOCT Intravascular Optical Coherence TomographyAn acquisition device, process or method that performs intravascular optical coherence tomography
IVUS Intravascular UltrasoundIntravascular Ultrasound device
KER KeratometryKeratometry device
KO Key Object SelectionKey Object Selection object
LEN LensometryLensometry device
LOG Procedure LoggingProcedure Logging device; includes cath lab logging
LP LaparoscopyLaparoscopyDeprecated
LS Laser surface scanLaser surface scan device
M MaleMale sex
MA Magnetic resonance angiographyMagnetic resonance angiographyDeprecated
MC Male changed to FemaleMale sex changed to Female sex
MCD Media Creation DeviceA device that creates DICOM PS3.10 interchange media; e.g. a CD creator that is managed by the Media Creation Management Service Class
MEDIM Portable Media Importer EquipmentEquipment that retrieved and imported objects from interchange Media
MG MammographyMammography device
MP Male PseudohermaphroditeMale Pseudohermaphrodite
MR Magnetic ResonanceMagnetic Resonance device
MS Magnetic resonance spectroscopyMagnetic resonance spectroscopyDeprecated
NEARLINE NearlineInstances need to be retrieved from relatively slow media such as optical disk or tape
NM Nuclear MedicineNuclear Medicine device
OAM Ophthalmic Axial MeasurementsMeasurements of the axial length of the eye, which are done by various devices
OCT Optical Coherence TomographyModality device that uses an interferometric, non-invasive optical tomographic technique to image 2D slices and 3D volumes of tissue using visible and near visible frequencies
OFFLINE OfflineInstances need to be retrieved by manual intervention
ONLINE OnlineInstances are immediately available
OP Ophthalmic photographyOphthalmic photography modality
OPM Ophthalmic MappingModality device that measures corneal topography, corneal or retinal thickness, and other similar parameters that are typically displayed as maps
OPR Ophthalmic RefractionModality device that measures the refractive characteristics of the eye
OPT Ophthalmic TomographyTomography of the eye acquired by a modality that is based on light and optical principles. Tomography based on other principles, such as ultrasound, is excluded
OPV Ophthalmic Visual FieldModality device that measures visual fields and perform visual perimetry
OSS Optical Survace ScannerAn acquisition device, process or method that performs optical surface scanning
OT Other ModalityOther Modality device
PR Presentation StatePresentation State object
PRINT Hard Copy Print ServerHard Copy Print Server; includes printers with embedded DICOM print server
PT Positron emission tomographyPositron emission tomography (PET) device
PX Panoramic X-RayPanoramic X-Ray device
REG RegistrationRegistration
RF RadiofluoroscopyRadiofluoroscopy device
RG Radiographic imagingRadiographic imaging (conventional film/screen)
RT Radiation Therapy DeviceRadiation Therapy Device; includes linear accelerator, proton therapy
RTDOSE Radiotherapy DoseRadiotherapy Dose
RTIMAGE Radiotherapy ImageRadiotherapy Imaging device; includes portal imaging
RTPLAN Radiotherapy PlanRadiotherapy Plan
RTRECORD Radiotherapy Treatment RecordRadiotherapy Treatment Record
RTSTRUCT Radiotherapy Structure SetRadiotherapy Structure Set
SEG SegmentationSegmentation
SM Slide MicroscopySlide Microscopy
SMR Stereometric RelationshipStereometric image pairing modality
SR Structured Report DocumentStructured Report Document
SRF Subjective RefractionSubjective Refraction device
ST Single-photon emission computed tomographySingle-photon emission computed tomography (SPECT) deviceDeprecated
TG ThermographyThermography device
U Unknown SexUnknown Sex
UNAVAILABLE UnavailableInstances cannot be retrieved
US UltrasoundUltrasound device
VA Visual AcuityVisual Acuity device
VF VideofluorographyVideofluorographyDeprecated
VIDD Video Tape Digitizer EquipmentEquipment that digitizes video tape and imports it
WSD WorkstationWorkstation
XA X-Ray AngiographyX-Ray Angiography device
XC External-camera PhotographyExternal-camera Photography device
109001 Digital timecode (NOS)A signal transmitted for the purpose of interchange of the current time, not specific to any source or methodology
109002 ECG-based gating signal, processedA signal that is generated for each detection of a heart beat
109003 IRIG-B timecodeA signal transmitted by the Inter-Range Instrumentation Group for the purpose of synchronizing time clocks
109004 X-Ray Fluoroscopy On SignalA signal that indicated that X-Ray source has been activated for fluoroscopy use
109005 X-Ray On TriggerA signal that indicated that the X-Ray source has been activated for image recording
109006 Differential signalAn electrical signal derived from two electrodes
109007 His bundle electrogramAn electrophysiological recording from the HIS nerve bundle
109008 Monopole signalAn electrical signal from one electrode relative to an indifferent potential
109009 Pacing (electrical) stimulus, voltageThe voltage stimulus during cardiac pacing
109010 Radio frequency ablation, powerThe power injected during RF ablation procedure
109011 Voltage measurement by basket catheterElectrophysiological signals acquired using a multi-splined catheter each equipped with multiple electrodes
109012 Voltage measurement by mapping catheterElectrophysiological signals acquired using a steerable catheter
109013 Voltage measurement, NOSA voltage measurement not otherwise specified
109014 35% of thermal COA signal point that is 35% of the peak thermal cardiac output signal
109015 70% of thermal COA signal point that is 70% of the peak thermal cardiac output signal
109016 A wave peak pressureThe peak pressure of each heart beat in the atrium caused by the atrial contraction
109017 A wave pressure, averageThe average of several A wave pressure measurements
109018 Beat detected (accepted)An identified cardiac beat used in the determination of a measurement
109019 Beat detected (rejected)An identified cardiac beat not used in the determination of a measurement
109020 Diastolic pressure, averageThe average of several diastolic pressure measurementsDeprecated
109021 Diastolic pressure nadirThe lowest pressure value excluding any undershoot artifactDeprecated
109022 End diastoleThe moment at the end of the diastolic phase of the cardiac cycleDeprecated
109023 End of expirationThe moment at the end of respiratory expiration
109024 End of inspirationThe moment at the end of respiratory inspiration
109025 Max dp/dtThe maximum positive rate of change of pressure
109026 Max neg dp/dtThe maximum negative rate of change of pressure
109027 Mean blood pressureThe average blood pressure value, generally over 2 or more secondsDeprecated
109028 Peak of thermal cardiac output bolusThe peak change in blood temperature during a thermal cardiac output measurement
109029 Start of expirationThe moment respiratory expiration begins
109030 Start of inspirationThe moment of respiratory inspiration begins
109031 Start of thermal cardiac output bolusThe first discernible blood temperature change following the injectate during a thermal cardiac output measurement
109032 Systolic pressure, averageThe average of several systolic blood pressure measurementsDeprecated
109033 Systolic peak pressureThe highest systolic blood pressure value excluding any overshoot artifactDeprecated
109034 V wave peak pressureThe peak pressure of each heart beat in the atrium caused by the filling of the atrium
109035 V wave pressure, averageThe average of several V wave pressure measurements
109036 Valve closeThe moment at which a heart valve closes
109037 Valve openThe moment at which a heart valve opens
109038 Ablation offThe moment when RF ablation current is turned off
109039 Ablation onThe moment when RF ablation current is turned on
109040 HIS bundle waveThe moment in the cardiac cycle when the HIS bundle nerves depolarize
109041 P waveThe surface electrocardiogram of the atrial contraction
109042 Q waveThe first negative deflection of the electrocardiogram caused by ventricular depolarization
109043 R waveThe first positive deflection the electrocardiogram caused by ventricular depolarization
109044 S waveThe first negative deflection after the R wave
109045 Start of atrial contractionThe beginning of the atrial contraction
109046 Start of atrial contraction (subsequent)The beginning of the second atrial contraction of two consecutive beats
109047 Stimulation at rate 1 intervalThe stimulation interval during cardiac stimulation first used in a pacing train
109048 Stimulation at rate 2 intervalThe stimulation interval different from the first stimulation interval used in a pacing train
109049 Stimulation at rate 3 intervalA stimulation interval different from and subsequent to the second interval in a pacing train
109050 Stimulation at rate 4 intervalDescribes a stimulation interval different from and subsequent to the third interval in a pacing train
109051 T waveThe electrocardiogram deflection caused by ventricular repolarization
109052 V waveThe peak pressure of each heart beat monitored in the atrium caused by the filling of the atrium
109053 V wave of next beatThe second V wave measurement of two consecutive beats
109054 Patient StateA description of the physiological condition of the patient
109055 Protocol StageThe exercise level during a progressive cardiac stress test
109056 Stress ProtocolA series of physiological challenges designed to progressively increase the work of the heart
109057 Catheterization Procedure PhaseA subpart of a cardiac catheterization procedureDeprecated
109058 Contrast PhaseThe subpart of a cardiac catheterization procedure in which a radio-opaque contrast medium is injected into the patient
109059 Physiological challengesPhysical changes administered to a patient in order to elicit an physiological response
109060 Procedure Step NumberEnumeration of a subpart of a catheterization procedure
109061 EP Procedure PhaseA subpart of an electrophysiological procedure
109063 Pulse train definitionA means of defining a series of cardiac stimulation pulses
109070 End of systoleEnd of the contraction phase of the cardiac cycleDeprecated
109071 Indicator mean transit timeTime for a median particle to travel from point of injection to point of detection
109072 TauThe time constant of isovolumic pressure fall
109073 V max myocardialMaximum velocity of myocardial contractility
109080 Real time acquisitionTotal time for the acquisition is shorter than cardiac cycle, no gating is applied; see Cardiac Synchronization Technique (0018,9037)
109081 Prospective gatingCertain thresholds have been set for a gating window that defines the acceptance of measurement data during the acquisition; see Cardiac Synchronization Technique (0018,9037)
109082 Retrospective gatingCertain thresholds have been set for a gating window that defines the acceptance of measurement data after the acquisition; see Cardiac Synchronization Technique (0018,9037)
109083 PacedThere is a constant RR interval, which makes thresholding not required; see Cardiac Synchronization Technique (0018,9037); e.g. Pacemaker
109091 Cardiac Stress StateImaging after injection of tracer during increased cardiac workload or increased myocardial blood flow, achieved by either exercise or pharmacologic meansDeprecated
109092 Reinjection StateImaging after injection of additional tracer under resting conditions
109093 Redistribution StateImaging after allowing a moderate amount of time for tracer to move from its initial sites of uptake. Example: For Thallium imaging this would correspond to imaging 2-6 hours after injection
109094 Delayed Redistribution StateImaging after allowing an extended amount of time for tracer to move from its initial sites of uptake. Example: For Thallium imaging this would correspond to imaging more than 6 hours after injection
109095 Peak stress statePeak cardiac stress stateDeprecated
109096 Recovery stateRecovery from cardiac stressDeprecated
109101 Acquisition EquipmentEquipment that originally acquired the data stored within composite instances; e.g. a CT, MR or Ultrasound modality
109102 Processing EquipmentEquipment that has processed composite instances to create new composite instances; e.g. a 3D Workstation
109103 Modifying EquipmentEquipment that has modified existing composite instances (without creating new composite instances); e.g. a QA Station or Archive
109104 De-identifying EquipmentEquipment that has modified an existing composite instance to remove patient identifying information
109105 Frame Extracting EquipmentEquipment that has processed composite instances to create new composite instances by extracting selected frames from the original instance
109106 Enhanced Multi-frame Conversion EquipmentEquipment that has processed composite instances to create new composite instances by converting classic single frame images to enhanced multi-frame image, or vice versa and updating other instances to maintain referential integrity
109110 VoiceThe sound of a human's speech, recorded during a procedure
109111 Operator's narrativeThe voice of a device operator, recorded during a procedure
109112 Ambient room environmentThe ambient sound recorded during a procedure, which may or may not include voice and other types of sound
109113 Doppler audioThe Doppler waveform recorded as an audible signal
109114 PhonocardiogramThe sound of the human heart beating
109115 Physiological audio signalAny sound made by the human body
109116 Arterial Pulse WaveformA digitized signal from the patient arterial system collected through pulse oximetry or other means
109117 Respiration WaveformA digitized signal from the patient respiratory system representing respiration
109120 On admission to unitThe occasion on which a procedure was performed on admission to a specialist unit; e.g. intensive care
109121 On dischargeThe occasion on which a procedure was performed on discharge from hospital as an in-patient
109122 On discharge from unitThe occasion on which a procedure was performed on discharge from a specialist unit; e.g. intensive care
109123 Pre-interventionThe occasion on which a procedure was performed immediately prior to non-surgical intervention; e.g, percutaneous angioplasty, biopsy
109124 Post-interventionThe occasion on which a procedure was performed immediately after to non-surgical intervention; e.g, percutaneous angioplasty, biopsy
109125 At last appointmentThe occasion on which a procedure was performed at the most recent outpatient visit
109132 Joint position methodThe active or passive joint positioning during acquisition
109133 Physical forceA physical force applied during acquisition
109134 Prior to voidingPrior to voiding
109135 Post voidingPost voiding
109136 Neutral musculoskeletal positionNeutral musculoskeletal position
109200 America Kennel ClubAmerica Kennel Club
109201 America's Pet Registry Inc.America's Pet Registry Inc
109202 American Canine AssociationAmerican Canine Association
109203 American Purebred RegistryAmerican Purebred Registry
109204 American Rare Breed AssociationAmerican Rare Breed Association
109205 Animal Registry UnlimitedAnimal Registry Unlimited
109206 Animal Research FoundationAnimal Research Foundation
109207 Canadian Border Collie AssociationCanadian Border Collie Association
109208 Canadian Kennel ClubCanadian Kennel Club
109209 Canadian Livestock Records AssociationCanadian Livestock Records Association
109210 Canine Federation of CanadaCanine Federation of Canada
109211 Continental Kennel ClubContinental Kennel Club
109212 Dog Registry of AmericaDog Registry of America
109213 Federation of International CaninesFederation of International Canines
109214 International Progressive Dog Breeders' AllianceInternational Progressive Dog Breeders' Alliance
109215 National Kennel ClubNational Kennel Club
109216 North American Purebred Dog RegistryNorth American Purebred Dog Registry
109217 United All Breed RegistryUnited All Breed Registry
109218 United Kennel ClubUnited Kennel Club
109219 Universal Kennel Club InternationalUniversal Kennel Club International
109220 Working Canine Association of CanadaWorking Canine Association of Canada
109221 World Kennel ClubWorld Kennel Club
109222 World Wide Kennel ClubWorld Wide Kennel Club
109701 Overall image quality evaluationEvaluation of overall image quality as described in section 7.3.2 of [IEC 62563-1]
109702 Grayscale resolution evaluationVisual verification of sufficient grayscale resolution based on 8 and 10-bit markers as described in section 7.3.3 of [IEC 62563-1]
109703 Luminance response evaluationVisual evaluation of luminance response using the TG18-CT test pattern as described in section 7.3.4 of [IEC 62563-1]
109704 Luminance uniformity evaluationVisual detection of luminance non-uniformities as described in section 7.3.5 of [IEC 62563-1]
109705 Chromaticity evaluationVisual verification of color uniformity as described in section 7.3.6 of [IEC 62563-1]
109706 Pixel faults evaluationVisual detection of defective pixels on dark (TG18-UN80) and bright (TG18-UN10) images as described in section 7.3.7 of [IEC 62563-1]
109707 Veiling glare evaluationVisual evaluation of veiling glare by looking at low contrast objects on 2 test patterns as described in section 7.3.8 of [IEC 62563-1]
109708 Geometrical image evaluationVisual evaluation of geometry, phase/clock correction and clipping as described in section 7.3.9 of [IEC 62563-1]
109709 Angular viewing evaluationVisual evaluation of viewing angle as described in section 7.3.10 of [IEC 62563-1]
109710 Clinical evaluationVisual evaluation of the appearance of clinical images as described in section 7.3.11 of [IEC 62563-1]
109801 TG18-QC PatternAAPM TG18-QC Pattern used for evaluation of resolution, luminance, distortion, artifacts. See [AAPM OR 03]
109802 TG18-BR PatternAAPM TG18-BR Pattern used for the evaluation of the display of low-contrast, fine-detail image structures See [AAPM OR 03]
109803 TG18-PQC PatternAAPM TG18-PQC Pattern used for evaluation of resolution, luminance, contrast transfer for prints. See [AAPM OR 03]
109804 TG18-CT PatternAAPM TG18-CT Pattern used for evaluation of luminance response. See [AAPM OR 03]
109805 TG18-LN8-01 PatternThe 1st image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109806 TG18-LN8-02 PatternThe 2nd image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109807 TG18-LN8-03 PatternThe 3rd image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109808 TG18-LN8-04 PatternThe 4th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109809 TG18-LN8-05 PatternThe 5th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109810 TG18-LN8-06 PatternThe 6th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109811 TG18-LN8-07 PatternThe 7th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109812 TG18-LN8-08 PatternThe 8th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109813 TG18-LN8-09 PatternThe 9th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109814 TG18-LN8-10 PatternThe 10th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration series. See [AAPM OR 03]
109815 TG18-LN8-11 PatternThe 11th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109816 TG18-LN8-12 PatternThe 12th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109817 TG18-LN8-13 PatternThe 13th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109818 TG18-LN8-14 PatternThe 14th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109819 TG18-LN8-15 PatternThe 15th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109820 TG18-LN8-16 PatternThe 16th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109821 TG18-LN8-17 PatternThe 17th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109822 TG18-LN8-18 PatternThe 18th image in the AAPM TG18-LN8- set used for DICOM grayscale calibration. See [AAPM OR 03]
109823 TG18-LN12-01 PatternThe 1st image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109824 TG18-LN12-02 PatternThe 2 nd image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109825 TG18-LN12-03 PatternThe 3rd image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109826 TG18-LN12-04 PatternThe 4th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109827 TG18-LN12-05 PatternThe 5th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109828 TG18-LN12-06 PatternThe 6th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109829 TG18-LN12-07 PatternThe 7th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109830 TG18-LN12-08 PatternThe 8th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109831 TG18-LN12-09 PatternThe 9th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109832 TG18-LN12-10 PatternThe 10th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109833 TG18-LN12-11 PatternThe 11th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109834 TG18-LN12-12 PatternThe 12th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109835 TG18-LN12-13 PatternThe 13th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109836 TG18-LN12-14 PatternThe 14th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109837 TG18-LN12-15 PatternThe 15th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109838 TG18-LN12-16 PatternThe 16th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109839 TG18-LN12-17 PatternThe 17th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109840 TG18-LN12-18 PatternThe 18th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109841 TG18-UN10 PatternThe AAPM TG18-UN10 Pattern used for evaluation of luminance and color uniformity, and angular response. See [AAPM OR 03]
109842 TG18-UN80 PatternThe AAPM TG18-UN80 Pattern used for evaluation of luminance and color uniformity, and angular response. See [AAPM OR 03]
109843 TG18-UNL10 PatternThe AAPM TG18-UNL10 Pattern is the AAPM TG-18 UN10 Pattern with added defining lines. See [AAPM OR 03]
109844 TG18-UNL80 PatternThe AAPM TG18-UNL80 Pattern is the AAPM TG-18 UN80 Pattern with added defining lines. See [AAPM OR 03]
109845 TG18-AD PatternThe AAPM TG18-AD Pattern used for visual evaluation of the reflection of ambient light from the display. See [AAPM OR 03]
109846 TG18-MP PatternThe AAPM TG18-MP Pattern used for evaluation of Luminance response (bit-depth resolution). See [AAPM OR 03]
109847 TG18-RH10 PatternThe AAPM TG18-RH10 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 10% luminance level. See [AAPM OR 03]
109848 TG18-RH50 PatternThe AAPM TG18-RH50 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 50% luminance level. See [AAPM OR 03]
109849 TG18-RH89 PatternThe AAPM TG18-RH89 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 89% luminance level. See [AAPM OR 03]
109850 TG18-RV10 PatternThe AAPM TG18-RV10 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 10% luminance level. See [AAPM OR 03]
109851 TG18-RV50 PatternThe AAPM TG18-RV50 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 50% luminance level. See [AAPM OR 03]
109852 TG18-RV89 PatternThe AAPM TG18-RV89 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 89% luminance level. See [AAPM OR 03]
109853 TG18-PX PatternThe AAPM TG18-PX Pattern used for the assessment of display resolution. See [AAPM OR 03]
109854 TG18-CX PatternThe AAPM TG18-CX Pattern used to assess display resolution and resolution uniformity. See [AAPM OR 03]
109855 TG18-LPH10 PatternThe AAPM TG18-LPH10 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03]
109856 TG18-LPH50 PatternThe AAPM TG18-LPH50 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 50% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03]
109857 TG18-LPH89 PatternThe AAPM TG18-LPH89 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 89% background level of the maximum pixel value. See [AAPM OR 03]
109858 TG18-LPV10 PatternThe AAPM TG18-LPV10 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03]
109859 TG18-LPV50 PatternThe AAPM TG18-LPV50 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 50% background level of the maximum pixel value. See [AAPM OR 03]
109860 TG18-LPV89 PatternThe AAPM TG18-LPV89 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 89% background level of the maximum pixel value. See [AAPM OR 03]
109861 TG18-AFC PatternThe AAPM TG18-AFC Pattern used to assess display noise. See [AAPM OR 03]
109862 TG18-NS10 PatternThe AAPM TG18-NS10 Pattern is AAPM TG18-RV10/RH10 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03]
109863 TG18-NS50 PatternThe AAPM TG18-NS50 Pattern is AAPM TG18-RV50/RH50 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03]
109864 TG18-NS89 PatternThe AAPM TG18-NS89 Pattern is AAPM TG18-RV89/RH89 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03]
109865 TG18-GV PatternThe TG18-GV Pattern used to assess display veiling. See [AAPM OR 03]
109866 TG18-GVN PatternThe TG18-GVN Pattern used to assess display veiling. This pattern is identical to AAPM TG18-GV Pattern except that the large-diameter white circle is replaced with a black circle, creating a completely black pattern except for the presence of low-contrast targets. See [AAPM OR 03]
109867 TG18-GQ PatternThe TG18-GQ Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GV except that is lacks the central low-contrast objects. See [AAPM OR 03]
109868 TG18-GQN PatternTG18-GQN Pattern used for the quantitative assessment of veiling glare. This pattern is identical to AAPM TG18-GQ Pattern except that the large-diameter white circle is replaced with a black circle, creating a completely black pattern except for the presence of low-contrast targets. See [AAPM OR 03]
109869 TG18-GQB PatternThe TG18-GQB Pattern used for the quantitative assessment of veiling glare. This pattern is identical to AAPM TG18-GQ Pattern except eliminating the central black circle. See [AAPM OR 03]
109870 TG18-GA03 PatternThe TG18-GA03 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 3. See [AAPM OR 03]
109871 TG18-GA05 PatternThe TG18-GA05 Pattern This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 5. See [AAPM OR 03]
109872 TG18-GA08 PatternThe TG18-GA08 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 8. See [AAPM OR 03]
109873 TG18-GA10 PatternThe TG18-GA10 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 10. See [AAPM OR 03]
109874 TG18-GA15 PatternThe TG18-GA15 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 15
109875 TG18-GA20 PatternThe TG18-GA20 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 20. See [AAPM OR 03]
109876 TG18-GA25 PatternThe TG18-GA25 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 25. See [AAPM OR 03]
109877 TG18-GA30 PatternThe TG18-GA30 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 30. See [AAPM OR 03]
109878 TG18-CH ImageThe AAPM TG18-CH Image is a reference anatomical PA chest image. See [AAPM OR 03]
109879 TG18-KN ImageThe AAPM TG18-KN Image is a reference anatomical knee image. See [AAPM OR 03]
109880 TG18-MM1 ImageThe AAPM TG18-MM1 Image is a reference anatomical mammogram image. See [AAPM OR 03]
109881 TG18-MM2 ImageThe AAPM TG18-MM2 Image is a reference anatomical mammogram image. See [AAPM OR 03]
109901 OIQ PatternThe IEC OIQ Pattern is used as an alternative to the TG18-QC Pattern. See [IEC 62563-1]
109902 ANG PatternThe IEC ANG Pattern used for angular viewing evaluation. See [IEC 62563-1]
109903 GD PatternThe IEC GD Pattern used for geometrical image evaluation. See [IEC 62563-1]
109904 BN01 PatternThe IEC BN01 Pattern is used as analternative to the TG18-LN-01 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109905 BN02 PatternThe IEC BN02 Pattern is used as analternative to the TG18-LN-02 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109906 BN03 PatternThe IEC BN03 Pattern is used as analternative to the TG18-LN-03 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109907 BN04 PatternThe IEC BN04 Pattern is used as analternative to the TG18-LN-04 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109908 BN05 PatternThe IEC BN05 Pattern is used as analternative to the TG18-LN-05 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109909 BN06 PatternThe IEC BN06 Pattern is used as analternative to the TG18-LN-06 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109910 BN07 PatternThe IEC BN07 Pattern is used as analternative to the TG18-LN-07 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109911 BN08 PatternThe IEC BN08 Pattern is used as analternative to the TG18-LN-08 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109912 BN09 PatternThe IEC BN09 Pattern is used as analternative to the TG18-LN-09 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109913 BN10 PatternThe IEC BN10 Pattern is used as analternative to the TG18-LN-10 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109914 BN11 PatternThe IEC BN11 Pattern is used as analternative to the TG18-LN-11 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109915 BN12 PatternThe IEC BN12 Pattern is used as analternative to the TG18-LN-12 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109916 BN13 PatternThe IEC BN13 Pattern is used as analternative to the TG18-LN-13 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109917 BN14 PatternThe IEC BN14 Pattern is used as analternative to the TG18-LN-14 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109918 BN15 PatternThe IEC BN15 Pattern is used as analternative to the TG18-LN-15 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109919 BN16 PatternThe IEC BN16 Pattern is used as analternative to the TG18-LN-16 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109920 BN17 PatternThe IEC BN17 Pattern is used as analternative to the TG18-LN-17 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109921 BN18 PatternThe IEC BN18 Pattern is used as analternative to the TG18-LN-18 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109931 DIN Grayscale PatternTest image "Bild 2" for the gray-scale reproduction of imaging devices. See [DIN 6868-57]
109932 DIN Geometry PatternTest image "Bild 3" for the geometrical imaging properties of imaging devices. See [DIN 6868-57]
109933 DIN Resolution PatternTest image "Bild 5" for displaying the spatial and contrast resolution as well as the line structure of imaging devices. See [DIN 6868-57]
109941 White PatternAn alternative to AAPM TG18-UN80, specified at 100% of maximum pixel value
109943 SMPTE PatternA standard display test pattern. See [SMPTE RP133]. A pattern is available at http://www.dclunie.com/images/smpte.512.512.8.gif
109991 CRT DisplayA Display Device that displays images on a Cathode Ray Tube
109992 Liquid Crystal DisplayA Display Device that displays images on a Liquid Crystal Display
109993 Plasma DisplayA Display Device that displays images on a Plasma Display
109994 OLEDA Display Device that displays images on an Organic Light Emitting Diode based display
109995 DLP Rear Projection SystemA Display Device that projects images on a surface from behind using a Digital Light Processing Projector
109996 DLP Front Projection SystemA Display Device that projects images on a surface from in front using a Digital Light Processing Projector
109997 CRT Rear Projection SystemA Display Device that projects images on a surface from behind using a Cathode Ray Tube
109998 CRT Front Projection SystemA Display Device that projects images on a surface from in front using a Cathode Ray Tube
109999 Other Projection SystemA Display Device that projects images on a surface from an unspecified direction using an unspecified means
110001 Image ProcessingImage processing work item
110002 Quality ControlQuality control work item
110003 Computer Aided DiagnosisComputer aided diagnosis work item
110004 Computer Aided DetectionComputer aided detection work item
110005 InterpretationInterpretation work item
110006 TranscriptionTranscription work item
110007 Report VerificationReport verification work item
110008 PrintPrint work item
110009 No subsequent WorkitemsThere will be no more work items scheduled
110010 FilmFilm type of output
110011 DictationDictation type of output
110012 TranscriptionTranscription type of output
110013 Media ImportThe procedure to read DICOM instances from DICOM interchange media, coerce identifying attributes into the local namespace if necessary, and make the instances available
110020 Sheet Film DigitizedDigitization of Sheet Film
110021 Cine Film DigitizedDigitization of Cine Film
110022 Video Tape DigitizedDigitization of Video Tape
110023 Paper DigitizedDigitization of pages of a paper document (Units may be specified as Pages, Documents)
110024 CD ImportedImportation of CD
110025 DVD ImportedImportation of DVD
110026 MOD ImportedImportation of MOD
110027 Studies ImportedImportation of DICOM Studies
110028 Instances ImportedImportation of DICOM Composite Instances
110030 USB Disk EmulationA device that connects using the USB hard drive interface. These may be USB-Sticks, portable hard drives, and other technologies
110031 EmailEmail and email attachments used as a media for data transport
110032 CDCD-R, CD-ROM, and CD-RW media used for data transport
110033 DVDDVD, DVD-RAM, and other DVD formatted media used for data transport
110034 Compact FlashMedia that comply with the Compact Flash standard
110035 Multi-media CardMedia that comply with the Multi-media Card standard
110036 Secure Digital CardMedia that comply with the Secure Digital Card standard
110037 URIURI Identifier for network or other resource, see RFC 3968
110038 Paper DocumentAny paper or similar document
110100 Application ActivityAudit event: Application Activity has taken place
110101 Audit Log UsedAudit event: Audit Log has been used
110102 Begin Transferring DICOM InstancesAudit event: Storage of DICOM Instances has begun
110103 DICOM Instances AccessedAudit event: DICOM Instances have been created, read, updated, or deleted
110104 DICOM Instances TransferredAudit event: Storage of DICOM Instances has been completed
110105 DICOM Study DeletedAudit event: Entire Study has been deleted
110106 ExportAudit event: Data has been exported out of the system
110107 ImportAudit event: Data has been imported into the system
110108 Network EntryAudit event: System has joined or left network
110109 Order RecordAudit event: Order has been created, read, updated or deleted
110110 Patient RecordAudit event: Patient Record has been created, read, updated, or deleted
110111 Procedure RecordAudit event: Procedure Record has been created, read, updated, or deleted
110112 QueryAudit event: Query has been made
110113 Security AlertAudit event: Security Alert has been raised
110114 User AuthenticationAudit event: User Authentication has been attempted
110120 Application StartAudit event: Application Entity has started
110121 Application StopAudit event: Application Entity has stopped
110122 LoginAudit event: User login has been attempted
110123 LogoutAudit event: User logout has been attempted
110124 AttachAudit event: Node has been attached
110125 DetachAudit event: Node has been detached
110126 Node AuthenticationAudit event: Node Authentication has been attempted
110127 Emergency Override StartedAudit event: Emergency Override has started
110128 Network ConfigurationAudit event: Network configuration has been changed
110129 Security ConfigurationAudit event: Security configuration has been changed
110130 Hardware ConfigurationAudit event: Hardware configuration has been changed
110131 Software ConfigurationAudit event: Software configuration has been changed
110132 Use of Restricted FunctionAudit event: A use of a restricted function has been attempted
110133 Audit Recording StoppedAudit event: Audit recording has been stopped
110134 Audit Recording StartedAudit event: Audit recording has been started
110135 Object Security Attributes ChangedAudit event: Security attributes of an object have been changed
110136 Security Roles ChangedAudit event: Security roles have been changed
110137 User security Attributes ChangedAudit event: Security attributes of a user have been changed
110138 Emergency Override StoppedAudit event: Emergency Override has Stopped
110139 Remote Service Operation StartedAudit event: Remote Service Operation has Begun
110140 Remote Service Operation StoppedAudit event: Remote Service Operation has Stopped
110141 Local Service Operation StartedAudit event: Local Service Operation has Begun
110142 Local Service Operation StoppedAudit event: Local Service Operation Stopped
110150 ApplicationAudit participant role ID of software application
110151 Application LauncherAudit participant role ID of software application launcher, i.e., the entity that started or stopped an application
110152 Destination Role IDAudit participant role ID of the receiver of data
110153 Source Role IDAudit participant role ID of the sender of data
110154 Destination MediaAudit participant role ID of media receiving data during an export
110155 Source MediaAudit participant role ID of media providing data during an import
110180 Study Instance UIDParticipantObjectID type: Study Instance UID
110181 SOP Class UIDParticipantObjectID type: SOP Class UID
110182 Node IDID of a node that is a participant object of an audit message
110190 Issuer of IdentifierSystem, organization, agency, or department that has assigned an instance identifier (such as placer or filler number, patient or provider identifier, etc.)
110500 Doctor canceled procedureProcedure order canceled by requesting physician or other authorized physician
110501 Equipment failureEquipment failure prevented completion of procedure
110502 Incorrect procedure orderedProcedure discontinued due to incorrect procedure being ordered
110503 Patient allergic to media/contrastProcedure discontinued due to patient allergy to media/contrast (reported or reaction)
110504 Patient diedProcedure discontinued due to death of Patient
110505 Patient refused to continue procedureProcedure discontinued due to patient refusal to continue procedure
110506 Patient taken for treatment or surgeryProcedure discontinued due to patient being taken for treatment or surgery
110507 Patient did not arrivePatient did not arrive for procedure
110508 Patient pregnantProcedure discontinued due to patient pregnancy (reported or determined)
110509 Change of procedure for correct chargingProcedure discontinued to restart with new procedure code for correct charging
110510 Duplicate orderProcedure discontinued due to duplicate orders received for same procedure
110511 Nursing unit cancelProcedure order canceled by nursing unit
110512 Incorrect side orderedProcedure discontinued due to incorrect side (laterality) being ordered
110513 Discontinued for unspecified reasonProcedure discontinued for unspecified reason
110514 Incorrect worklist entry selectedProcedure discontinued due to incorrect patient or procedure step selected from modality worklist
110515 Patient condition prevented continuingPatient condition prevented continuation of procedure
110516 Equipment changeProcedure step is discontinued to change to other equipment or modality
110518 Patient MovementA movement of the patient affecting test quality
110519 Operator ErrorAn error of the operator affecting test quality
110521 Objects incorrectly formattedOne or more of the objects is malformed
110522 Object Types not supportedReceiving System is unable to accept the object type
110523 Object Set incompleteOne or more objects associated with the object set is missing
110524 Media FailureThe contents of the Media could not be accessed properly
110526 Resource pre-emptedProcedure discontinued due to necessary equipment, staff or other resource becoming (temporarily) unavailable to the procedure
110527 Resource inadequateProcedure discontinued due to necessary equipment, staff or other resource being inadequate to complete the procedure
110528 Discontinued Procedure Step rescheduledA new Procedure Step has been scheduled to replace the Discontinued Procedure Step
110529 Discontinued Procedure Step rescheduling recommendedIt is recommended that a new Procedure Step be scheduled to replace the Discontinued Procedure Step
110700 Ventral DiencephalonVentral structures of the diencephalon that cannot readily be distinguished on MR imaging, including the hypothalamus, mammillary body, subthalamic nuclei, substantia nigra, red nucleus, lateral geniculate nucleus, medial geniculate nucleus, zona incerta, cerebral peduncle, lenticular fasciculus, medial lemniscus, and optic tract. See http://neuromorphometrics.org:8080/Seg/html/segmentation/ventral%20diencephalon.html
110701 White Matter T1 HypointensityArea(s) of reduced intensity on T1 weighted images relative to the surrounding white matter. These may be indicative of age-related or neurodegenerative white matter lesions, and may be co-located with areas of white matter T2 hyperintensity, but the concept is specifically confined to the MR appearance on T1 weighted images
110702 White Matter T2 HyperintensityArea(s) of increased intensity on T2 weighted images relative to the surrounding white matter. These may be indicative of age-related or neurodegenerative white matter lesions, and may be co-located with areas of white matter T1 hypointensity, but the concept is specifically confined to the MR appearance on T2 weighted images
110703 superior longitudinal fasciculus IThe dorsal component of the SLF originating from the medial and dorsal parietal cortex and ending in the dorsal and medial part of the frontal lobe. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186
110704 superior longitudinal fasciculus IIThe major component of the SLF, derived from the caudal-inferior parietal region corresponding to the angular gyrus in the human and terminating within the dorsolateral frontal region. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186
110705 superior longitudinal fasciculus IIIThe ventral component of the SLF, originating from the supramarginal gyrus and terminating predominantly in the ventral premotor and prefrontal areas. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186
110706 Perilesional White MatterWhite matter that surrounds a lesion of interest; e.g. to identify the otherwise unclassified white matter that surrounds a tumor to be surgically resected
110800 Spin Tagging Perfusion MR Signal IntensitySignal intensity of a Spin tagging Perfusion MR image. Spin tagging is a technique for the measurement of blood perfusion, based on magnetically labeled arterial blood water as an endogenous tracer
110801 Contrast Agent Angio MR Signal IntensitySignal intensity of a Contrast Agent Angio MR image
110802 Time Of Flight Angio MR Signal IntensitySignal intensity of a Time-of-flight (TOF) MR image. Time-of-flight (TOF) is based on the phenomenon of flow-related enhancement of spins entering into an imaging slice. As a result of being unsaturated, these spins give more signal that surrounding stationary spins
110803 Proton Density Weighted MR Signal IntensitySignal intensity of a Proton Density Weighted MR image. All MR images have intensity proportional to proton density. Images with very little T1 or T2 weighting are called 'PD-weighted'
110804 T1 Weighted MR Signal IntensitySignal intensity of T1 Weighted MR image. A T1 Weighted MR image is created typically by using short TE and TR times
110805 T2 Weighted MR Signal IntensitySignal intensity of a T2 Weighted MR image. T2 Weighted image contrast state is approached by imaging with a TR long compared to tissue T1 (to reduce T1 contribution to image contrast) and a TE between the longest and shortest tissue T2s of interest
110806 T2* Weighted MR Signal IntensitySignal intensity of a T2* Weighted MR image. The T2* phenomenon results from molecular interactions (spin spin relaxation) and local magnetic field non-uniformities, which cause the protons to precess at slightly different frequencies
110807 Field Map MR Signal IntensitySignal intensity of a Field Map MR image. A Field Map MR image provides a direct measure of the B 0 inhomogeneity at each point in the image
110808 Fractional AnisotropyCoefficient reflecting the fractional anisotropy of the tissues, derived from a diffusion weighted MR image. Fractional anisotropy is proportional to the square root of the variance of the Eigen values divided by the square root of the sum of the squares of the Eigen values
110809 Relative AnisotropyCoefficient reflecting the relative anisotropy of the tissues, derived from a diffusion weighted MR image
110810 Volumetric Diffusion Dxx ComponentDxx Component of the diffusion tensor, quantifying the molecular mobility along the X axis
110811 Volumetric Diffusion Dxy ComponentDxy Component of the diffusion tensor, quantifying the correlation of molecular displacements in the X and Y directions
110812 Volumetric Diffusion Dxz ComponentDxz Component of the diffusion tensor, quantifying the correlation of molecular displacements in the X and Z directions
110813 Volumetric Diffusion Dyy ComponentDyy Component of the diffusion tensor, quantifying the molecular mobility along the Y axis
110814 Volumetric Diffusion Dyz ComponentDyz Component of the diffusion tensor, quantifying the correlation of molecular displacements in the Y and Z directions
110815 Volumetric Diffusion Dzz ComponentDzz Component of the diffusion tensor, quantifying the molecular mobility along the Z axis
110816 T1 Weighted Dynamic Contrast Enhanced MR Signal IntensitySignal intensity of a T1 Weighted Dynamic Contrast Enhanced MR image. A T1 Weighted Dynamic Contrast Enhanced MR image reflects the dynamics of diffusion of the exogenous contrast media from the blood pool into the extra vascular extracellular space (EES) of the brain at a rate determined by the blood flow to the tissue, the permeability of the Brain Blood Barrier (BBB), and the surface area of the perfusing vessels
110817 T2 Weighted Dynamic Contrast Enhanced MR Signal IntensitySignal intensity of a T2 Weighted Dynamic Contrast Enhanced MR image. A T2 Weighted Dynamic Contrast Enhanced MR image reflects the T2 of tissue decrease as the Gd contrast agent bolus passes through the brain
110818 T2* Weighted Dynamic Contrast Enhanced MR Signal IntensitySignal intensity of a T2* Weighted Dynamic Contrast Enhanced MR image. A T2* Weighted Dynamic Contrast Enhanced MR image reflects the T2* of tissue decrease as the Gd contrast agent bolus passes through the brain
110819 Blood Oxygenation LevelSignal intensity of a Blood Oxygenation Level image. BOLD imaging is sensitive to blood oxygenation (but also to cerebral blood flow and volume). This modality is essentially used for detecting brain activation (functional MR)
110820 Nuclear Medicine Projection ActivityAccumulated decay event counts in a nuclear medicine projection image
110821 Nuclear Medicine Tomographic ActivityAccumulated decay event counts in a Nuclear Medicine Tomographic image (including PET)
110822 Spatial Displacement X ComponentSpatial Displacement along axis X of a non-linear deformable spatial registration image. The X axis is defined in reference to the patient's orientation, and is increasing to the left hand side of the patient
110823 Spatial Displacement Y ComponentSpatial Displacement along axis Y of a non-linear deformable spatial registration image. The Y axis is defined in reference to the patient's orientation, and is increasing to the posterior side of the patient
110824 Spatial Displacement Z ComponentSpatial Displacement along axis Z of a non-linear deformable spatial registration image. The Z axis is defined in reference to the patient's orientation, and is increasing toward the head of the patient
110825 Hemodynamic ResistanceMeasured resistance to the flow of blood; e.g. through the vasculature or through a heart value
110826 Indexed Hemodynamic ResistanceMeasured resistance to the flow of blood; e.g. through the vasculature or through a heart value, normalized to a particular indexed scale
110827 Tissue VelocityVelocity of tissue based on Doppler measurements
110828 Flow VelocityVelocity of blood flow based on Doppler measurements
110829 Flow VarianceStatistical variance of blood velocity relative to mean
110830 ElasticityScalar value related to the elastic properties of the tissue
110831 PerfusionScalar value related to the volume of blood perfusing into tissue
110832 Speed of soundSpeed of sound in tissue
110833 Ultrasound AttenuationReduction in strength of ultrasound signal as the wave
110834 RGB R ComponentRed component of a true color image (RGB)
110835 RGB G ComponentGreen component of a true color image (RGB)
110836 RGB B ComponentBlue component of a true color image (RGB)
110837 YBR FULL Y ComponentY (Luminance) component of a YBR FULL image, as defined in JPEG 2000
110838 YBR FULL CB ComponentCB (Blue chrominance) component of a YBR FULL image, as defined in JPEG 2000
110839 YBR FULL CR ComponentCR (Red chrominance) component of a YBR FULL image, as defined in JPEG 2000
110840 YBR PARTIAL Y ComponentY (Luminance) component of a YBR PARTIAL image, as defined in JPEG 2000
110841 YBR PARTIAL CB ComponentCB (Blue chrominance) component of a YBR PARTIAL image, as defined in JPEG 2000
110842 YBR PARTIAL CR ComponentCR (Red chrominance) component of a YBR PARTIAL image, as defined in JPEG 2000
110843 YBR ICT Y ComponentY (Luminance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000
110844 YBR ICT CB ComponentCB (Blue chrominance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000
110845 YBR ICT CR ComponentCR (Red chrominance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000
110846 YBR RCT Y ComponentY (Luminance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000
110847 YBR RCT CB ComponentCB (Blue chrominance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000
110848 YBR RCT CR ComponentCR (Red chrominance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000
110849 EchogenicityThe ability of a material to create an ultrasound return echo
110850 X-Ray AttenuationDecrease in the number of photons in an X-Ray beam due to interactions with the atoms of a material substance. Attenuation is due primarily to two processes, absorption and scattering
110851 X-Ray Attenuation CoefficientCoefficient that describes the fraction of a beam of X-Rays or gamma rays that is absorbed or scattered per unit thickness of the absorber. This value basically accounts for the number of atoms in a cubic cm volume of material and the probability of a photon being scattered or absorbed from the nucleus or an electron of one of these atomsDeprecated
110852 MR signal intensitySignal intensity of an MR image, not otherwise specified
110853 Binary SegmentationBinary value denoting that the segmented property is present
110854 Fractional Probabilistic SegmentationProbability, defined as a percentage, that the segmented property occupies the spatial area defined by the voxel
110855 Fractional Occupancy SegmentationPercentage of the voxel area occupied by the segmented property
110856 Linear DisplacementSpatial dimension, denoting a linear displacement
110857 Photon EnergyDimension denoting the energy (frequency or wavelength) of photons
110858 TimeDimension used to sequence events, to compare the duration of events and the intervals between events
110859 AngleSpatial dimension, denoting an angle
110860 Left-Right AxisA spatial dimension axis running along a line between the patient's left and right side
110861 Head-Foot AxisA spatial dimension axis running along a line between the patient's head and foot
110862 Anterior-Posterior AxisA spatial dimension axis running along a line between the patient's anterior and posterior sides
110863 Apex-Base AxisA spatial dimension axis running along a line between the apex and base of an organ, object, or chamber
110864 Anterior-Inferior AxisA spatial dimension axis running along a line between the anterior and inferior sides of an organ, object, or chamber
110865 Septum-Wall AxisA spatial dimension axis running along a line between the septum and wall of a chamber
110866 Right To LeftOrientation of a spatial dimension where increasing values run from the right to the left side of the patient
110867 Left To RightOrientation of a spatial dimension where increasing values run from the left to the right side of the patient
110868 Head To FootOrientation of a spatial dimension where increasing values run from the head to the foot of the patient
110869 Foot To HeadOrientation of a spatial dimension where increasing values run from the foot to the head of the patient
110870 Anterior To PosteriorOrientation of a spatial dimension where increasing values run from the anterior to the posterior side of the patient
110871 Posterior To AnteriorOrientation of a spatial dimension where increasing values run from the posterior to the anterior side of the patient
110872 Apex To BaseOrientation of a spatial dimension where increasing values run from the apex to the base
110873 Base To ApexOrientation of a spatial dimension where increasing values run from the base to the apex
110874 Anterior To InferiorOrientation of a spatial dimension where increasing values run from the anterior to the inferior
110875 Inferior To AnteriorOrientation of a spatial dimension where increasing values run from the inferior to the anterior
110876 Septum To WallOrientation of a spatial dimension where increasing values run from the septum of a chamber to the opposite wall
110877 Wall To SeptumOrientation of a spatial dimension where increasing values run from the opposite wall to the septum of a chamber
110901 Image Position (Patient) XThe x coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system
110902 Image Position (Patient) YThe y coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system
110903 Image Position (Patient) ZThe z coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system
110904 Image Orientation (Patient) Row XThe x value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system
110905 Image Orientation (Patient) Row YThe y value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system
110906 Image Orientation (Patient) Row ZThe z value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system
110907 Image Orientation (Patient) Column XThe x value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system
110908 Image Orientation (Patient) Column YThe y value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system
110909 Image Orientation (Patient) Column ZThe z value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system
110910 Pixel Data RowsNumber of rows in the pixel data of the image
110911 Pixel Data ColumnsNumber of columns in the pixel data of the image
111001 Algorithm NameThe name assigned by a manufacturer to a specific software algorithm
111002 Algorithm ParametersThe input parameters used by a manufacturer to configure the behavior of a specific software algorithm
111003 Algorithm VersionThe software version identifier assigned by a manufacturer to a specific software algorithm
111004 Analysis PerformedThe type of correlation applied to detection results; e.g. temporal, spatial
111005 Assessment CategoryAssignment of intermediate or overall interpretation results to a general category
111006 Breast compositionAssessment of annotating tissues in breast; generally including fatty, mixed or denseDeprecated
111007 Breast Outline including Pectoral Muscle TissuePurpose of reference for an SCOORD content item that is an outline of the breast that includes the pectoral muscle tissue
111008 Calcification DistributionThe type of distribution associated with detected calcifications
111009 Calcification TypeIdentification of the morphology of detected calcifications
111010 CenterPurpose of reference for an SCOORD content item that identifies the central point of a finding or feature
111011 Certainty of FeatureThe likelihood that the feature analyzed is in fact the type of feature identified
111012 Certainty of FindingThe likelihood that the finding detected is in fact the type of finding identified
111013 Certainty of ImpressionThe certainty that a device places on an impression, where 0 equals no certainty and 100 equals certainty
111014 Clockface or regionA location identifier based on clock-face numbering or anatomic sub-region
111015 Composite FeatureAn item that is an inferred correlation relating two or more individual findings or features
111016 Composite typeThe inferred relationship between the findings or features making up a composite feature
111017 CAD Processing and Findings SummaryGeneral assessment of whether or not CAD processing was successful, and whether any findings resulted
111018 Content DateThe date the data creation started
111019 Content TimeThe time the data creation started
111020 DepthA location identifier based on a feature's inferred distance from the surface of the associated anatomy
111021 Description of ChangeA textual description of the change that occurred over time in a qualitative characteristic of a feature
111022 Detection PerformedThe type of finding sought after by a specific algorithm applied to one image
111023 Differential Diagnosis/ImpressionA general change that occurred within an imaged area between a prior imaging procedure and the current imaging procedure
111024 Failed AnalysesA group of analysis algorithms that were attempted, but failed
111025 Failed DetectionsA group of detection algorithms that were attempted, but failed
111026 Horizontal Pixel SpacingFor projection radiography, the horizontal physical distance measured at the front plane of an Image Receptor housing between the center of each pixel. For tomographic images, the horizontal physical distance in the patient between the center of each pixel
111027 Image LateralityLaterality of (possibly paired) body part contained in an image
111028 Image LibraryA container that references all image data used as evidence to produce a report
111029 Image Quality RatingA numeric value in the range 0 to 100, inclusive, where 0 is worst quality and 100 is best quality
111030 Image RegionPurpose of reference for an SCOORD content item that identifies a specific region of interest within an image
111031 Image ViewThe projection of the anatomic region of interest on an image receptor
111032 Image View ModifierModifier for Image View
111033 Impression DescriptionFree-form text describing the overall or an individual impression
111034 Individual Impression/RecommendationA container for a group of related results from interpretation of one or more images and associated clinical information
111035 Lesion DensityThe X-Ray attenuation of a lesion relative to the expected attenuation of an equal volume of fibroglandular breast tissue
111036 Mammography CAD ReportA structured report containing the results of computer-aided detection or diagnosis applied to breast imaging and associated clinical information
111037 MarginsThe characteristic of the boundary, edges or border of a detected lesion
111038 Number of calcificationsThe quantity of calcifications detected within an identified group or cluster
111039 Object typeA non-lesion object identified within one or more images
111040 Original SourcePurpose of reference for a COMPOSITE content item that identifies it as the original source of evidence for another content item in the report
111041 OutlinePurpose of reference for an SCOORD content item that identifies the outline or bounding region of a finding or feature
111042 PathologyThe inferred type of disease associated with an identified feature
111043 Patient Orientation ColumnThe patient orientation relative to the image plane, specified by a value that designates the anatomical direction of the positive column axis (top to bottom)
111044 Patient Orientation RowThe patient orientation relative to the image plane, specified by a value that designates the anatomical direction of the positive row axis (left to right)
111045 Pectoral Muscle OutlinePurpose of reference for an SCOORD content item that is an outline of the pectoral muscle tissue only
111046 Percent Fibroglandular TissuePercent of breast area that is mammographically dense, excluding pectoralis muscle
111047 Probability of cancerThe likelihood that an identified finding or feature is cancerous
111048 Quadrant locationA location identifier based on the division of an area into four regions
111049 Qualitative DifferenceA qualitative characteristic of a feature that has changed over time
111050 Quality AssessmentThe effect of the quality of an image on its usability
111051 Quality Control StandardThe quality control standard used to make a quality assessment
111052 Quality FindingA specific quality related deficiency detected within an image
111053 Recommended Follow-upRecommended type of follow-up to an imaging procedure, based on interpreted results
111054 Recommended Follow-up DateRecommended follow-up date to an imaging procedure, based on interpreted results
111055 Recommended Follow-up IntervalRecommended follow-up interval to an imaging procedure, based on interpreted results
111056 Rendering IntentThe recommendation of the producer of a content item regarding presentation of the content item by recipients of the report
111057 Scope of FeatureAn indication of how widespread the detection of a feature is within the analyzed image data set
111058 Selected Region DescriptionA textual description of the contents of a selected region identified within an image
111059 Single Image FindingAn item that was detected on one image
111060 Study DateDate on which the acquisition of the study information was started
111061 Study TimeTime at which the acquisition of the study information was started
111062 Successful AnalysesA group of analysis algorithms that were attempted and completed successfully
111063 Successful DetectionsA group of detection algorithms that were attempted and completed successfully
111064 Summary of DetectionsAn overall indication of whether the CAD detection algorithms applied were completed successfully
111065 Summary of AnalysesAn overall indication of whether the CAD analysis algorithms applied were completed successfully
111066 Vertical Pixel SpacingFor projection radiography, the vertical physical distance measured at the front plane of an Image Receptor housing between the center of each pixel. For tomographic images, the vertical physical distance in the patient between the center of each pixel
111069 CrosstableA radiographic projection that has been with the patient lying on a table with the X-Ray source on one side of the table and the detector on the other; e.g. may describe a cross-table cervical spine, chest or pelvis X-Ray image
111071 CAD Operating PointOne of a number of discrete points on the Receiver-Operator Characteristics (ROC) curve that reflects the expected sensitivity and specificity of a CAD algorithm, where zero indicates the highest specificity, lowest sensitivity operating point. The value should not exceed the Maximum CAD Operating Point
111072 Maximum CAD Operating PointThe maximum value of CAD Operating Point for the specific CAD algorithm used
111081 CAD Operating Point DescriptionThe intended interpretation of a CAD Operating Point
111086 False Markers per ImageThe number of false CAD markers per image. Correlates to inverse of Image Specificity
111087 False Markers per CaseThe number of false markers per collection of images that are CAD processed as a group. Correlates to inverse of Case Specificity
111088 Case SensitivityThe percentage of cancers that should be detected by a CAD algorithm where CAD marks the cancers in at least one view
111089 Lesion SensitivityThe percentage of cancers that should be detected by a CAD algorithm where CAD marks the cancers in each view
111090 Case SpecificityThe percentage of cases (collections of images CAD processed as a group) without cancer that have no CAD findings whatsoever. Correlates to inverse of False Markers per Case
111091 Image SpecificityThe percentage of images without cancer that have no CAD findings whatsoever. Correlates to inverse of False Markers per Image
111092 Recommended CAD Operating PointThe CAD operating point that is recommended for initial display by the creator of the structured report
111093 CAD Operating Point TableA list of CAD operating points including their corresponding characteristics
111099 Selected regionA specific area of interest noted within an image
111100 Breast geometryThe surface shape of all or a portion of breast related anatomy
111101 Image QualityImage quality incorporates the following clinical image evaluation parameters: assessment of positioning, compression, artifacts, exposure, contrast, sharpness, and labeling
111102 Non-lesionA finding or feature that is identified as a non-anatomic foreign object
111103 DensityA space-occupying lesion identified in a single image or projectionDeprecated
111104 Individual CalcificationA single identified calcificationDeprecated
111105 Calcification ClusterMultiple calcifications identified as occupying a small area of tissue (less than 2 cc)Deprecated
111111 Cooper's ligament changesStraightening or thickening of Cooper's ligaments
111112 Mass in the skinAn abnormality noted at imaging within the dermis of the breast
111113 Mass on the skinAn abnormality noted at imaging on the epidermis of the breast
111120 Post Procedure Mammograms for Marker PlacementAn assessment category to indicate that images have been acquired to assess marker placement following a breast interventional procedure
111121 Follow-up post biopsy as directed by clinicianAn indication that the patient should seek post procedural follow-up directives from a clinical health care provider
111122 Known biopsy proven malignancy - take appropriate actionA recommendation on a patient with known cancer to take steps appropriate to the diagnosis
111123 Marker placementPositioning of a radiopaque marker
111124 Personal history of breast cancer with mastectomyPatient has previous diagnosis of breast cancer resulting in mastectomy
111125 Known biopsy proven malignancyPatient has had biopsy containing proven malignancy
111126 Image detected massPatient has a finding of mass reported on a prior imaging exam
111127 TargetedA breast imaging procedure performed on a specific area of the breast
111128 SurveyA breast imaging procedure performed on the entire breast
111129 Clustered microcystsA cluster of tiny anechoic foci each smaller than 2-3 mm in diameter with thin (less than 0.5 mm) intervening septations and no discrete solid components
111130 Complicated cystA fluid filled mass most commonly characterized by homogeneous low-level internal echoes on ultrasound
111135 Additional projectionsViews not inclusive of MLO and CC (BI-RADS®)
111136 Spot magnification view(s)A spot or coned down compression of the breast providing a reduction in the thickness and a magnification of the localized area of interest and improved separation of breast tissue
111137 UltrasoundUse of sound waves to visualize muscles, tendons, and many internal organs, to capture their size, structure and any pathological lesions with real time tomographic images.Deprecated
111138 Old films for comparisonObtain previous mammography studies to compare to present study
111139 DuctographyA medical procedure used for the sampling of mammary duct tissueDeprecated
111140 Normal interval follow-upFollow up study at 12 months for women 40 years of age having a prior negative study and no mitigating risk factors for breast cancer
111141 Any decision to biopsy should be based on clinical assessmentAny decision to perform tissue acquisition should be based on clinical assessment
111142 Follow-up at short interval (1-11 months)Follow-up at short interval (1-11 months)
111143 Biopsy should be consideredTissue acquisition should be considered
111144 Needle localization and biopsyBreast tissue acquisition following the identification of an area of concern with the placement of a needle or needle-wire assembly
111145 Histology using core biopsyPathologic analysis of breast tissue and lesions using core tissue samples
111146 Suggestive of malignancy - take appropriate actionLesions that do not have the characteristic morphologies of breast cancer but have a definite probability of being malignant. There is a sufficient concern to urge a biopsy
111147 Cytologic analysisCellular analysis of specimen
111148 Biopsy should be strongly consideredTissue acquisition should be strongly considered
111149 Highly suggestive of malignancy - take appropriate actionLesions have a high probability of being cancer, which require additional action
111150 Presentation Required: Rendering device is expected to presentThe producer of a report intends for a recipient of the report to present or display the associated content item
111151 Presentation Optional: Rendering device may presentThe producer of a report considers the presentation or display of the associated content item by a recipient to be optional
111152 Not for Presentation: Rendering device expected not to presentThe producer of a report intends for a recipient of the report NOT to present or display the associated content item
111153 Target content items are related temporallyThe associated content items are identified as being the same finding or feature at different points in time
111154 Target content items are related spatiallyThe associated content items are identified as being the same finding or feature on different projections taken at the same point in time
111155 Target content items are related contra-laterallyThe associated content items are identified as being related side-to-side
111156 Feature detected on the only imageThere is one image in the interpreted data set
111157 Feature detected on only one of the imagesThere is more than one image of the same modality in the interpreted data set
111158 Feature detected on multiple imagesThere is more than one image of the same modality in the interpreted data set
111159 Feature detected on images from multiple modalitiesThe interpreted data set contains images from multiple modalities
111168 Scar tissueThe fibrous tissue replacing normal tissues destroyed by disease or injuryDeprecated
111170 J WireA medical appliance used for localization of non palpable breast lesions to insure that the proper area is removed in a surgical biopsyDeprecated
111171 PacemakerA medical appliance used for regulating cardiac rhythmsDeprecated
111172 PaddleA compression device used for obtaining mammographic imagesDeprecated
111173 CollimatorA device used for restricting an X-Ray beamDeprecated
111174 ID PlateAn area designated on a radiographic film for facility and patient ID informationDeprecated
111175 Other MarkerSite specific markers
111176 UnspecifiedThe value of the concept is not specified
111177 View and Laterality Marker is missingImage quality deficiency according to MQSA
111178 View and Laterality Marker does not have both view and lateralityImage quality deficiency according to MQCM
111179 View and Laterality Marker does not have approved codesImage quality deficiency according to MQCM
111180 View and Laterality Marker is not near the axillaImage quality deficiency according to MQCM
111181 View and Laterality Marker overlaps breast tissueImage quality deficiency according to MQCM
111182 View and Laterality Marker is partially obscuredImage quality deficiency according to MQCM
111183 View and Laterality Marker is incorrectImage quality deficiency
111184 View and Laterality Marker is off imageImage quality deficiency
111185 Flash is not near edge of filmImage quality deficiency according to MQCM
111186 Flash is illigible, does not fit, or is lopsidedImage quality deficiency according to MQSA
111187 Flash doesn't include patient name and additional patient idImage quality deficiency according to MQCM
111188 Flash doesn't include date of examinationImage quality deficiency according to MQCM
111189 Flash doesn't include facility name and locationImage quality deficiency according to MQSA
111190 Flash doesn't include technologist identificationImage quality deficiency according to MQCM
111191 Flash doesn't include cassette/screen/detector identificationImage quality deficiency according to MQCM
111192 Flash doesn't include mammography unit identificationImage quality deficiency according to MQCM
111193 Date sticker is missingImage quality deficiency according to MQCM
111194 Technical factors missingImage quality deficiency according to MQCM
111195 Collimation too close to breastImage quality deficiency according to MQCM
111196 Inadequate compressionImage quality deficiency according to MQCM
111197 MLO Insufficient pectoral muscleImage quality deficiency according to MQCM
111198 MLO No fat is visualized posterior to fibroglandular tissuesImage quality deficiency according to MQCM
111199 MLO Poor separation of deep and superficial breast tissuesImage quality deficiency according to MQCM
111200 MLO Evidence of motion blurImage quality deficiency according to MQCM
111201 MLO Inframammary fold is not openImage quality deficiency according to MQCM
111202 CC Not all medial tissue visualizedImage quality deficiency according to MQCM
111203 CC Nipple not centered on imageImage quality deficiency according to MQCM
111204 CC Posterior nipple line does not measure within 1 cm of MLOImage quality deficiency according to MQCM
111205 Nipple not in profileImage quality deficiency
111206 Insufficient implant displacement incorrectImage quality deficiency according to MQCM
111207 Image artifact(s)Signals that do not faithfully reproduce actual anatomic structures because of distortion or of addition or deletion of information
111208 Grid artifact(s)Feature(s) arising from the acquisition unit's anti-scatter grid mechanism. For two-dimensional systems, such features include those of mechanically damaged or incorrectly positioned grids. For moving or Bucky grids, artifacts may result from intentional grid motion that is inadequate in duration or velocity uniformity
111209 PositioningInadequate arrangement of the anatomy of interest with respect to the X-Ray field and image detector sensitive area. Examples: 1) positioning is "cutoff" when the projection of anatomy of interest falls outside the sensitive area of the detector; 2) "cone cut", in which the X-Ray field does not adequately cover the anatomy of interest; 3) detector's sensitive surface is too small to cover the projection of the anatomy of interest; 4) improper angular orientation or "rotation" of anatomy of interest with respect to the X-Ray source, or detector; 5) projection of other anatomy or clothing over the anatomy of interest in the image
111210 Motion blurUnacceptable image blur resulting from motion of the anatomy of interest during exposure or the inadequately compensated motion of X-Ray source with respect to the image detector during exposure
111211 Under exposedInadequate number of quanta reached the detector during exposure. Reasons for under exposed images include low kVp, low mAs product, excess Source Image Distance. Under exposed images have inadequate signal and higher noise in the areas of interest
111212 Over exposedAn excess number of quanta reached the detector during exposure. Reasons for over exposed images include high kVp, high mAs product, short Source Image Distance. Over exposed images have high signal and lower noise in the areas of interest. Over exposed area may demonstrate lack of contrast from over saturation of the detector
111213 No imageNo evidence of a patient exposure
111214 Detector artifact(s)Superposed features or flaws of the detector
111215 Artifact(s) other than grid or detector artifactFeatures or discontinuities arising from causes other than the anti-scatter grid and image detector
111216 Mechanical failureFailure of the device to operate according to mechanical design specifications
111217 Electrical failureFailure of a device to operate according to electrical design specifications
111218 Software failureAttributable to software used in generation or handling of image
111219 Inappropriate image processingImages processed inappropriately, not following appropriate protocol
111220 Other failureFailure that is not mechanical or electrical or otherwise described
111221 Unknown failureUnidentified or unknown cause of failure
111222 SucceededThe attempted process was completely successful
111223 Partially SucceededThe attempted process succeeded in some ways, but failed in others
111224 FailedThe attempted process completely failed
111225 Not AttemptedNo process was performed
111233 Individual Impression / Recommendation AnalysisAnalysis of a related group of findings or features detected during image data inspection, to produce a summary impression and/or recommendation
111234 Overall Impression / Recommendation AnalysisAnalysis of all groups of findings or features, to produce a single impression and/or recommendation
111235 Unusable - Quality renders image unusableThe usability of an image for diagnostic interpretation or CAD, based on a quality control standard
111236 Usable - Does not meet the quality control standardThe usability of an image for diagnostic interpretation or CAD, based on a quality control standard
111237 Usable - Meets the quality control standardThe usability of an image for diagnostic interpretation or CAD, based on a quality control standard
111238 Mammography Quality Control Manual 1999, ACRAn image quality control standard specified by the American College of Radiology
111239 Title 21 CFR Section 900, Subpart BAn image quality control standard in the US Code of Federal Regulations
111240 Institutionally defined quality control standardAn image quality control standard specified or adopted by the institution responsible for the document
111241 All algorithms succeeded; without findingsNo findings resulted upon successful completion of all attempted computer-aided detection and/or analysis
111242 All algorithms succeeded; with findingsOne or more findings resulted upon successful completion of all attempted computer-aided detection and/or analysis
111243 Not all algorithms succeeded; without findingsNo findings resulted from the attempted computer-aided detection and/or analysis, but one or more failures occurred in the process
111244 Not all algorithms succeeded; with findingsOne or more findings resulted from the attempted computer-aided detection and/or analysis, but one or more failures occurred in the process
111245 No algorithms succeeded; without findingsAll of the attempted computer-aided detection and/or analysis failed, so there could be no findings
111248 AdenolipomaA benign tumor having glandular characteristics but composed of fat, with the presence of normal mammary ductsDeprecated
111249 Ductal hyperplasiaHyperplasia is also known as epithelial hyperplasia or proliferative breast disease. It's an overgrowth of the cells that line the ducts or the lobules. Based on how the cells look under a microscope, the hyperplasia is called either ductal hyperplasia (also called duct epithelial hyperplasia) or lobular hyperplasia. Based on the pattern of the cells, hyperplasia may be called usual or atypical. In usual hyperplasia, the pattern of cells is very close to normal. Atypical hyperplasia (or hyperplasia with atypia) is a term used when the cells are more distorted. FROM: http://www.cancer.org/healthy/findcancerearly/womenshealth/non-cancerousbreastconditions/non-cancerous-breast-conditions-hyperplasiaDeprecated
111250 AdenomyoepitheliomaNeoplasms composed of myoepithelial cellsDeprecated
111251 Normal axillary nodeAxillary node that is normal in appearance with no associated pathology
111252 Axillary node with calcificationsAxillary node containing calcifications
111253 Axillary node hyperplasiaExcessive proliferation of normal tissue arrangement of the axillary node
111254 Asynchronous involutionDeprecated
111255 Benign cyst with bloodCyst with benign morphology containing blood
111256 Benign CalcificationsCalcifications having typically benign morphology. They are not of intermediate or high probability of concern for malignancy
111257 Intracystic papillomaGrowing within a cystic adenoma, filling the cavity with a mass of branching epithelial processesDeprecated
111258 Ductal adenomaAdenoma located in mammary duct, present as discrete sclerotic nodules, solitary or multiple
111259 Diabetic fibrous mastopathyThe occurrence of fibrous tumor-forming stromal proliferation in patients with diabetes mellitus
111260 Extra abdominal desmoidA deep seated firm tumor frequently occurring on the chest consisting of collagenous tissue that infiltrates surround muscle; frequently recurs but does not metastasizeDeprecated
111262 Epidermal inclusion cystA cyst formed of a mass of epithelial cells, as a result of trauma has been pushed beneath the epidermis. The cyst is lined with squamous epithelium and contains concentric layers or keratinDeprecated
111263 Fibroadenomatoid hyperplasiaExcessive proliferation of fibroadenoma tissue
111264 FibroadenolipomaA lipoma with an abundant stroma of fibrous tissue
111265 Foreign body (reaction)Deprecated
111269 GalactoceleRetention cyst caused by occlusion of a lactiferous ductDeprecated
111271 Hemangioma - nonparenchymal, subcutaneousA congenital anomaly that leads to a proliferation of blood vessels leading to a mass that resembles a neoplasm, not located in parenchymal areas but subcutaneousDeprecated
111273 Hyperplasia, usualHyperplasia is also known as epithelial hyperplasia or proliferative breast disease. It's an overgrowth of the cells that line the ducts or the lobules. Based on how the cells look under a microscope, the hyperplasia is called either ductal hyperplasia (also called duct epithelial hyperplasia) or lobular hyperplasia. FROM: http://www.cancer.org/healthy/findcancerearly/womenshealth/non-cancerousbreastconditions/non-cancerous-breast-conditions-hyperplasiaDeprecated
111277 Juvenile papillomatosisA form of fibrocystic disease in young woman with florid and sclerosing adenosis that microscopically may suggest carcinoma
111278 Lactating adenomaEnlarging masses during lactation. A circumscribed benign tumor composed primarily of glandular structures with scanty stroma, with prominent secretory changes in the ductDeprecated
111279 Lactational changeChanges related to the process of lactation
111281 Large duct papillomaA papilloma pertaining to large mammary duct
111283 MyofibroblastomaSolitary or multiple tumors of muscles and fibrous tissues, or tumors composed of myofibroblastsDeprecated
111284 Microglandular adenosisIrregular clusters of small tubules are present in adipose or fibrous tissue, resembling tubular carcinoma but lacking stromal fibroblastic proliferation
111285 Multiple Intraductal PapillomasPapilloma typically involving an aggregate of adjacent ducts in the periphery of the breast, likely representing involvement of several foci of one or two duct systems
111286 No abnormalityNo abnormality
111287 Normal breast tissueNormal breast tissue
111288 NeurofibromatosisCondition in which there are tumors of various sizes on peripheral nerves. They may be neuromas or fibromasDeprecated
111290 Oil cyst (fat necrosis cyst)A cyst resulting from the loss of the epithelial lining of a sebaceous dermoid or lacteal cyst
111291 Post reduction mammoplastyBreast tissue with characteristics of a benign nature, following breast reduction surgery
111292 Pseudoangiomatous stromal hyperplasiaA benign stromal lesion composed of intermixed stromal and epithelial elements. The lobular and duct structures of the breast parenchyma are separated by an increased amount of stroma, non specific proliferative epithelial changes include hyperplasia of duct and lobular epithelium often with accentuation of myoepithelial cells and aprocine metaplasia with or without cyst formation
111293 Radial scarAn nonencapsulated stellate lesion consisting of a fibroelastic core and radiating bands of fibrous connective tissue containing lobules manifesting adenosis and ducts with papillary or diffuse intraductal hyperplasiaDeprecated
111294 Sclerosing adenosisProminent interductal fibrosis of the terminal ductulesDeprecated
111296 Silicone granulomaNodular inflammatory lesions due to the presence of silicone in the breast tissue
111297 Nipple CharacteristicThe morphologic status of the nipple
111298 Virginal hyperplasiaSpontaneous excessive proliferation of breast tissue, usually found in younger women
111299 Peripheral duct papillomasPapilloma(s) pertaining the peripheral ducts
111300 Axillary node with lymphomaAxillary node with lymphoid tissue neoplasm
111301 Axillary nodal metastasesMetastatic disease to the axillary node
111302 AngiosarcomaA malignant neoplasm occurring most often in breast and skin, believed to originate from endothelial cells of blood vessels, microscopically composed of closely packed round or spindle shaped cells, some of which line small spaces resembling vascular cleftsDeprecated
111303 Blood vessel (vascular) invasionHistological changes to the vascular system related to an invasive process
111304 Carcinoma in childrenCarcinoma of the breast found in patients less than 20 years of age
111305 Carcinoma in ectopic breastA carcinoma found in supernumerary breasts and aberrant breast tissue
111306 Carcinoma with endocrine differentiationA carcinoma that synthesizes substances, including hormones, not considered to be normal products of the breast
111307 Basal cell carcinoma of nippleA basal cell carcinoma that arises in the nipple of the breast
111308 Carcinoma with metaplasiaMetaplastic carcinoma is cancer that begins in cells that have changed into another cell type (for example, a squamous cell of the esophagus changing to resemble a cell of the stomach). In some cases, metaplastic changes alone may mean there is an increased chance of cancer developing at the site. Metaplastic carcinoma is a relatively uncommon type of cancer with treatment generally similar to that of invasive ductal carcinoma of no special type.[1] FROM: https://en.wikipedia.org/wiki/Metaplastic_carcinomaDeprecated
111309 Cartilaginous and osseous changeTissue changes to bones and cartilage
111310 Carcinoma in pregnancy and lactationCarcinoma of the breast presenting during pregnancy or lactation
111311 CarcinosarcomaA malignant neoplasm that contains elements of carcinoma and sarcoma, so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissueDeprecated
111312 Intraductal comedocarcinoma with necrosisComedocarcinoma of a duct with areas of necrotic tissue
111313 Intraductal carcinoma, low gradeA non-invasive carcinoma restricted to the glandular lumen characterized by less aggressive malignant cytologic features and behavior
111314 Intraductal carcinoma micro-papillaryPapillary and micropapillary Ductal Carcinoma In Situ (DCIS): the cancer cells arrange themselves in a fern-like pattern within the affected breast ducts; micropapillary DCIS cells are smaller than papillary DCIS cells. FROM: http://www.imaginis.com/breast-cancer-diagnosis/ductal-carcinoma-in-situ-dcis-3Deprecated
111315 Intracystic papillary carcinomaA malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells found in a cyst
111316 Invasive and in-situ carcinomaCarcinoma with both characteristics of localized and spreading disease
111317 Invasive lobular carcinomaInvasive lobular carcinoma is a type of breast cancer that begins in the milk-producing glands (lobules) of the breast. Invasive cancer means the cancer cells have broken out of the lobule where they began and have the potential to spread to the lymph nodes and other areas of the body. Invasive lobular carcinoma typically doesn't form a lump, which is common in breast cancer. Instead, there is a change in the breast that feels like a thickening or fullness in one part of the breast and is different from the surrounding breast tissue. FROM: http://www.mayoclinic.org/diseases-conditions/invasive-lobular-carcinoma/basics/definition/con-20033968Deprecated
111318 Leukemic infiltrationMammary infiltrates as a secondary manifestation in patients with established leukemia
111320 Lympathic vessel invasionHistological changes to the lymphatic system related to an invasive process
111321 LymphomaA heterogeneous group of neoplasms arising in the reticuloendoethelial and lymphatic systemsDeprecated
111322 Occult carcinoma presenting with axillary lymph node metastasesA small carcinoma, either asymptomatic or giving rise to metastases without symptoms due to the primary carcinoma presenting with metastatic disease in the axillary lymph nodes
111323 Metastatic cancer to the breastA malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a non-mammary malignant neoplasm
111324 Metastatic cancer to the breast from the colonA malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the colon
111325 Metastatic cancer to the breast from the lungA malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the lung
111326 Metastatic melanoma to the breastA malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a melanoma
111327 Metastatic cancer to the breast from the ovaryA malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the ovary
111328 Metastatic sarcoma to the breastA malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a sarcoma
111329 Multifocal intraductal carcinomaMultiple foci of non-invasive carcinoma restricted to the glandular lumen
111330 Metastatic disease to axillary nodeA malignant lesion in an axillary node arising from a non-axillary neoplasm
111331 Malignant fibrous histiocytomaPleomorphic undifferentiated sarcoma (abbreviated PUS), also undifferentiated pleomorphic sarcoma and previously malignant fibrous histiocytoma (abbreviated MFH), is a type of soft tissue sarcoma. FROM: https://en.wikipedia.org/wiki/Pleomorphic_undifferentiated_sarcomaDeprecated
111332 Multifocal invasive ductal carcinomaMultiple sites of ductal carcinoma
111333 Metastasis to an intramammary lymph nodeA malignant lesion in a intramammary lymph node arising from a non-intramammary lymph node neoplasm
111334 Malignant melanoma of nippleA malignant melanoma of the skin that arises in the nipple of the breast
111335 Neoplasm of the mammary skinDeprecated
111336 Papillary carcinoma in-situPapillary and micropapillary Ductal Carcinoma In Situ (DCIS): the cancer cells arrange themselves in a fern-like pattern within the affected breast ducts; micropapillary DCIS cells are smaller than papillary DCIS cells. FROM: http://www.imaginis.com/breast-cancer-diagnosis/ductal-carcinoma-in-situ-dcis-3Deprecated
111338 Recurrent malignancyRecurrent malignancy
111340 Squamous cell carcinoma of the nippleSquamous cell carcinoma to the terminal portion of the alveolar
111341 Intraductal carcinoma, high gradeA non-invasive carcinoma restricted to the glandular lumen characterized by more aggressive malignant cytologic features and behavior
111342 Invasive cribriform carcinomaInvasive tumor with cribriform pattern similar to cribriform DCIS. Low grade, cribriform appearance (well defined spaces formed by arches of cells) similar to cribriform DCIS but with larger cells, more cytoplasm and more vesicular nuclei: Tumor cells are small, often have apical snouts, mild/moderate nuclear pleomorphism; Also stromal invasion by islands of cells, often angulated; May have predominantly solid appearance; Associated with cribriform DCIS; Often mixed with tubular carcinoma. FROM: http://www.pathologyoutlines.com/topic/breastmalignantcribriform.htmlDeprecated
111343 Angular marginsAn indication that some or all of the margin of a lesion has sharp corners, often forming acute angles
111344 Fine pleomorphic calcificationCalcifications that vary in sizes and shapes and are usually smaller than0.5 mm in diameter
111345 MacrocalcificationsCoarse calcifications that are 0.5 mm or greater in size
111346 Calcifications within a massAn indicator that calcifications are imbedded within a mass
111347 Calcifications outside of a massAn indicator that calcifications are imaged outside of a mass finding
111350 Breast background echotextureTissue composition of the breast noted on sonography
111351 Homogeneous fat echotextureFat lobules and uniformly echogenic bands of supporting structures comprise the bulk of breast tissue
111352 Homogeneous fibroglandular echotextureA uniformly echogenic layer of fibroglandular tissue is seen beneath a thin layer of subcutaneous fat
111353 Heterogeneous echotextureThe breast texture is characterized by multiple small areas of increased and decreased echogenicity
111354 OrientationReferential relationship of the finding to the imaging device as noted on sonography
111355 ParallelThe long axis of a lesion parallels the skin line ("wider-than-tall" or in a horizontal orientation)
111356 Not parallelThe anterior-posterior or vertical dimension is greater than the transverse or horizontal dimension
111357 Lesion boundaryThe lesion boundary describes the transition zone between themas and the surrounding tissue
111358 Abrupt interfaceThe sharp demarcation between the lesion and surrounding tissue can be imperceptible or a distinct well-defined echogenic rim of any thickness
111359 Echogenic haloThere is no sharp demarcation between the mass and the surrounding tissue, which is bridged by an echogenic transition zone
111360 Echo patternAn imaging characteristic of resonance noted during sonography
111361 AnechoicWithout internal echoes
111362 HyperechoicHaving increased echogenicity relative to fat or equal to fibroglandular tissue
111363 ComplexMass contains both anechoic and echogenic components
111364 HypoechoicDefined relative to fat; masses are characterized by low-level echoes throughout; e.g. appearance of a complicated cyst or fibroadenoma
111365 IsoechoicHaving the same echogenicity as fat (a complicated cyst or fibroadenoma may be isoechoic or hypoechoic)
111366 Posterior acoustic featuresThe attenuation characteristics of a mass with respect to its acoustic transmission
111367 No posterior acoustic featuresNo posterior shadowing or enhancement
111368 Posterior enhancementIncreased posterior echoes
111369 Posterior shadowingDecreased posterior echoes; edge shadows are excluded
111370 Combined posterior enhancement and shadowingMore than one pattern of posterior attenuation, both shadowing and enhancement
111371 Identifiable effect on surrounding tissuesSonographic appearance of adjacent structures relative to a mass finding
111372 VascularityCharacterization of vascularization in region of interest
111373 Vascularity not presentVascularity not evident, such as on ultrasound
111374 Vascularity not assessedVascularity not evaluated
111375 Vascularity present in lesionVascularity on imaging is seen within a lesion
111376 Vascularity present immediately adjacent to lesionVascularity on imaging is seen immediately adjacent to a lesion
111377 Diffusely increased vascularity in surrounding tissueVascularity on imaging is considered diffusely elevated within the surrounding breast tissue
111380 Correlation to other FindingsRelationship of the new anomaly to other clinical or imaging anomalies
111381 Correlates to physical exam findingsAn indication that the current imaging finding relates to a finding from a clinical breast exam
111382 Correlates to mammography findingsAn indication that the current imaging finding relates to a finding from a mammography exam
111383 Correlates to MRI findingsAn indication that the current imaging finding relates to a finding from a breast MRI exam
111384 Correlates to ultrasound findingsAn indication that the current imaging finding relates to a finding from a breast ultrasound exam
111385 Correlates to other imaging findingsAn indication that the current imaging finding relates to a finding from an imaging exam
111386 No correlation to other imaging findingsAn indication that the current imaging finding has no relation to findings from any other imaging exam
111387 No correlation to clinical findingsAn indication that the current imaging finding has no relation to any other clinical findings
111388 Malignancy TypeClassification of the cancer as invasive, DCIS, or other
111389 Invasive breast carcinomaA malignancy that has spread beyond an area of focus
111390 Other malignancy typeA breast cancer with malignant pathology findings that are not classified as invasive or in situ
111391 Menstrual Cycle PhaseA specific timeframe during menses
111392 1st weekIn the first week of the menstrual cycle phase, that is, one week following menses
111393 2nd weekIn the second week of the menstrual cycle phase, that is, two weeks following menses
111394 3rd weekIn the third week of the menstrual cycle phase, that is, three weeks following menses
111395 Estimated TimeframeAn estimated period of time
111396 < 3 months agoAn event occurred less than 3 months ago
111397 4 months to 1 year agoAn event occurred between 4 months and 1 year ago
111398 > 1 year agoAn event occurred longer than 1 year ago
111399 Timeframe uncertainThe timing of an event is not recalled
111400 Breast Imaging ReportReport title for the diagnostic report for one or more breast imaging or intervention procedures
111401 Reason for procedureConcept name for the description of why a procedure has been performed
111402 Clinical FindingA finding during clinical examination (i.e., history and physical examination) such as pain, palpable mass or discharge
111403 Baseline screening mammogramFirst screening mammogram taken for patient that is used as a comparison baseline for further examinations
111404 First mammogram everFirst mammogram taken for a patient without regard to whether it was for screening or a diagnostic procedure
111405 Implant typeConcept name for the material of which a breast prosthetic device is constructed
111406 Number of similar findingsA numeric count of findings classified as similar in nature
111407 Implant findingConcept name for the status of a breast prosthetic device as noted by imaging
111408 Film Screen MammographyMammogram using traditional X-Ray film
111409 Digital MammographyMammogram using a digital image acquisition system
111410 Surgical consultReferred for evaluation by a surgeon
111411 Mammography CADComputer aided detection and/or computer aided diagnosis for mammography
111412 Narrative SummaryConcept name for a text-based section of a report
111413 Overall AssessmentA title for a report section that summarizes all interpretation results for a report with one overriding assessment; e.g. benign or negative
111414 Supplementary DataConcept name for a collection of supporting evidence for a report
111415 Additional evaluation requested from prior studyPrior study indicates that additional imaging be performed to further evaluate a suspicious or questionable anatomic region
111416 Follow-up at short interval from prior studyThe prior study recommended a follow-up breast imaging exam in 1 to 11 months (generally in 6 months)
111417 History of breast augmentation, asymptomaticPrior breast augmentation (breast enlargement) and is not presenting with any symptoms
111418 Review of an outside studyReview or second opinion made on an image performed outside of the facility
111419 Additional evaluation requested from abnormal screening examAdditional breast imaging performed at the time of the patient's screening mammogram
111420 History of benign breast biopsyPatient has had previous benign breast biopsies
111421 Personal history of breast cancer with breast conservation therapyPatient has had a prior surgery such as a lumpectomy or quadrantectomy to remove malignant breast tissue, but breast tissue remains
111423 Physical Examination ResultsThe results of a physical examination performed on the patient, possibly including the results of inspection, palpation, auscultation, or percussion
111424 Comparison to previous findingsThe result of assessing the current imaging exam in comparison to previous imaging exams
111425 Intraluminal filling defectAn abnormality observed during ductography where the ductal system within the breast fills in an abnormal pattern. Ductography is an imaging exam in which a radio opaque contrast media is introduced into the ductal system of the breast through the nipple and images of the ductal system are obtained
111426 Multiple filling defectDuring ductography an observation of more than one filling abnormality within the breast ductal system
111427 Abrupt duct terminationAn abnormality observed during ductography where the ductal system within the breast terminates in an unusual fashion
111428 ExtravasationAbnormal flowage of contrast media within the breast noted on ductography
111429 Duct narrowingAn abnormality observed during ductography where the ductal system within the breast appears narrow
111430 Cyst fillDuring ductography an observation of the contrast media filling a cyst within the breast
111431 Instrument ApproachThe area and line within the anatomy through which a needle or instrument passes during an interventional procedure
111432 Inferolateral to superomedialThe line within the anatomy from the lower outer to the upper inner aspect; e.g. through which a needle or instrument passes in an interventional procedure
111433 Inferomedial to superolateralThe line within the anatomy from the lower inner to the upper outer aspect; e.g. through which a needle or instrument passes in an interventional procedure
111434 Superolateral to inferomedialThe line within the anatomy from the upper outer to the lower inner aspect; e.g. through which a needle or instrument passes in an interventional procedure
111435 Superomedial to inferolateralThe line within the anatomy from the upper inner to the lower outer aspect; e.g. through which a needle or instrument passes in an interventional procedure
111436 Number of passesThe number of times a biopsy instrument is passed through an area of interest
111437 Number of specimensThe number of biopsy specimens obtained from an interventional procedure
111438 Needle in targetAn indicator of whether or not a biopsy or localizing needle in an interventional procedure is seen to be in the area of interest
111439 Number of needles around targetThe number of localizing needles placed around the area of interest in an interventional procedure
111440 Incision madeAn indicator of whether or not an incision was made in the anatomy during an interventional procedure
111441 Microclip placedAn indicator of whether or not a radio opaque microclip was placed in the anatomy during an interventional procedureDeprecated
111442 Confirmation of targetAn indicator of the degree of success of an interventional procedure
111443 Target completely contained in the specimenAn indicator that during an interventional procedure the area of interest was fully excised and is noted in the resultant biopsy specimen
111444 Target partially obtained in the specimenAn indicator that during an interventional procedure the area of interest was partially excised and is noted in the resultant biopsy specimen
111445 Target not in the specimenAn indicator that following an interventional procedure the area of interest is not seen in the resultant biopsy specimen
111446 Calcifications seen in the coreAn indicator that following an interventional procedure the targeted calcifications are noted in the resultant biopsy specimen
111447 Lesion completely removedAn indicator that during an interventional procedure the area of interest was fully excised and is noted in the resultant biopsy specimen
111448 Lesion partially removedAn indicator that during an interventional procedure the area of interest was partially excised and is noted in the resultant biopsy specimen
111449 Fluid obtainedAn indicator that during an interventional procedure fluid was successfully aspirated
111450 Light brown colorColor that is a light shade of brown
111451 Dark red colorColor that is a dark shade of red
111452 Dark brown colorColor that is a dark shade of brown
111453 Bright red colorColor that is a bright shade of red
111454 Blood tinged colorColor that is tinged with the color of blood
111455 Occult blood test resultAn indicator of whether or not the fluid obtained during an interventional procedure contains red blood cells
111456 Action on fluidAn indicator of whether or not fluid during an interventional procedure was sent for cytological analysis or simply discarded
111457 Sent for analysisAn indicator that fluid obtained during an interventional procedure was sent to a laboratory for analysis
111458 DiscardedAn indicator that fluid obtained during an interventional procedure was discarded
111459 Mass with calcificationsA radiopaque density noted during diagnostic imaging that has associated calcific densities
111460 Complex cystA fluid-filled sac with greater than normal characteristics
111461 Intracystic lesionA tumor within a cyst
111462 Solid massA tumor or lesion
111463 Supplementary Data for InterventionSupporting evidence for interpretation results of an interventional procedure
111464 Procedure ModifierA descriptor that further qualifies or characterizes a type of procedure
111465 Needle GaugeNeedle size (diameter) characterization; e.g. of a biopsy needle
111466 Severity of ComplicationAn indicator of the gravity of a problem experienced by a patient, related to a procedure that was performed
111467 Needle LengthDistance from the hub or bushing to the tip of the needle
111468 Pathology ResultsThe collection of observations and findings from pathologic analysis
111469 Sampling DateTimeThe date and time that the sample was collected from the patient
111470 UninvolvedIndicates that the margin of the biopsy specimen was not involved with the tumor
111471 InvolvedIndicates that the margin of the biopsy specimen was involved with the tumor
111472 Nipple involvedIndicates whether the nipple was involved in an interventional procedure or pathologic analysis
111473 Number of nodes removedIndicates the number of lymph nodes removed
111474 Number of nodes positiveIndicates the number of lymph nodes removed that contain cancer cells
111475 Estrogen receptorThe result of a test for the presence of a protein that binds with estrogen
111476 Progesterone receptorThe result of a test for the presence of a protein that binds with progesterone
111477 S PhaseIndicates the percentage of cells in S phase. Cell division is defined by phases; the S phase is the stage during which DNA replicates
111478 Non-bloody discharge (from nipple)The visible emission of non-bloody fluid from the nipple
111479 Difficult physical/clinical examinationThe inability to discern normal versus abnormal breast tissue during palpation
111480 Cancer elsewhereAn indication that a patient has or had a malignant occurrence in an area of the body other than the breast
111481 Saline implantA salt water filled prosthetic device implanted in the breast
111482 Polyurethane implantA polymer based (plastic) prosthetic device implanted in the breast
111483 Percutaneous silicone injectionThe introduction of polymeric organic silicon based material through the skin, as for breast augmentation or reconstruction
111484 Combination implantA prosthetic device that contains more than one material implanted in the breast
111485 Pre-pectoral implantA breast implant placed in front of the pectoralis major muscle
111486 Retro-pectoral implantA breast implant placed behind the pectoralis major muscle
111487 Mammographic (crosshair)Using X-Ray technique and a superimposed set of crossed lines for detection or placement
111488 Mammographic (grid)Using X-Ray technique and a superimposed aperture for detection or placement
111489 Palpation guidedUsing physical touch for detection or placement
111490 Vacuum assistedThe performance of a biopsy procedure using a vacuum device attached to the biopsy needle
111491 Abnormal dischargeUnusual or unexpected emission of fluid
111492 No complicationsHaving experienced no adverse medical conditions related to or resulting from an interventional procedure
111494 Stage 0TNM grouping of tumor stage, from AJCC, where primary tumor is Tis, regional lymph node is N0, and distant metastasis is M0
111495 Stage ITNM grouping of tumor stage, from AJCC, where primary tumor is T1, regional lymph node is N0, and distant metastasis is M0
111496 Stage IIATNM grouping of tumor stage, from AJCC, where primary tumor is T0 or T1, with regional lymph node N1 and distant metastasis is M0, or T2 with N0 and M0
111497 Stage IIBTNM grouping of tumor stage, from AJCC, where primary tumor is T2, with regional lymph node N1 and distant metastasis is M0, or T3 with N0 and M0
111498 Stage IIIATNM grouping of tumor stage, from AJCC, where primary tumor is T0, T1 or T2, with regional lymph node N2 and distant metastasis is M0, or T3 with N1 or N2 and M0
111499 Stage IIIBTNM grouping of tumor stage, from AJCC, where primary tumor is T4, regional lymph node is N0, N1 or N2, and distant metastasis is M0
111500 Stage IIICTNM grouping of tumor stage, from AJCC, where primary tumor is any T value, regional lymph node is N3, and distant metastasis is M0
111501 Stage IVTNM grouping of tumor stage, from AJCC, where primary tumor is any T value, regional lymph node is any N value, and distant metastasis is M1
111502 Bloom-Richardson GradeHistologic tumor grade (sometimes called Scarff-Bloom-Richardson grade) is based on the arrangement of the cells in relation to each other -- whether they form tubules, how closely they resemble normal breast cells (nuclear grade) and how many of the cancer cells are in the process of dividing (mitotic count)
111503 Normal implantsBreast prosthetic devices are intact, not leaking, and are in a normal shape and form
111504 Asymmetric implantsBreast prosthetic devices are not symmetric, equal, corresponding in form, or are in one breast (unilateral)
111505 Calcified implantFibrous or calcific contracture of the tissue capsule that forms around a breast prosthetic device
111506 Distorted implantBreast prosthetic device is twisted out of normal shape or form
111507 Silicone-laden lymph nodesSilicone from breast prosthetic device found in lymphatic tissue
111508 Free siliconeSilicone found in breast tissue outside of the prosthetic capsule or implant membrane
111509 Herniated implantProtrusion of part of the structure normally encapsulating the content of the breast prosthetic device
111510 ExplantationEvidence of removal of a breast prosthetic device
111511 Relevant Patient Information for Breast ImagingHistorical patient health information of interest to the breast health clinician
111512 Medication HistoryInformation regarding usage by the patient of certain medications, such as hormonesDeprecated
111513 Relevant Previous ProceduresInterventional or non-interventional procedures previously performed on the patient, such as breast biopsies
111514 Relevant Indicated ProblemsAbnormal conditions experienced by the patient that serve as the reason for performing a procedure, such as a breast examDeprecated
111515 Relevant Risk FactorsPersonal, familial, and other health factors that may indicate an increase in the patient's chances of developing a health condition or disease, such as breast cancer
111516 Medication TypeA classification of a medicinal substance, such as hormonal contraceptive or antibiotic
111517 Relevant Patient InformationHistorical patient health information for general purpose use
111518 Age when first menstrual period occurredThe age of the patient at the first occurrence of menses
111519 Age at First Full Term PregnancyThe age of the patient at the time of her first full term pregnancy
111520 Age at MenopauseThe age of the patient at the cessation of menses
111521 Age when hysterectomy performedThe age of the patient at the time her uterus was removed
111522 Age when left ovary removedThe age of the patient at the time she had her left ovary removed
111523 Age when right ovary removedThe age of the patient at the time she had her right ovary removed
111524 Age StartedThe age of a patient on the first occurrence of an event, such as the first use of a medication
111525 Age EndedThe age of a patient on the last occurrence of an event, such as the last use of a medication
111526 DateTime StartedThe date and time of the first occurrence of an event, such as the first use of a medication
111527 DateTime EndedThe date and time of the last occurrence of an event, such as the last use of a medication
111528 OngoingAn indicator of whether an event is still in progress, such as the use of a medication or substance, or environmental exposure
111529 Brand NameProduct name of a device or substance, such as medication, to identify it as the product of a single firm or manufacturer
111530 Risk Factor modifierA descriptor that further qualifies or characterizes a risk factor
111531 Previous ProcedureA prior non-interventional exam or interventional procedure performed on a patient
111532 Pregnancy StatusDescribes the pregnancy state of a referenced subject
111533 Indicated ProblemA symptom experienced by a patient that is used as the reason for performing an exam or procedure
111534 Role of person reportingThe function of the individual who is reporting information on a patient, which could be a specific health care related profession, the patient him/herself, or a relative or friend
111535 DateTime problem observedThe date and time that a symptom was noted
111536 DateTime of last evaluationThe date and time of the most recent evaluation of an indicated problem
111537 Family Member with Risk FactorA patient's biological relative who exhibits a health factor that may indicate an increase in the patient's chances of developing a particular disease or medical problem
111538 Age at OccurrenceThe age at which an individual experienced a specific event, such as breast cancer
111539 Menopausal phaseThe current stage of an individual in her gynecological development
111540 Side of FamilyAn indicator of paternal or maternal relationship
111541 MaternalRelating to biological female parentage
111542 Unspecified gynecological hormoneA gynecological hormone for which the specific type is not specified; e.g. contraceptive, estrogen, Tamoxifen
111543 Breast feeding historyAn indicator of whether or not a patient ever provided breast milk to her offspring
111544 Average breast feeding periodThe average length of time that a patient provided breast milk to her offspring
111545 Substance Use HistoryInformation regarding usage by the patient of certain legal or illicit substances
111546 Used Substance TypeA classification of a substance, such as alcohol or a legal or illicit drug
111547 Environmental Exposure HistoryInformation regarding exposure of the patient to potentially harmful environmental factors
111548 Environmental FactorA classification of a potentially harmful substance or gas in a subject's environment, such as asbestos, lead, or carcinogens
111549 Previous ReportsPrevious Structured Reports that could have relevant information for a current imaging service request
111550 Personal breast cancer historyAn indication that a patient has had a previous malignancy of the breast
111551 History of endometrial cancerIndicates a previous occurrence of cancer of the lining of the uterus
111552 History of ovarian cancerIndicates a previous occurrence of cancer of the lining of the ovary
111553 History of high risk lesion on previous biopsyIndicates a prior diagnosis of pre-cancerous cells or tissue removed for pathologic evaluation
111554 Post menopausal patientA female patient whose menstrual periods have ceased
111555 Late child bearing (after 30)A female patient whose first child was born after the patient was 30 years old
111556 BRCA1 breast cancer geneThe first level genetic marker indicating risk for breast cancer
111557 BRCA2 breast cancer geneThe second level genetic marker indicating risk for breast cancer
111558 BRCA3 breast cancer geneThe third level genetic marker indicating risk for breast cancer
111559 Weak family history of breast cancerA patient's biological aunt, grandmother, or female cousin was diagnosed with breast cancer. Definition from BI-RADS®
111560 Intermediate family history of breast cancerA patient's biological mother or sister was diagnosed with breast cancer after they had gone through menopause. Definition from BI-RADS®
111561 Very strong family history of breast cancerA patient's biological mother or sister was diagnosed with breast cancer before they had gone through menopause, or more than one of the patient's first-degree relatives (biological mother or sister) were diagnosed with breast cancer after they had gone through menopause. Definition from BI-RADS®
111562 Family history of prostate cancerPrevious diagnosis of a malignancy of the prostate gland in a biological relative
111563 Family history unknownThe health record of a patient's biological relatives is not known
111564 Nipple discharge cytologyThe study of cells obtained from fluid emitted from the breast
111565 Uterine malformationsA developmental abnormality resulting in an abnormal shape of the uterus
111566 Spontaneous AbortionA naturally occurring premature expulsion from the uterus of the products of conception - the embryo or a nonviable fetus
111567 Gynecologic conditionAn ailment/abnormality or state of the female reproductive tract
111568 Gynecologic surgeryA surgical operation performed on any portion of the female reproductive tract
111569 Previous LBW or IUGR birthPrior pregnancy with a low birth weight baby or a fetus with Intrauterine Growth Restriction or Retardation
111570 Previous fetal malformation/syndromeHistory of at least one prior pregnancy with fetal anatomic abnormality(s)
111571 Previous RH negative or blood dyscrasia at birthHistory of delivering a Rhesis Isoimmunization affected child(ren) or a child(ren) with another blood disorder
111572 History of multiple fetusesHistory of at least one pregnancy that contained more than one fetus; e.g. twins, triplets, etc.
111573 Current pregnancy, known or suspected malformations/syndromesAt least one fetus of this pregnancy has an anatomic abnormality(s) that is known to exist, or a "marker" is present that suggests the abnormality(s) may be present
111574 Family history, fetal malformation/syndromeBiological relatives have previously conceived a fetus with an anatomic abnormality(s)
111575 HighA subjective descriptor for an elevated amount of exposure, use, or dosage, incurring high risk of adverse effects
111576 MediumA subjective descriptor for a moderate amount of exposure, use, or dosage, incurring medium risk of adverse effects
111577 LowA subjective descriptor for a limited amount of exposure, use, or dosage, incurring low risk of adverse effects
111578 Dose frequencyA measurement of the rate of occurrence of which a patient takes a certain medication
111579 Rate of exposureThe quantity per unit of time that a patient was or is being exposed to an environmental irritant
111580 Volume of useThe quantity per unit of time that a medication or substance was or is being used
111581 Relative dose amountA qualitative descriptor for the amount of a medication that was or is being taken
111582 Relative amount of exposureA qualitative descriptor for the amount of present or past exposure to an environmental irritant
111583 Relative amount of useA qualitative descriptor for the amount of a medication or substance that was or is being used
111584 Relative dose frequencyA qualitative descriptor for the frequency with which a medication was or is being taken
111585 Relative frequency of exposureA qualitative descriptor for the frequency of present or past exposure to an environmental irritant
111586 Relative frequency of useA qualitative descriptor for the frequency with which a medication or substance was or is being used
111587 No known exposurePatient is not known to have been exposed to or used the substance or medication
111590 Recall for technical reasonsPatient returns for additional images to improve the quality of the most recent exam
111591 Recall for imaging findingsPatient returns for additional images to clarify findings from the most recent exam
111592 Recall for patient symptoms/ clinical findingsPatient returns for additional images to clarify symptoms or signs reported by the patient or a healthcare professional at the time of the most recent exam
111593 LBW or IUGRNumber of births with low birth weight or intrauterine growth restriction
111601 Green filterFilter that transmits green light while blocking the other colors, typically centered at 510-540 nmDeprecated
111602 Red filterFilter that transmits red light while blocking the other colors, typically centered at 630-680 nmDeprecated
111603 Blue filterFilter that transmits blue while blocking the other colors, typically centered at 460-480 nmDeprecated
111604 Yellow-green filterA filter of 560nm that is used for retinal imaging and can provide good contrast and good visibility of the retinal vasculatureDeprecated
111605 Blue-green filterA filter of 490nm that is used for retinal imaging because of excessive scattering of some retinal structures at very short wavelengthsDeprecated
111606 Infrared filterFilter that transmits the infrared spectrum, which is light that lies outside of the visible spectrum, with wavelengths longer than those of red light, while blocking visible lightDeprecated
111607 Polarizing filterA filter that reduces reflections from non-metallic surfaces such as glass or water by blocking light waves that are vibrating at selected angles to the filterDeprecated
111609 No filterNo filter used
111621 Field 1 for Joslin 3 fieldJoslin NM-1 is a 45 degree field focused centrally between the temporal margin of optic disc and the center of the macula: Center the camera on the papillomacular bundle midway between the temporal margin of the optic disc and the center of the macula. The horizontal centerline of the image should pass directly through the center of the disc
111622 Field 2 for Joslin 3 fieldJoslin NM-2 is a 45 degree field focused superior temporal to the optic disc: Center the camera laterally approximately one-half disc diameter temporal to the center of the macula. The lower edge of the field is tangent to a horizontal line passing through the upper edge of the optic disc. The image is taken temporal to the macula but includes more retinal nasal and superior to the macula than standard field 2
111623 Field 3 for Joslin 3 fieldJoslin NM-3 is a 45 degree field focused nasal to the optic disc: This field is nasal to the optic disc and may include part of the optic disc. The horizontal centerline of the image should pass tangent to the lower edge of the optic disc
111625 Diffuse direct illuminationA broad or "soft" light supplied from a single source
111626 Scheimpflug CameraA slit reflected light microscope, which has the ability to form an image of the back scattered light from the eye in a sagittal plane. Scheimpflug cameras are able to achieve a wide depth of focus by employing the "Sheimpflug principle" where the lens and image planes are not parallel with each other. Rotating Sheimplug cameras are able to generate three-dimensional images and calculate measurements of the anterior chamber of the eye
111627 Scotopic lightLighting condition approximately 0.04 lux
111628 Mesopic lightLighting condition approximately 4 lux
111629 Photopic lightLighting condition approximately 40 lux
111630 Dynamic lightAcquisition preceded by intense light
111631 Average Glandular DoseCalculated from values of entrance exposure in air, the X-Ray beam quality (half-value layer), and compressed breast thickness, is the energy deposited per unit mass of glandular tissue averaged over all the glandular tissue in the breast
111632 Anode Target MaterialThe primary material in the anode of an X-Ray source
111633 Compression ThicknessThe average thickness of the body part examined when compressed, if compression has been applied during X-Ray exposure
111634 Half Value LayerThickness of Aluminum required to reduce the X-Ray output at the patient entrance surface by a factor of two
111635 X-Ray GridAn anti-scatter device based on radiation absorbing strips above the detector; e.g. in the patient support
111636 Entrance Exposure at RPExposure measurement in air at the reference point that does not include back scatter, according to MQCM 1999
111637 Accumulated Average Glandular DoseAverage Glandular Dose to a single breast accumulated over multiple images
111638 Patient Equivalent ThicknessValue of the control variable used to parametrize the Automatic Exposure Control (AEC) closed loop; e.g. "Water Value"
111641 Fixed gridAn X-Ray Grid that does not move during exposure
111642 Focused gridAn X-Ray Grid with radiation absorbing strips that are focused toward the focal spot, to eliminate grid cutoff
111643 Reciprocating gridAn X-Ray Grid that is designed to move during exposure, to eliminate the appearance of grid lines on the image
111644 Parallel gridAn X-Ray Grid with radiation absorbing strips that are parallel to each other and that is used only with long source to image distances
111645 Crossed gridAn X-Ray Grid with crossed radiation absorbing strips used for more complete cleanup of scatter radiation
111646 No gridNo X-Ray Grid was used due to low scatter conditions
111671 Spectacle Prescription ReportThe spectacle prescription for a patient
111672 Add NearRefractive measurements of the eye to correct for inability to focus at near while wearing the distance prescription
111673 Add IntermediateRefractive measurements of the eye to correct for inability to focus at intermediate distance while wearing the distance prescription
111674 Add OtherRefractive measurements of the eye to correct for inability to focus at the specified distance while wearing the distance prescription
111675 Horizontal Prism PowerThe power of a prism to bend light in the horizontal direction, in prism diopters
111676 Horizontal Prism BaseDirection of the base of a horizontal prism -- either in (toward the nose), or out (away from the nose)
111677 Vertical Prism PowerThe power of a prism to bend light in the vertical direction, in prism diopters
111678 Vertical Prism BaseDirection of the base of a vertical prism -- either up, or down
111679 Distance Pupillary DistanceDistance in mm between the pupils when the patient's object of regard is in the distance
111680 Near Pupillary DistanceDistance in mm between the pupils when the patient's object of regard is at near
111685 Autorefraction Visual AcuityA patient's vision with the correction measured by an autorefractor in place
111686 Habitual Visual AcuityA patient's vision with whichever vision correction the patient customarily wears
111687 Prescription Visual AcuityA patient's vision with the final spectacle prescription in place
111688 Right Eye RxThe spectacle prescription for the right eye
111689 Left Eye RxThe spectacle prescription for the left eye
111690 Macular Grid Thickness and Volume ReportA macular grid thickness and volume report for a patient. The macular grid is an analytic tool described in PS3.1
111691 Number of Images Used for Macular MeasurementsNumber of images used for the macular grid measurement
111692 Number of Samples Used per ImageNumber of samples used per Image for analysis
111693 Analysis Quality RatingA numeric rating of the quality of the entire analysis with respect to grading and diagnostic purposes. Higher numbers indicate greater quality
111694 Image Set Quality RatingA numeric rating of the quality of an entire image set with respect to grading and diagnostic purposes. Higher numbers indicate greater quality
111695 Interfering Tears or DropsTear film or drops affecting test quality
111696 Visual Fixation Quality During AcquisitionThe assessment of the centricity and persistence of the visual fixation (direction of gaze) during the acquisition
111697 Visual Fixation Quality ProblemThe reason why the patient's visual fixation was not steady or was indeterminate
111698 Ophthalmic Macular Grid ProblemThe reason why the macular grid measurements may be questionable
111700 Specimen Container IdentifierIdentifier of container (box, block, microscope slide, etc.) for the specimen under observation
111701 Processing typeType of processing that tissue specimen underwent
111702 DateTime of processingDate and time of processing step
111703 Processing step descriptionDescription of the individual step in the tissue processing sequence
111704 Sampling MethodMethod of sampling used to derive specimen from its parent
111705 Parent Specimen IdentifierIdentifier of the parent specimen that gave rise to the current specimen
111706 Issuer of Parent Specimen IdentifierAssigning authority for parent specimen's identifier
111707 Parent specimen typeParent specimen type that gave rise to current specimen
111708 Position Frame of ReferenceDescription of coordinate system and origin reference point on parent specimen, or parent specimen container, or image used for localizing the sampling site or location within container or image
111709 Location of sampling siteReference to image of parent specimen localizing the sampling site; may include referenced Presentation State object
111710 Location of sampling site X offsetLocation of sampling site of specimen (nominal center) relative to the Position Frame of Reference in the X dimension
111711 Location of sampling site Y offsetLocation of sampling site of specimen (nominal center) relative to the Position Frame of Reference in the Y dimension
111712 Location of sampling site Z offsetLocation of sampling site of specimen (nominal center) relative to the Position Frame of Reference in the Z dimension
111718 Location of SpecimenDescription of specimen location, either in absolute terms or relative to the Position Frame of Reference
111719 Location of Specimen X offsetLocation of specimen (nominal center) relative to the Position Frame of Reference in the X dimension
111720 Location of Specimen Y offsetLocation of specimen (nominal center) relative to the Position Frame of Reference in the Y dimension
111721 Location of Specimen Z offsetLocation of specimen (nominal center) relative to the Position Frame of Reference in the Z dimension
111723 Visual Marking of SpecimenDescription of visual distinguishing identifiers; e.g. ink, or a particular shape of the specimen
111724 Issuer of Specimen IdentifierAssigning authority for specimen identifier
111726 Dissection with entire specimen submissionDissection of specimen with submission of all its sections for further processing or examination
111727 Dissection with representative sections submissionDissection of specimen with submission of representative sections for further processing or examination
111729 Specimen storageA workflow step, during which tissue specimens are stored in a climate-controlled environment
111741 Transmission illuminationTransmission illumination method for specimen microscopy
111742 Reflection illuminationReflection illumination method for specimen microscopy
111743 Epifluorescence illuminationEpifluorescence illumination method for specimen microscopy
111744 Brightfield illuminationBrightfield illumination method for specimen microscopy
111745 Darkfield illuminationDarkfield illumination method for specimen microscopy
111746 Oblique illuminationOblique illumination method for specimen microscopy
111747 Phase contrast illuminationPhase contrast illumination method for specimen microscopy
111748 Differential interference contrastDifferential interference contrast method for specimen microscopy
111749 Total internal reflection fluorescenceTotal internal reflection fluorescence method for specimen microscopy
111750 Ultrasound ContactA method of obtaining ophthalmic axial measurements that uses ultrasound, and that requires applanation of the cornea
111751 Ultrasound ImmersionA method of obtaining ophthalmic axial measurements that uses ultrasound, and that requires immersion of the patient's eye in fluid as he lies in a supine position
111752 OpticalA method of obtaining ophthalmic axial measurements that uses light
111753 Manual KeratometryMeasurements taken of the corneal curvature using a manual keratometer
111754 Auto KeratometryMeasurements taken of the corneal curvature using an automated keratometer
111755 Simulated KeratometrySimulated Keratometry measurements derived from corneal topography
111756 Equivalent K-readingCorneal power measurements using Scheimpflug camera
111760 HaigisThe Haigis IOL calculation formula. Haigis W, Lege B, Miller N, Schneider B. Comparison of immersion ultrasound biometry and partial coherence interferometry for intraocular lens calculation according to Haigis. Graefes Arch Clin Exp Ophthalmol 2000;238:765-73
111761 Haigis-LThe Haigis-L IOL calculation formula. Haigis W. Intraocular lens calculation after refractive surgery for myopia: Haigis-L formula. J Cataract Refract Surg. 2008 Oct;34(10):1658-63
111762 Holladay 1The Holladay 1 IOL calculation formula. Holladay JT, Prager TC, Chandler TY, Musgrove KH, Lewis JW, Ruiz RS. A three-part system for refining intraocular lens power calculations. J Cataract Refract Surg. 1988; 14:17-24
111763 Holladay 2The Holladay 2 IOL calculation formula
111764 Hoffer QThe Hoffer Q IOL calculation formula. Hoffer KJ. The Hoffer Q formula: a comparison of theoretic and regression formulas. J Cataract Refract Surg 1993;19:700-12. Errata. J Cataract Refract Surg 1994;20:677 and 2007;33:2-3
111765 OlsenThe Olsen IOL calculation formula. Olsen T. Calculation of intraocular lens power: a review. Acta Ophthalmol. Scand. 2007: 85: 472-485
111766 SRKIIThe SRKII IOL calculation formula. Sanders DR, Retzlaff J, Kraff MC. Comparison of the SRK II formula and other second generation formulas. J Cataract Refract Surg. 1988 Mar;14(2):136-41
111767 SRK-TThe SRK-T IOL calculation formula. Retzlaff JA, Sanders DR, Kraff MC. Development of the SRK/T intraocular lens implant power calculation formula. J Cataract Refract Surg 1990;16:333-40. Erratum 1990;16:528
111768 ACD ConstantThe "ACD Constant" used in IOL calculation
111769 Haigis a0The "Haigis a0" constant used in IOL calculation
111770 Haigis a1The "Haigis a1" constant used in IOL calculation
111771 Haigis a2The "Haigis a2" constant used in IOL calculation
111772 Hoffer pACD ConstantThe "Hoffer pACD Constant" used in IOL calculation
111773 Surgeon FactorThe "Surgeon Factor" constant used in IOL calculation
111776 Front Of Cornea To Front Of LensAnterior chamber depth defined as the front of the cornea to the front of the lens
111777 Back Of Cornea To Front Of LensAnterior chamber depth defined as the back of the cornea to the front of the lens
111778 Single or Anterior LensRefers to the anterior lens when there are two lenses in the eye. The distance, in mm, from the anterior surface of the lens to the posterior surface of the lens
111779 Posterior LensRefers to the posterior lens when there are two lenses in the eye. The distance, in mm, from the anterior surface of the lens to the posterior surface of the lens
111780 Measurement From This DeviceValue obtained from measurements taken by the device creating this SOP Instance
111781 External Data SourceValue obtained by data transfer from an external source - not from measurements taken by the device providing the value
111782 Axial Measurements SOP InstanceAxial Measurements DICOM SOP Instance
111783 Refractive Measurements SOP InstanceRefractive Measurements DICOM SOP Instance
111786 Standard Deviation of measurements usedStandard Deviation is a simple measure of the variability of a data set
111787 Signal to Noise RatioSignal to Noise Ratio of the data samples taken to create a measurement
111791 Spherical projectionProjection from 2D image pixels to 3D Cartesian coordinates based on a spherical mathematical model
111792 Surface contour mappingMapping from 2D image pixels to 3D Cartesian coordinates based on measurements of the retinal surface; e.g. of the retina, derived via a measurement technology such as Optical Coherence Tomography, Ultrasound etc.
111800 Visual Field 24-2 Test PatternTest pattern, nominally covering an area within 24° of fixation. Consists of 54 test points a minimum of 3° from each meridian and placed 6° apart. The "-2" distinguishes this from another 24° pattern (no longer supported)
111801 Visual Field 10-2 Test PatternTest pattern, nominally covering an area within 10° of fixation. Consists of 68 test points a minimum of 1° from each meridian and placed 2° apart. The "-2" in this case indicates its point layout to be similar to the 30-2 and 24-2
111802 Visual Field 30-2 Test PatternTest pattern consisting of test point locations within 30° of fixation. Consists of 76 test points a minimum of 3° from each meridian and placed 6° apart. The "-2" distinguishes this from another 30° pattern (no longer supported)
111803 Visual Field 60-4 Test PatternTest pattern consisting of 60 test point locations between 30° and 60° of fixation a minimum of 6° from each meridian and placed 12° apart. The "-4" distinguishes this from a similar 60° pattern having 4 additional points
111804 Visual Field Macula Test PatternTest pattern consisting of 16 test point locations within 10° of fixation a minimum of 1° from each meridian and placed 2° apart
111805 Visual Field Central 40 Point Test PatternTest pattern consisting of 40 test point locations within 30° of fixation that spread out radially from fixation
111806 Visual Field Central 76 Point Test PatternTest pattern consisting of 76 test point locations within 30° of fixation a minimum of 3° from each meridian and placed 6° apart
111807 Visual Field Peripheral 60 Point Test PatternTest pattern consisting of 60 test point locations between 30° and 60° of fixation a minimum of 6° from each meridian and placed 12° apart
111808 Visual Field Full Field 81 Point Test PatternTest pattern consisting of 81 test point locations within 60° of fixation that spread out radially from fixation
111809 Visual Field Full Field 120 Point Test PatternTest pattern consisting of 120 test point locations within 60° of fixation that spread out radially from fixation, concentrated in the nasal hemisphere
111810 Visual Field G Test PatternTest pattern for Glaucoma and general visual field assessment with 59 test locations of which 16 test locations are in the macular area (up to 10° eccentricity) and where the density of test location is reduced with eccentricity. The test can be extended with the inclusion of 14 test locations between 30° and 60° eccentricity, 6 of which are located at the nasal step
111811 Visual Field M Test PatternTest pattern for the macular area. Orthogonal test pattern with 0.7° spacing within the central 4° of eccentricity and reduced density of test locations between 4 and 10, 5° of eccentricity. 81 test locations over all. The test can be extended to include the test locations of the Visual Field G Test Pattern between 10, 5° and 60°
111812 Visual Field 07 Test PatternFull field test pattern with 48 test locations from 0-30° and 82 test locations from 30-70°. Reduced test point density with increased eccentricity. Can be combined with screening and threshold strategies
111813 Visual Field LVC Test PatternLow Vision Central. Orthogonal off-center test pattern with 6° spacing. 75 test locations within the central 30°. Corresponds with the 32/30-2 excluding the 2 locations at the blind spot, including a macular test location. The LVC is linked with a staircase threshold strategy starting at 0 dB intensity and applies stimulus area V
111814 Visual Field Central Test PatternGeneral test corresponding to the 30-2 but excluding the 2 test locations in the blind spot area, hence with 74 instead of 76 test locations
111815 Visual Field SITA-Standard Test StrategySwedish Interactive Thresholding Algorithm (SITA). Strategy gains testing efficiency through use of visual field and information theory models. In: Bengtsson B, Olsson J, Heijl A, Rootzen H. A new generation of algorithms for computerized threshold perimetry, SITA. Acta Ophthalmologica Scandinavica, 1997, 75: 368-375
111816 Visual Field SITA-SWAP Test StrategyAdaptation of SITA testing methods to Blue-Yellow testing
111817 Visual Field SITA-Fast Test StrategySimilar to SITA-Standard but with less strict criteria for closing test points. Intended for patients who must be tested in the shortest possible time. In: Bengtsson B, Hejl A. SITA Fast, a new rapid perimetric threshold test. Description of methods and evaluation in patients with manifest and suspect glaucoma. Acta Ophthalmologica Scandinavica, 1998, 76: 431-437
111818 Visual Field Full Threshold Test StrategyThreshold test algorithm that determines a patient's sensitivity at each test point in the threshold test pattern by adjusting intensity by 4 dB steps until the patient changes their response, and then adjusts the intensity in the opposite direction by 2 dB steps until the patient changes their response again. The last stimulus seen by the patient is recognized as the threshold for that point. The starting values are determined by first thresholding a "primary" point in each quadrant then using the results of each primary point to determine the starting values for neighboring points
111819 Visual Field FastPac Test StrategySimilar to the Full Threshold algorithm except that it steps by 3 dB and only crosses the threshold only once. In: Flanagan JG, Wild JM, Trope GE. Evaluation of FASTPAC, a new strategy for threshold estimation with the Humphrey Field Analyzer, in a glaucomatous population. Ophthalmology, 1993, 100: 949-954
111820 Visual Field Full From Prior Test StrategyIdentical to Full Threshold except that starting values are determined by the results of a previous test performed using the same test pattern and the Full Threshold test strategy
111821 Visual Field Optima Test StrategySimilar to FastPac except that the steps are pseudo-dynamic (differ based on the intensity of the last presentation)
111822 Visual Field Two-Zone Test StrategySuprathreshold testing strategy, in which each point is initially tested using stimulus that is 6 dB brighter than the expected hill of vision. If the patient does not respond, the stimulus is presented a second time at the same brightness. If the patient sees either presentation, the point is marked as "seen"; otherwise it is marked as "not seen"
111823 Visual Field Three-Zone Test StrategyAn extension of the two-zone strategy in which test points where the second stimulus is not seen are presented with a third stimulus at maximum brightness
111824 Visual Field Quantify-Defects Test StrategyAn extension of the two-zone strategy, in which test points where the second stimulus is not seen receive threshold testing to quantify the depth of any detected scotomas
111825 Visual Field TOP Test StrategyTendency Oriented Perimetry. Fast thresholding algorithm. Test strategy makes use of the interaction between neighboring test locations to reduce the test time compared to normal full threshold strategy by 60-80%. In: Morales J, Weitzman ML, Gonzalez de la Rosa M. Comparison between Tendency-Oriented Perimetry (TOP) and octopus threshold perimetry. Ophthalmology, 2000, 107: 134-142
111826 Visual Field Dynamic Test StrategyDynamic strategy is a fast thresholding strategy reducing test duration by adapting the dB step sizes according to the frequency-of-seeing curve of the threshold. Reduction of test time compared to normal full threshold strategy 30-50%
111827 Visual Field Normal Test StrategyTraditional full threshold staircase strategy. Initial intensities are presented, based on anchor point sensitivities in each quadrant and based on already known neighboring sensitivities. In a first run, thresholds are changed in 4dB steps until the first response reversal. Then the threshold is changed in 2 dB steps until the second response reversal. The threshold is calculated as the average between the last seen and last not-seen stimulus, supposed to correspond with the 50% point in the frequency-of-seeing curve
111828 Visual Field 1-LT Test StrategyOne level screening test: Each test location is tested with a single intensity. The result is shown as seen or not-seen. The intensity can either be a 0 dB stimulus or a predefined intensity
111829 Visual Field 2-LT Test StrategyTwo level screening test: Each test location is initially tested 6 dB brighter than the age corrected normal value
111830 Visual Field LVS Test StrategyLow Vision Strategy is a full threshold normal strategy with the exception that it starts at 0 dB intensity and applies stimulus area V
111831 Visual Field GATE Test StrategyGerman Adaptive Threshold Estimation is a fast strategy based on a modified 4-2 staircase algorithm, using prior visual fields to calculate the starting intensity. In: Chiefer U, Pascual JP, Edmunds B, Feudner E, Hoffmann EM, Johnson CA, Lagreze WA, Pfeiffer N, Sample PA, Staubach F, Weleber RG, Vonthein R, Krapp E, Paetzold J. Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies. Investigative Ophthalmology and Visual Science, 2009, 51: 488-494
111832 Visual Field GATEi Test StrategySimilar to GATE. The i stands for initial. If there was no prior visual field test to calculate the starting values, an anchor point method is used to define the local start values
111833 Visual Field 2LT-Dynamic Test StrategyA test started as two level screening test. In the course of the test, the threshold of relative defects and/or normal test locations has been quantified using the dynamic threshold strategy
111834 Visual Field 2LT-Normal Test StrategyA test started as two level screening test. In the course of the test, the threshold of relative defects and/or normal test locations has been quantified using the normal full threshold strategy
111835 Visual Field Fast Threshold Test StrategyTakes neighborhood test point results into account and offers stimuli with an adapted value to save time
111836 Visual Field CLIP Test StrategyContinuous Luminance Incremental Perimetry, which measures at first the individual reaction time of the patient and threshold values in every quadrant. The starting value for the main test is slightly below in individual threshold
111837 Visual Field CLASS StrategyA supra threshold screening strategy. The starting stimuli intensities depend on the classification of the patient's visual hill by measuring the central (fovea) or peripheral (15° meridian) threshold. The result of each dot slightly underestimates the sensitivity value (within 5 dB)
111838 Age correctedMode for determining the starting luminance for screening test points - the starting luminance s is chosen based on the age of the patient
111839 Threshold relatedMode for determining the starting luminance for screening test points - the starting luminance is chosen based on the results of thresholding a set of "primary" test points (one in each quadrant)
111840 Single luminanceMode for determining the starting luminance for screening test points - in this case, all starting luminance is set to the same value
111841 Foveal sensitivity relatedMode for determining the starting luminance for screening test points - the starting luminance is chosen based on the result of the foveal threshold value
111842 Related to non macular sensitivityMode for determining the starting luminance for screening test points - the starting luminance is chosen based on the result of four threshold values measured near the 15° meridian (one in each quadrant)
111843 Automated OpticalReal time evaluation of the camera image to recognize blinks and fixation losses with influence on the test procedure. Blinks that interfere with stimuli presentation cause the automated repetition of such stimulus presentations. Fixation losses can be used to delay the stimulus presentation until correct fixation is regained
111844 Blind Spot MonitoringA method of monitoring the patient's fixation by periodically presenting stimulus in a location on the background surface that corresponds to the patient's blind spot
111845 Macular Fixation TestingA method of monitoring the patient's fixation by presenting the stimulus to the patient's macula
111846 Observation by ExaminerA method of monitoring the patient's fixation by observation from the examiner of the patient
111847 Outside normal limitsAnalysis Results are outside normal limits
111848 BorderlineAnalysis Results are borderline
111849 Abnormally high sensitivityAnalysis Results identify abnormally high sensitivity
111850 General reduction in sensitivityAnalysis Results identify general reduction in sensitivity
111851 Borderline and general reduction in sensitivityAnalysis Results identify Borderline and general reduction in sensitivity
111852 Visual Field IndexIndex of a patient's remaining visual field normalized for both age and generalized defect
111853 Visual Field Loss Due to Diffuse DefectEstimate of the portion of a patient's visual field loss that is diffuse (i.e., spread evenly across all portions of the visual field)
111854 Visual Field Loss Due to Local DefectEstimate of the portion of a patient's visual field loss that is local (i.e., not spread evenly across all portions of the visual field)
111855 Glaucoma Hemifield Test AnalysisAn analysis of asymmetry between zones of the superior and inferior visual field. It is designed to be specific for defects due to glaucoma
111856 Optical Fixation MeasurementsThe data output of an optical fixation monitoring process, consisting of a list of positive and negative numbers indicating the quality of patient fixation over the course of a visual field test. The value 0 represents the initial fixation. Negative numbers indicate a measuring error (i.e., the patient blinked). Positive numbers quantify the degree of eccentricity from initial fixation
111900 Macula centeredAn image of at least 15° angular subtend that is centered on the macula; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111901 Disc centeredAn image of at least 15° angular subtend that is centered on the optic disc; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111902 Lesion centeredAn image of any angular subtend that is centered on a lesion located in any region of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111903 Disc-macula centeredAn image of at least 15° angular subtend centered midway between the disc and macula and containing at least a portion of the disc and both the disc and the macula; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111904 Mid-peripheral-superiorAn image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the superior-temporal and superior-nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111905 Mid-peripheral-superior temporalAn image of at least 15° angular subtend positioned between the central zone and the equator in the superior-temporal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111906 Mid-peripheral-temporalAn image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the superior-temporal and inferior-temporal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111907 Mid-peripheral-inferior temporalAn image of at least 15° angular subtend positioned between the central zone and the equator in the inferior-temporal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111908 Mid-peripheral-inferiorAn image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the inferior-temporal and inferior-nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111909 Mid-peripheral-inferior nasalAn image of at least 15° angular subtend positioned between the central zone and the equator in the inferior-nasal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111910 Mid-peripheral-nasalAn image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the superior-nasal and inferior-nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111911 Mid-peripheral-superior nasalAn image of at least 15° angular subtend positioned between the central zone and the equator in the superior-nasal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111912 Peripheral-superiorAn image of at least 15° angular subtend positioned between the equator and the ora serrata, and spanning both the superior temporal and superior nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111913 Peripheral-superior temporalAn image of at least 15° angular subtend positioned between the equator and ora serrata in the superior-temporal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111914 Peripheral-temporalAn image of at least 15° angular subtend positioned between the equator and ora serrata, and spanning both the superior-temporal and inferior-temporal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111915 Peripheral-inferior temporalAn image of at least 15° angular subtend positioned between the equator and ora serrata in the inferior-temporal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111916 Peripheral-inferiorAn image of at least 15° angular subtend positioned between the equator and ora serrata, and spanning both the inferior-temporal and inferior-nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111917 Peripheral-inferior nasalAn image of at least 15° angular subtend positioned between the equator and ora serrata in the inferior-nasal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111918 Peripheral-nasalAn image of at least 15° angular subtend positioned between the equator and ora serrata, and spanning both the superior-nasal and inferior-nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111919 Peripheral-superior nasalAn image of at least 15° angular subtend positioned between the equator and ora serrata in the superior-nasal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111920 Time domainIdentifies the use of physical signals with respect to time to capture information
111921 Spectral domainIdentifies the use of physical signals with respect to multiple frequencies to capture information
111922 No corneal compensationNo compensation algorithm for corneal birefringence
111923 Corneal birefringence compensationAlgorithm to compensate for variability in corneal birefringence
111924 Retinal topographyMeasurement of the retinal surface contour relative to an assigned datum plane
111925 Retinal nerve fiber layer thicknessMeasurement approximating the distance related to the structure between the internal limiting membrane (ILM) and the outer boarder of the retinal nerve fiber layer (RNFL); see Section III.6 "Retinal Thickness Definition" in PS3.17
111926 Ganglion cell complex thicknessMeasurement approximating the distance related to the structure between the ILM and the outer border of the inner plexiform layer (IPL), called the ganglion cell complex (GCC); see Section III.6 "Retinal Thickness Definition" in PS3.17
111927 Total retinal thickness (ILM to IS-OS)Measurement approximating the distance related to the structure between the ILM and the inner-outer segment junction (IS-OS); see Section III.6 "Retinal Thickness Definition" in PS3.17
111928 Total retinal thickness (ILM to RPE)Measurement approximating the distance related to the structure between the ILM and the retinal pigment epithelium (RPE); see Section III.6 "Retinal Thickness Definition" in PS3.17
111929 Total retinal thickness (ILM to BM)Measurement approximating the distance related to the structure between the ILM and the Bruch's membrane (BM); see Section III.6 "Retinal Thickness Definition" in PS3.17
111930 Absolute ophthalmic thicknessThickness of a component of the posterior segment of the eye; e.g. thickness of retina, choroid, etc.
111931 Thickness deviation category from normative dataOphthalmic Thickness map based upon statistical significance category (such as percentile) from a normative data set
111932 Thickness deviation from normative dataOphthalmic Thickness map based upon deviation (such as microns) from a normative data set
111933 Related ophthalmic thickness mapOphthalmic Thickness Map related to another Ophthalmic Thickness Map or another SOP Instance
111934 Disc-FoveaAn anatomic point centered midway between the disc and fovea centralis
111935 p>5%Assuming the null hypothesis is true, the conditional percent probability of observing this result is not statistically significant
111936 p<5%Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 95% unlikely to happen by chance
111937 p<2%Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 98% unlikely to happen by chance
111938 p<1%Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 99% unlikely to happen by chance
111939 p<0.5%Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 99.5% unlikely to happen by chance
111940 Corneal axial power mapA two dimensional representation of the axial curvature of the cornea. Axial curvature is calculated from the reciprocal of the distance from a point on a meridian normal at the point to the corneal topographer axis. Also known as sagittal curvature
111941 Corneal instantaneous power mapA two dimensional representation of the instantaneous curvature of the cornea. Instantaneous curvature is calculated from the reciprocal of the distance from a point on a meridian normal at the point to the center of curvature of that point. Also called tangential curvature
111942 Corneal refractive power mapA two dimensional representation of the refractive power of the cornea. Corneal refractive power is calculated using Snell's Law
111943 Corneal elevation mapA two dimensional representation of the elevation of the cornea. Elevation is calculated as the distance from a point on the corneal surface to a point on a reference surface along a line parallel to the corneal topographer axis. For the purpose of visualization the reference surface is usually a sphere or an ellipse
111944 Corneal wavefront mapA two dimensional representation of a wavefront aberration surface of the cornea. Wavefront aberration surface is calculated from the corneal elevation data fit with either the Zernike polynomial series or the Fourier Series. Maps generally display total aberrations and selectable higher order aberrations
111945 Elevation-based corneal tomographerA device that measures corneal anterior surface shape using elevation-based methods (stereographic and light slit-based). Rasterstereography images a grid pattern illuminating the fluorescein dyed tear film with 2 cameras to produce 3D. Slit-based devices scan the cornea, usually by rotation about the instrument axis centered on the cornea vertex
111946 Reflection-based corneal topographerA reflection-based device that projects a pattern of light onto the cornea and an image of the reflection of that pattern from the tear film is recorded in one video frame. Light patterns include the circular mire pattern (Placido disc) and spot matrix patterns. Sequential scanning of light spots reflected from the corneal surface is also used requiring multiple video frames for recording
111947 Interferometry-based corneal tomographerAn Interference-based device that projects a beam of light onto and through the cornea. Light reflected from within the cornea is combined with a reference beam giving rise to an interference pattern. Appropriately scanned, this imaging is used to construct 3-dimensional images of the cornea from anterior to posterior surfaces; e.g. swept source OCT
112000 Chest CAD ReportA structured report containing the results of computer-aided detection or diagnosis applied to chest imaging and associated clinical information
112001 OpacityThe shadow of an absorber that attenuates the X-Ray beam more effectively than do surrounding absorbers. In a radiograph, any circumscribed area that appears more nearly white (of lesser photometric density) than its surround [Fraser and Pare]
112002 Series Instance UIDA unique identifier for a series of DICOM SOP instances
112003 Associated Chest ComponentA named anatomic region within the chest cavity
112004 Abnormal interstitial patternA collection of opacities detected within the continuum of loose connective tissue throughout the lung, that is not expected in a diagnostically normal radiograph
112005 Radiographic anatomyA type of anatomy that is expected to be detectable on a radiographic (X-Ray based) image
112006 Distribution DescriptorCharacteristic of the extent of spreading of a finding or feature
112007 Border definitionCharacteristic of the clarity of the boundary or edges of a finding or feature
112008 Site involvementThe part(s) of the anatomy affected or encompassed by a finding or feature
112009 Type of ContentCharacteristic of the matter or substance within a finding or feature
112010 Texture DescriptorCharacteristic of the surface or consistency of a finding or feature
112011 Positioner Primary AnglePosition of the X-Ray beam about the patient from the RAO to LAO direction where movement from RAO to vertical is positive
112012 Positioner Secondary AnglePosition of the X-Ray beam about the patient from the caudal to cranial direction where movement from caudal to vertical is positive
112013 Location in ChestThe zone, lobe or segment within the chest cavity in which a finding or feature is situated
112014 Orientation DescriptorVertical refers to orientation parallel to the superior-inferior (cephalad-caudad) axis of the body, with horizontal being perpendicular to this, and an oblique orientation having projections in both the horizontal and vertical
112015 Border shapeCharacteristic of the shape formed by the boundary or edges of a finding or feature
112016 Baseline CategoryIndicates whether a finding was considered a target lesion, non-target lesion, or non-lesion during evaluation of a baseline series, according to a method such as RECIST
112017 Cavity extent as percent of volumeThe extent of a detected cavity, represented as the percent of the surrounding volume that it occupies
112018 Calcification extent as percent of surfaceThe extent of a detected calcification, represented as the percent of the surrounding surface that it occupies
112019 Calcification extent as percent of volumeThe extent of a detected calcification, represented as the percent of the surrounding volume that it occupies
112020 Response EvaluationA heading for the reporting of response evaluation for treatment of solid tumors
112021 Response Evaluation MethodThe system applied in the reporting of response evaluation for treatment of solid tumors
112022 RECISTResponse Evaluation Criteria In Solid Tumors; see Normative References
112023 Composite Feature ModifierA term that further specifies the name of an item that is an inferred correlation relating two or more individual findings or features
112024 Single Image Finding ModifierA term that further specifies the name of an item that was detected on one image
112025 Size DescriptorA qualitative descriptor for the extent of a finding or feature
112026 Width DescriptorA qualitative descriptor for the thickness of tubular structures, such as blood vessels
112027 Opacity DescriptorA characteristic that further describes the nature of an opacity
112028 Abnormal Distribution of Anatomic StructureThe type of adverse affect that a finding or feature is having on the surrounding anatomy
112029 WHOResponse evaluation method as defined in chapter 5, "Reporting of Response" of the WHO Handbook for Reporting Results for Cancer Treatment; see Normative References
112030 Calcification DescriptorIdentification of the morphology of detected calcifications
112031 Attenuation CoefficientA quantitative numerical statement of the relative attenuation of the X-Ray beam at a specified point. Coefficient that describes the fraction of a beam of X-Rays or gamma rays that is absorbed or scattered per unit thickness of the absorber. This value basically accounts for the number of atoms in a cubic cm volume of material and the probability of a photon being scattered or absorbed from the nucleus or an electron of one of these atoms. Usually expressed in Hounsfield units [referred to as CT Number in Fraser and Pare]
112032 Threshold Attenuation CoefficientAn X-Ray attenuation coefficient that is used as a threshold; e.g. in calcium scoring
112033 Abnormal opacityAn opacity that is not expected in a diagnostically normal radiograph
112034 Calculation DescriptionA textual description of the mathematical method of calculation that resulted in a calculated value
112035 Performance of Pediatric and Adult Chest Radiography, ACRAmerican College of Radiology. ACR Standard for the Performance of Pediatric and Adult Chest Radiography. In: Standards. Reston, Va: 2001:95-98
112036 ACR Position StatementAmerican College of Radiology. ACR Position Statement for Quality Control and Improvement, Safety, Infection Control, and Patient Concerns. In: Practice Guidelines and Technical Standards. Reston, Va: 2001:iv
112037 Non-lesion ModifierA descriptor for a non-lesion object finding or feature, used to indicate whether the object was detected as being internal or external to the patient's body
112038 Osseous ModifierA concept modifier for an Osseous Anatomy, or bone related, finding
112039 Tracking IdentifierA text label used for tracking a finding or feature, potentially across multiple reporting objects, over time. This label shall be unique within the domain in which it is used
112040 Tracking Unique IdentifierA unique identifier used for tracking a finding or feature, potentially across multiple reporting objects, over time
112041 Target Lesion Complete ResponseDisappearance of all target lesions
112042 Target Lesion Partial ResponseAt least a 30% decrease in the sum of the Longest Diameter of target lesions, taking as reference the baseline sum Longest Diameter
112043 Target Lesion Progressive DiseaseAt least a 20% increase in the sum of the Longest Diameter of target lesions, taking as reference the smallest sum Longest Diameter recorded since the treatment started, or the appearance of one or more new lesions
112044 Target Lesion Stable DiseaseNeither sufficient shrinkage to qualify for Partial Response nor sufficient increase to qualify for Progressive Disease, taking as reference the smallest sum Longest Diameter since the treatment started
112045 Non-Target Lesion Complete ResponseDisappearance of all non-target lesions and normalization of tumor marker level
112046 Non-Target Lesion Incomplete Response or Stable DiseasePersistence of one or more non-target lesions and/or maintenance of tumor marker level above the normal limits
112047 Non-Target Lesion Progressive DiseaseAppearance of one or more new lesions and/or unequivocal progression of existing non-target lesions
112048 Current ResponseThe current response evaluation for treatment of solid tumors, according to a method such as RECIST
112049 Best Overall ResponseBest response recorded from the start of the treatment until disease progression/recurrence, taking as reference for Progressive Disease the smallest measurements recorded since the treatment started, according to a method such as RECIST
112050 Anatomic IdentifierA text identifier of an anatomic feature when a multiplicity of features of that type may be present, such as "Rib 1", "Rib 2" or thoracic vertebrae "T1" or "T2"
112051 Measurement of ResponseA measured or calculated evaluation of response; e.g. according to a method such as RECIST, the value would be the calculated sum of the lengths of the longest axes of a set of target lesions
112052 BronchovascularOf or relating to a bronchial (lung) specific channel for the conveyance of a body fluid
112053 OsseousOf, relating to, or composed of bone
112054 Secondary pulmonary lobuleThe smallest unit of lung surrounded by connective tissue septa; the unit of lung subtended by any bronchiole that gives off three to five terminal bronchioles [Fraser and Pare]
112055 Agatston scoring methodA method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the maximum X-Ray attenuation coefficient and the area of calcium deposits
112056 Volume scoring methodA method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the volume of each calcification, typically expressed in mm3
112057 Mass scoring methodA method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the total mass of calcification, typically expressed in mg
112058 Calcium scoreA measure often arrived at through calculation of findings from CT examination, which is a common predictor of significant stenosis of the coronary arteries
112059 Primary complexThe combination of a focus of pneumonia due to a primary infection with granulomas in the draining hilar or mediastinal lymph nodes [Fraser and Pare]
112060 OligemiaGeneral or local decrease in the apparent width of visible pulmonary vessels, suggesting less than normal blood flow (reduced blood flow) [Fraser and Pare]
112061 Abnormal lines (1D)Linear opacity of very fine width, i.e., a nearly one dimensional opacity
112062 Abnormal lucencyArea of abnormal very low X-Ray attenuation, typically lower than aerated lung when occurring in or projecting over lung, or lower than soft tissue when occurring in or projecting over soft tissue
112063 Abnormal calcificationsA calcific opacity within the lung that may be organized, but does not display the trabecular organization of true bone [Fraser and Pare]
112064 Abnormal textureRelatively homogeneous, extended, pattern of abnormal opacity in the lung, typically low in contrast
112065 Reticulonodular patternA collection of innumerable small, linear, and nodular opacities that together produce a composite appearance resembling a net with small superimposed nodules. The reticular and nodular elements are dimensionally of similar magnitude [Fraser and Pare]
112066 Beaded septum signIrregular septal thickening that suggests the appearance of a row of beads; usually a sign of lymphangitic carcinomatosis, but may also occur rarely in sarcoidosis [Fraser and Pare]
112067 Nodular patternA collection of innumerable, small discrete opacities ranging in diameter from 2-10 mm, generally uniform in size and widespread in distribution, and without marginal spiculation [Fraser and Pare]
112068 PseudoplaqueAn irregular band of peripheral pulmonary opacity adjacent to visceral pleura that simulates the appearance of a pleural plaque and is formed by coalescence of small nodules [Fraser and Pare]
112069 Signet-ring signA ring of opacities (usually representing a dilated, thick-walled bronchus) in association with a smaller, round, soft tissue opacity (the adjacent pulmonary artery) suggesting a "signet ring" [Fraser and Pare]
112070 Air bronchiologramEquivalent of air bronchogram, but in airways assumed to be bronchioles because of peripheral location and diameter [Fraser and Pare]
112071 Air bronchogramRadiographic shadow of an air-containing bronchus; presumed to represent an air-containing segment of the bronchial tree (identity often inferred) [Fraser and Pare]
112072 Air crescentAir in a crescentic shape in a nodule or mass, in which the air separates the outer wall of the lesion from an inner sequestrum, which most commonly is a fungus ball of Aspergillusspecies [Fraser and Pare]
112073 Halo signGround-glass opacity surrounding the circumference of a nodule or mass. May be a sign of invasive aspergillosis or hemorrhage of various causes [Fraser and Pare]
112074 Target Lesion at BaselineFlag denoting that this lesion was identified, at baseline, as a target lesion intended for tracking over time [RECIST]
112075 Non-Target Lesion at BaselineFlag denoting that this lesion was not identified, at baseline, as a target lesion, and was not intended for tracking over time [RECIST]
112076 Non-Lesion at BaselineFlag denoting that this finding was identified, at baseline, as a category other than a lesion, and was not intended for tracking over time [RECIST]
112077 VasoconstrictionLocal or general reduction in the caliber of visible pulmonary vessels, presumed to result from decreased flow occasioned by contraction of muscular pulmonary arteries [Fraser and Pare]
112078 VasodilationLocal or general increase in the width of visible pulmonary vessels resulting from increased pulmonary blood flow [Fraser and Pare]
112079 Architectural distortionA manifestation of lung disease in which bronchi, pulmonary vessels, a fissure or fissures, or septa of secondary pulmonary lobules are abnormally displaced [Fraser and Pare]
112080 Mosaic perfusionA patchwork of regions of varied attenuation, interpreted as secondary to regional differences in perfusion [Fraser and Pare]
112081 PleonemiaIncreased blood flow to the lungs or a portion thereof, manifested by a general or local increase in the width of visible pulmonary vessels [Fraser and Pare]
112082 InterfaceThe common boundary between the shadows of two juxtaposed structures or tissues of different texture or opacity (edge, border) [Fraser and Pare]
112083 LineA longitudinal opacity no greater than 2 mm in width [Fraser and Pare]
112084 LucencyThe shadow of an absorber that attenuates the primary X-Ray beam less effectively than do surrounding absorbers. In a radiograph, any circumscribed area that appears more nearly black (of greater photometric density) than its surround [Fraser and Pare]
112085 Midlung windowA midlung region, characterized by the absence of large blood vessels and by a paucity of small blood vessels, that corresponds to the minor fissure and adjacent peripheral lung [Fraser and Pare]
112086 Carina angleThe angle formed by the right and left main bronchi at the tracheal bifurcation [Fraser and Pare]
112087 Centrilobular structuresThe pulmonary artery and its immediate branches in a secondary lobule; HRCT depicts these vessels in certain cases; a.k.a. core structures or lobular core structures [Fraser and Pare]
112088 Anterior junction lineA vertically oriented linear or curvilinear opacity approximately 1-2 mm wide, commonly projected on the tracheal air shadow [Fraser and Pare]
112089 Posterior junction lineA vertically oriented, linear or curvilinear opacity approximately 2 mm wide, commonly projected on the tracheal air shadow, and usually slightly concave to the right [Fraser and Pare]
112090 Azygoesophageal recess interfaceA space in the right side of the mediastinum into which the medial edge of the right lower lobe extends [Fraser and Pare]
112091 Paraspinal lineA vertically oriented interface usually seen in a frontal chest radiograph to the left of the thoracic vertebral column [Fraser and Pare]
112092 Posterior tracheal stripeA vertically oriented linear opacity ranging in width from 2-5 mm, extending from the thoracic inlet to the bifurcation of the trachea, and visible only on lateral radiographs of the chest [Fraser and Pare]
112093 Right tracheal stripeA vertically oriented linear opacity approximately 2-3 mm wide extending from the thoracic inlet to the right tracheobronchial angle [Fraser and Pare]
112094 StripeA longitudinal composite opacity measuring 2-5 mm in width; acceptable when limited to anatomic structures within the mediastinum [Fraser and Pare]
112095 HiatusA gap or passage through an anatomical part or organ; especially : a gap through which another part or organ passes
112096 Rib Scalene TubercleA small rounded elevation or eminence on the first rib for the attachment of the scalenus anterior
112097 Vertebral Intervertebral NotchA groove that serves for the transmission of the vertebral artery
112098 Subscapular FossaThe concave depression of the anterior surface of the scapula
112099 Scapular SpineA sloping ridge dividing the dorsal surface of the scapula into the supraspinatous fossa (above), and the infraspinatous fossa (below)
112100 Scapular Supraspinatus FossaThe portion of the dorsal surface of the scapula above the scapular spine
112101 Scapular Infraspinatus FossaThe portion of the dorsal surface of the scapula below the scapular spine
112102 Aortic knobThe portion of the aortic arch that defines the transition between its ascending and descending limbs
112103 Arch of the Azygos veinSection of Azygos vein near the fourth thoracic vertebra, where it arches forward over the root of the right lung, and ends in the superior vena cava, just before that vessel pierces the pericardium
112104 Air-fluid levelA local collection of gas and liquid that, when traversed by a horizontal X-Ray beam, creates a shadow characterized by a sharp horizontal interface between gas density above and liquid density below [Fraser and Pare]
112105 Corona radiataA circumferential pattern of fine linear spicules, approximately 5 mm long, extending outward from the margin of a solitary pulmonary nodule through a zone of relative lucency [Fraser and Pare]
112106 Honeycomb patternA number of closely approximated ring shadows representing air spaces 5-10 mm in diameter with walls 2-3 mm thick that resemble a true honeycomb; implies "end-stage" lung [Fraser and Pare]
112107 Fleischner's line(s)A straight, curved, or irregular linear opacity that is visible in multiple projections; usually situated in the lower half of the lung; vary markedly in length and width [Fraser and Pare]
112108 Intralobular linesFine linear opacities present in a lobule when the intralobular interstitium is thickened. When numerous, they may appear as a fine reticular pattern [Fraser and Pare]
112109 Kerley A lineEssentially straight linear opacity 2-6 cm in length and 1-3 mm in width, usually in an upper lung zone [Fraser and Pare]
112110 Kerley B lineA straight linear opacity 1.5-2 cm in length and 1-2 mm in width, usually at the lung base [Fraser and Pare]
112111 Kerley C linesA group of branching, linear opacities producing the appearing of a fine net, at the lung base [Fraser and Pare]
112112 Parenchymal bandElongated opacity, usually several millimeters wide and up to about 5 cm long, often extending to the pleura, which may be thickened and retracted at the site of contact [Fraser and Pare]
112113 Reticular patternA collection of innumerable small linear opacities that together produce an appearance resembling a net [Fraser and Pare]
112114 Septal line(s)Usually used in the plural, a generic term for linear opacities of varied distribution produced when the interstitium between pulmonary lobules is thickened [Fraser and Pare]
112115 Subpleural lineA thin curvilinear opacity, a few millimeters or less in thickness, usually less than 1 cm from the pleural surface and paralleling the pleura [Fraser and Pare]
112116 Tramline shadowParallel or slightly convergent linear opacities that suggest the planar projection of tubular structures and that correspond in location and orientation to elements of the bronchial tree [Fraser and Pare]
112117 Tubular shadowPaired, parallel, or slightly convergent linear opacities presumed to represent the walls of a tubular structure seen en face; used if the anatomic nature of a shadow is obscure [Fraser and Pare]
112118 DensityThe opacity of a radiographic shadow to visible light; film blackening; the term should never be used to mean an "opacity" or "radiopacity" [Fraser and Pare]
112119 Dependent opacitySubpleural increased attenuation in dependent lung. The increased attenuation disappears when the region of lung is nondependent; a.k.a. dependent increased attenuation [Fraser and Pare]
112120 Ground glass opacityHazy increased attenuation of lung, but with preservation of bronchial and vascular margins; caused by partial filling of air spaces, interstitial thickening, partial collapse of alveoli, normal expiration, or increased capillary blood volume [Fraser and Pare]
112121 InfiltrateAny ill-defined opacity in the lung [Fraser and Pare]
112122 MicronoduleDiscrete, small, round, focal opacity of at least soft tissue attenuation and with a diameter no greater than 7 mm [Fraser and Pare]
112123 Phantom tumor (pseudotumor)A shadow produced by a local collection of fluid in one of the interlobar fissures, usually elliptic in one radiographic projection and rounded in the other, resembling a tumor [Fraser and Pare]
112124 ShadowAny perceptible discontinuity in film blackening attributed to the attenuation of the X-Ray beam by a specific anatomic absorber or lesion on or within the body of the patient; to be employed only when more specific identification is not possible [Fraser and Pare]
112125 Small irregular opacitiesTerm used to define a reticular pattern specific to pneumoconioses [Fraser and Pare]
112126 Small rounded opacitiesTerm used to define a nodular pattern specific to pneumoconioses [Fraser and Pare]
112127 Tree-in-bud signNodular dilation of centrilobular branching structures that resembles a budding tree and represents exudative bronchiolar dilation [Fraser and Pare]
112128 Granular patternAny extended, finely granular pattern of pulmonary opacity within which normal anatomic details are partly obscured [Fraser and Pare]
112129 Miliary patternA collection of tiny discrete opacities in the lungs, each measuring 2 mm or less in diameter, generally uniform in size and widespread in distribution [Fraser and Pare]
112130 Mosaic patternGeneralized pattern of relatively well defined areas in the lung having different X-Ray attenuations due to a longstanding underlying pulmonary disease
112131 Extremely smallA qualitative descriptor of a size that is dramatically less than typical
112132 Very smallA qualitative descriptor of a size that is considerably less than typical
112133 Too smallA qualitative descriptor of a size that is so small as to be abnormal versus expected size
112134 EllipticShaped like an ellipse (oval)
112135 LobulatedA border shape that is made up of, provided with, or divided into lobules (small lobes, curved or rounded projections or divisions)
112136 SpiculatedRadially orientated border shape
112137 Sharply definedThe border of a shadow (opacity) is sharply defined [Fraser and Pare]
112138 Distinctly definedThe border of a shadow (opacity) is distinctly defined [Fraser and Pare]
112139 Well demarcatedThe border of a shadow (opacity) is well distinct from adjacent structures [Fraser and Pare]
112140 Sharply demarcatedThe border of a shadow (opacity) is sharply distinct from adjacent structures [Fraser and Pare]
112141 Poorly demarcatedThe border of a shadow (opacity) is poorly distinct from adjacent structures [Fraser and Pare]
112142 CircumscribedA shadow (opacity) possessing a complete or nearly complete visible border [Fraser and Pare]
112143 AirInspired atmospheric gas. The word is sometimes used to describe gas within the body regardless of its composition or site [Fraser and Pare]
112144 Soft tissueMaterial having X-Ray attenuation properties similar to muscle
112145 CalciumMaterial having X-Ray attenuation properties similar to calcium, a silver-white bivalent metallic element occurring in plants and animals
112146 AcinarA pulmonary opacity 4-8 mm in diameter, presumed to represent anatomic acinus, or a collection of opacities in the lung, each measuring 4-8 mm in diameter, and together producing an extended, homogeneous shadow [Fraser and Pare]
112147 Air spaceThe gas-containing portion of the lung parenchyma, including the acini and excluding the interstitium [Fraser and Pare]
112148 FibronodularSharply defined, approximately circular opacities occurring singly or in clusters, usually in the upper lobes [Fraser and Pare]
112149 FluffyA shadow (opacity) that is ill-defined, lacking clear-cut margins [Fraser and Pare]
112150 LinearA shadow resembling a line; any elongated opacity of approximately uniform width [Fraser and Pare]
112151 ProfusionThe number of small opacities per unit area or zone of lung. In the International Labor Organization (ILO) classification of radiographs of the pneumoconioses, the qualifiers 0 through 3 subdivide the profusion into 4 categories. The profusion categories may be further subdivided by employing a 12-point scale [Fraser and Pare]
112152 Silhouette signThe effacement of an anatomic soft tissue border by either a normal anatomic structure or a pathologic state such as airlessness of adjacent lung or accumulation of fluid in the contiguous pleural space; useful in detecting and localizing an opacity along the axis of the X-Ray beam [Fraser and Pare]
112153 SubpleuralSituated or occurring between the pleura and the body wall
112154 Bat's wing distributionSpatial arrangement of opacities that bears vague resemblance to the shape of a bat in flight; bilaterally symmetric [Fraser and Pare]
112155 Butterfly distributionSpatial arrangement of opacities that bears vague resemblance to the shape of a butterfly in flight; bilaterally symmetric [Fraser and Pare]
112156 CentrilobularReferring to the region of the bronchioloarteriolar core of a secondary pulmonary lobule [Fraser and Pare]
112157 CoalescentThe joining together of a number of opacities into a single opacity [Fraser and Pare]
112158 LobarOf or relating to a lobe (a curved or rounded projection or division); e.g. involving an entire lobe of the lung
112159 Hyper-acuteExtremely or excessively acute, as a qualitative measure of severity
112160 Homogeneous (uniform opacity)Of uniform opacity or texture throughout [Fraser and Pare]
112161 InhomogeneousLack of homogeneity in opacity or texture
112162 TargetDiscrete opacity centrally within a larger opacity, as a calcification descriptor
112163 FibrocalcificPertaining to sharply defined, linear, and/or nodular opacities containing calcification(s) [Fraser and Pare]
112164 FlocculentCalcifications made up of loosely aggregated particles, resembling wool
112165 Difference in border shapeA change in the shape formed by the boundary or edges of a finding or featureDeprecated
112166 Difference in border definitionA change in the clarity of the boundary or edges of a finding or featureDeprecated
112167 Difference in distributionA change in the extent of spreading of a finding or featureDeprecated
112168 Difference in site involvementA change in the part(s) of the anatomy affected or encompassed by a finding or featureDeprecated
112169 Difference in Type of ContentA change in the matter or substance within a finding or featureDeprecated
112170 Difference in TextureA change in the surface or consistency of a finding or featureDeprecated
112171 Fiducial markA location in image space, which may or may not correspond to an anatomical reference, which is often used for registering data sets
112172 PortacathConnected to an injection chamber placed under the skin in the upper part of the chest. When it is necessary to inject some drug, a specific needle is put in the chamber through the skin and a silicon membrane. The advantage of a portacath is that it may be left in place several months contrarily of "classical" catheters
112173 Chest tubeA tube inserted into the chest wall from outside the body, for drainage. Sometimes used for collapsed lung. Usually connected to a receptor placed lower than the insertion site
112174 Central lineA tube placed into the subclavian vein to deliver medication directly into the venous system
112175 Kidney stentA stent is a tube inserted into another tube. Kidney stent is a tube that is inserted into the kidney, ureter, and bladder, to help drain urine. Usually inserted through a scoping device presented through the urethra
112176 Pancreatic stentA stent is a tube inserted into another tube. Pancreatic stent is inserted through the common bile duct to the pancreatic duct, to drain bile
112177 Nipple ringA non-lesion object that appears to be a circular band, attached to the body via pierced nipple
112178 CoinA non-lesion object that appears to be a flat round piece of metal
112179 Minimum Attenuation CoefficientThe least quantity assignable, admissible, or possible; the least of a set of X-Ray attenuation coefficients
112180 Maximum Attenuation CoefficientThe greatest quantity or value attainable or attained; the largest of a set of X-Ray attenuation coefficients
112181 Mean Attenuation CoefficientThe value that is computed by dividing the sum of a set of X-Ray attenuation coefficients by the number of values
112182 Median Attenuation CoefficientThe value in an ordered set of X-Ray attenuation coefficients, below and above which there is an equal number of values
112183 Standard Deviation of Attenuation CoefficientFor a set of X-Ray attenuation coefficients: 1) a measure of the dispersion of a frequency distribution that is the square root of the arithmetic mean of the squares of the deviation of each of the class frequencies from the arithmetic mean of the frequency distribution; 2) a parameter that indicates the way in which a probability function or a probability density function is centered around its mean and that is equal to the square root of the moment in which the deviation from the mean is squared
112184 Performance of Pediatric and Adult Thoracic CTAmerican College of Radiology. ACR Standard for the Performance of Pediatric and Adult Thoracic Computed Tomography (CT). In: Standards. Reston, Va: 2001:103-107
112185 Performance of CT for Detection of Pulmonary Embolism in AdultsAmerican College of Radiology. ACR Standard for the Performance of Computed Tomography for the Detection of Pulmonary Embolism in Adults. In: Standards. Reston, Va: 2001:109-113
112186 Performance of High-Resolution CT of the Lungs in AdultsAmerican College of Radiology. ACR Standard for the Performance of High-Resolution Computed Tomography (HRCT) of the Lungs in Adults. In: Standards. Reston, Va: 2001:115-118
112187 Unspecified method of calculationThe method of calculation of a measurement or other type of numeric value is not specified
112188 Two-dimensional methodThe calculation method was performed in two-dimensional space
112189 Three-dimensional methodThe calculation method was performed in three-dimensional space
112191 Breast tissue densityThe relative density of parenchymal tissue as a proportion of breast volume
112192 Volume of parenchymal tissueThe volume of parenchymal tissue
112193 Volume of breastThe volume of the breast
112194 Mass of parenchymal tissueThe mass of parenchymal tissue
112195 Mass of breastThe mass of the breast
112196 Area of Vascular CalcificationA measured or calculated area of vascular calcification
112197 Volume of Vascular CalcificationA measured or calculated volume of vascular calcification
112198 Percentage of Vascular CalcificationA measured or calculated percentage of vascular calcification
112199 Mass of Vascular CalcificationA measured or calculated mass of vascular calcification
112200 Average calcification distance in a calcification clusterThe average nearest neighbor distance of all individual microcalcifications in a cluster
112201 Standard deviation distance of calcifications in a clusterThe standard deviation of nearest neighbor distance of all individual microcalcifications in a cluster
112220 Colon CAD ReportA structured report containing the results of computer-aided detection or diagnosis applied to colon imaging and associated clinical information
112222 Colon Overall AssessmentOverall interpretation of the colon using C-RADS categorization system
112224 Image Set PropertiesCharacteristics of a set of images
112225 Slice ThicknessNominal slice thickness, in mm
112226 Spacing between slicesDistance between contiguous images, measured from the center-to-center of each image
112227 Frame of Reference UIDUniquely identifies groups of composite instances that have the same coordinate system that conveys spatial and/or temporal information
112228 Recumbent Patient Position with respect to gravityPatient orientation with respect to downward direction (gravity)
112229 Identifying SegmentDistinguishes a part of a segmentation
112232 Polyp stalk widthThe diameter of a polyp stalk measured perpendicular to the axis of the stalk
112233 Distance from anusThe length of the path following the centerline of the colon from the anus to the area of interest
112238 Anatomic non-colonA location in the body that is outside the colon
112240 C0 - Inadequate Study/Awaiting Prior ComparisonsAn inadequate study or a study that is awaiting prior comparisons. The study may have inadequate preparation and cannot exclude lesions greater than or equal to ten millimeters owing to presence of fluid or feces. The study may have inadequate insufflation where one or more colonic segments collapsed on both views. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9
112241 C1 - Normal Colon or Benign LesionThe study has a normal colon or benign lesion, with the recommendation to continue routine screening. The study has no visible abnormalities of the colon. The study has no polyps greater than six millimeters. The study may have lipoma, inverted diverticulum, or nonneoplastic findings, such as colonic diverticula. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9
112242 C2 - Intermediate Polyp or Indeterminate FindingThe study has an intermediate polyp or indeterminate finding and surveillance or colonoscopy is recommended. There may be intermediate polyps between six and nine millimeters and there are less than three in number. The study may have an intermediate finding and cannot exclude a polyp that is greater than or equal to six millimeters in a technically adequate exam. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9
112243 C3 - Polyp, Possibly Advanced AdenomaThe study has a polyp, possibly advanced adenoma, and a follow-up colonoscopy is recommended. The study has a polyp greater than or equal to ten millimeters or the study has three or more polyps that are each between six to nine millimeters. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9
112244 C4 - Colonic Mass, Likely MalignantThe study has a colonic mass, likely malignant, and surgical consultation is recommended. The lesion compromises bowel lumen and demonstrates extracolonic invasion. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9
112248 ACR Guideline, Performance of Adult CT ColonographyAmerican College of Radiology Practice Guideline for the Performance of Computed Tomography (CT) Colonography in Adults. In: Practice Guidelines and Technical Standards.Reston, Va: American College of Radiology;2006:371-376
112249 ACR Standard, CT medical physics performance monitoringAmerican College of Radiology Technical Standard for Diagnostic Medical Physics Performance Monitoring of Computed Tomography (CT) Equipment. In: Practice Guidelines and Technical Standards.Reston, Va: American College of Radiology;2006:945-948
112300 AP+45View Orientation Modifier indicates that the view orientation of the imaging plane is rotated +45° along the cranial-caudal axis
112301 AP-45View Orientation Modifier indicates that the view orientation of the imaging plane is rotated -45° along the cranial-caudal axis
112302 Anatomical axis of femurThe axis following the shaft of the femur
112303 Acetabular Center of RotationCenter of Rotation of the natural Acetabulum
112304 Femur Head Center of RotationCenter of Rotation of the natural femur head
112305 Acetabular Cup ShellProsthetic component implanted into the acetabulum. Provides hold for the insert that is mounted inside the cup
112306 Acetabular Cup InsertProsthetic pelvic joint component. Inserted into the cup, takes in the femoral head replacement
112307 Acetabular Cup MonoblockProsthetic pelvic joint cup including insert
112308 Femoral Head Ball ComponentComponent for Femoral Head Prosthesis where the conic intake for the stem neck can be exchanged. Combined with a Femoral Head Cone Taper Component
112309 Femoral Head Cone Taper ComponentExchangeable neck intake for composite femoral head prosthesis. Combined with a Femoral Head Ball Component
112310 Femoral StemProsthesis Implanted into the femoral bone to provide force transmission between joint replacement and bone. On the proximal end a conic neck holds the femoral head replacement
112311 Femoral Stem Distal ComponentDistal half of a modular stem prosthesis system. Combined with a Stem Proximal Component
112312 Femoral Stem Proximal ComponentProximal half of a modular stem prosthesis system. Combined with a Stem Distal Component
112313 Femoral Stem ComponentStem prosthetic component with a modular insert for an exchangeable neck component. Combined with a Neck Component
112314 Neck ComponentProsthetic Neck to be combined with a Stem Component
112315 Monoblock StemProsthetic Stem and Femoral Head in one piece
112316 Prosthetic Shaft AugmentA proximal attachment to the shaft used to compensate for bone deficiencies or bone loss
112317 Femoral Head Resurfacing ComponentArtificial femur head surface needed for the partial replacement of the femoral head where only the surface is replaced
112318 PinningFixation using a pin
112319 SewingFixation sewing several objects together
112320 BoltingFixation using a bolt
112321 WedgingFixation due to forcing an object into a narrow space
112325 Distal CentralizerAttachment to the distal end of a cemented stem assuring that the stem is in a central position inside the drilled femoral canal before cementation
112340 Generic 2D PlanningPlanning by an unspecified 2D method
112341 Generic 3D PlanningPlanning by an unspecified 3D method
112342 Generic Planning for Hip ReplacementPlanning of a Hip Replacement, by an unspecified method
112343 Generic Planning for Knee ReplacementPlanning of Knee Replacement, by an unspecified method
112344 Müller Method Planning for Hip ReplacementPlanning of Hip Replacement according to the procedure of M. E. Müller [Eggli et. al.1998]
112345 Implantation PlanA Report containing the results of an Implantation Planning Activity
112346 Selected Implant ComponentA selection of one Implant Component
112347 Component IDIdentification ID of an Implant Component
112348 Implant TemplateAn implant template describing the properties (2D/3D geometry and other data) of one Implant Component
112350 Component ConnectionA connection of two Connected Implantation Plan Components
112351 Mating Feature Set IDID of a Mating Feature Set in an Implant Component
112352 Mating Feature IDID of the Mating Feature in a Mating Feature Set in an Implant Component
112353 Spatial RegistrationThe Spatial Registration of one or more Implant Components
112354 Patient ImagePatient Images used for an implantation planning activity
112355 AssemblyA collection of Component Connections of Implant Components
112356 User Selected FiducialFiducials that are selected by the user and may or may not belong to anatomical landmarks
112357 Derived FiducialFiducials that represent geometric characteristics, such as center of rotation, and are derived from other fiducials
112358 Information used for planningAll parameters and data that were used for the planning activity
112359 Supporting InformationA description of the plan as encapsulated PDF SOP Instance
112360 Implant Component ListA list of all Implant Components selected for an implantation
112361 Patient Data Used During PlanningReference to objects containing patient data that is used for planning
112362 Degrees of Freedom SpecificationA specification of the values from one or more Degrees of Freedom
112363 Degree of Freedom IDID of one Degree of Freedom
112364 Related Patient Data Not Used During PlanningReference to objects containing patient data that were not used for planning but are somehow related
112365 Related Implantation ReportsImplantation Reports that are somehow related; e.g. contemporaneous implantations that are independent
112366 Implant Assembly TemplateImplant Assembly Template
112367 Planning Information for Intraoperative UsageInformation that is intended to be used intra-operatively
112368 Implantation Patient PositioningPosition of the patient on the operating room table
112369 Fiducial IntentIntended use of the fiducial
112370 Component TypeType of an Implant Component
112371 Manufacturer Implant TemplateImplant Template released by the Manufacturer
112372 Derived Planning ImagesImages that are created by a planning application
112373 Other Derived Planning DataData that is created by a planning application
112374 Connected Implantation Plan ComponentOne Implant Component that is connected to another Implant Component
112375 Planning MethodThe method used for planning
112376 Degree of Freedom Exact Translational ValueDefines the exact value that was planned for translation
112377 Degree of Freedom Minimum Translational ValueDefines the minimum value that was planned for translation
112378 Degree of Freedom Maximum Translational ValueDefines the maximum value that was planned for translation
112379 Degree of Freedom Exact Rotational Translation ValueDefines the exact value that was planned for rotation
112380 Degree of Freedom Minimum Rotational ValueDefines the minimum value that was planned for rotation
112381 Degree of Freedom Maximum Rotational ValueDefines the maximum value that was planned for rotation
112700 Peri-operative Photographic ImagingProcedure step protocol for photographic imaging of surgical procedures, including photography of specimens collected
112701 Gross Specimen ImagingProcedure step protocol for imaging gross specimens, typically with a photographic camera (modality XC), and planning further dissection
112702 Slide MicroscopyProcedure step protocol for imaging slide specimens
112703 Whole Slide ImagingProcedure step protocol for imaging slide specimens using a whole slide scanner
112704 WSI 20X RGBProcedure step protocol for imaging slide specimens using a whole slide scanner with a 20X nominal objective lens, in full color, with a single imaging focal plane across the image
112705 WSI 40X RGBProcedure step protocol for imaging slide specimens using a whole slide scanner with a 40X nominal objective lens, in full color, with a single imaging focal plane across the image
112706 Illumination MethodTechnique of illuminating specimen
112707 Number of focal planesNumber of focal planes for a microscopy image acquisition
112708 Focal plane Z offsetNominal distance above a reference plane (typically a slide glass substrate top surface) of the focal plane
112709 Magnification selectionMicroscope magnification based on nominal objective lens power
112710 Illumination wavelengthNominal center wavelength for an imaging spectral band
112711 Illumination spectral bandName (coded) for an imaging spectral band
112712 Optical filter typeType of filter inserted into the optical imaging path
112713 Tissue selection methodTechnique for identifying tissue to be imaged versus area of slide not to be imaged
112714 Multiple planesImaging performed at multiple imaging (focal) planes
112715 5XNominal 5 power objective lens, resulting in a digital image at approximately 2 um/pixel spacing
112716 10XNominal 10 power objective lens, resulting in a digital image at approximately 1 um/pixel spacing
112717 20XNominal 20 power microscope objective lens, resulting in a digital image at approximately 0.5 um/pixel spacing
112718 40XNominal 40 power microscope objective lens, with a combined condenser and objective lens numerical aperture of approximately 1.3, resulting in a digital image at approximately 0.25 um/pixel spacing
112719 Nominal empty tile suppressionEquipment-specific nominal or default method for identifying tiles without tissue imaged for suppression from inclusion in image object
112720 High threshold empty tile suppressionEquipment-specific high threshold method for identifying tiles without tissue imaged for suppression from inclusion in image object
112721 No empty tile suppressionTiles without tissue imaged are not suppressed from inclusion in image object
113000 Of InterestOf Interest
113001 Rejected for Quality ReasonsRejected for Quality Reasons
113002 For Referring ProviderFor Referring Provider
113003 For SurgeryFor Surgery
113004 For TeachingFor Teaching
113005 For ConferenceFor Conference
113006 For TherapyFor Therapy
113007 For PatientFor Patient
113008 For Peer ReviewFor Peer Review
113009 For ResearchFor Research
113010 Quality IssueQuality Issue
113011 Document Title ModifierDocument Title Modifier
113012 Key Object DescriptionKey Object Description
113013 Best In SetA selection that represents the "best" chosen from a larger set of items; e.g. the best images within a Study or Series. The criteria against which "best" is measured is not defined. Contrast this with the more specific term "Best illustration of finding"
113014 StudyA study is a collection of one or more series of medical images, presentation states, and/or SR documents that are logically related for the purpose of diagnosing a patient. A study may include composite instances that are created by a single modality, multiple modalities or by multiple devices of the same modality. [From Section A.1.2.2 "Study IE" in PS3.3 ]
113015 SeriesA distinct logical set used to group composite instances. All instances within a Series are of the same modality, in the same Frame of Reference (if any), and created by the same equipment. [See Section A.1.2.3 "Series IE" in PS3.3 ]
113016 Performed Procedure StepAn arbitrarily defined unit of service that has actually been performed (not just scheduled). [From Section 7.3.1.9 "Modality Performed Procedure Step" in PS3.3 ]
113017 Stage-ViewAn image or set of images illustrating a specific stage (phase in a stress echo exam protocol) and view (combination of the transducer position and orientation at the time of image acquisition)
113018 For PrintingFor Printing
113020 For Report AttachmentSelection of information objects for attachment to the clinical report of the Current Requested Procedure
113021 For LitigationList of objects that are related to litigation and should be specially handled; e.g. may apply if a complaint has been received regarding a patient, or a specific set of images has been the subject of a subpoena, and needs to be sequestered or excluded from automatic purging according to retention policy
113026 Double exposureDouble exposure
113030 ManifestA list of objects that have been exported out of one organizational domain into another domain. Typically, the first domain has no direct control over what the second domain will do with the objects
113031 Signed ManifestA signed list of objects that have been exported out of one organizational domain into another domain, referenced securely with either Digital Signatures or MACs. Typically, the first domain has no direct control over what the second domain will do with the objects
113032 Complete Study ContentThe list of objects that constitute a study at the time that the list was created
113033 Signed Complete Study ContentThe signed list of objects that constitute a study at the time that the list was created, referenced securely with either Digital Signatures or MACs
113034 Complete Acquisition ContentThe list of objects that were generated in a single procedure step
113035 Signed Complete Acquisition ContentThe signed list of objects that were generated in a single procedure step, referenced securely with either Digital Signatures or MACs
113036 Group of Frames for DisplayA list of frames or single-frame or entire multi-frame instances that together constitute a set for some purpose, such as might be displayed together in the same viewport, as distinct from another set that might be displayed in a separate viewport
113037 Rejected for Patient Safety ReasonsList of objects whose use is potentially harmful to the patient; e.g. an improperly labeled image could lead to dangerous surgical decisions
113038 Incorrect Modality Worklist EntryList of objects that were acquired using an incorrect modality worklist entry, and that should not be used, since they may be incorrectly identified
113039 Data Retention Policy ExpiredList of objects that have expired according to a defined data retention policy
113040 Lossy CompressionLossy compression has been applied to an image
113041 Apparent Diffusion CoefficientValues are derived by calculation of the apparent diffusion coefficient
113042 Pixel by pixel additionValues are derived by the pixel by pixel addition of two images
113043 Diffusion weightedValues are derived by calculation of the diffusion weighting
113044 Diffusion AnisotropyValues are derived by calculation of the diffusion anisotropy
113045 Diffusion AttenuatedValues are derived by calculation of the diffusion attenuation
113046 Pixel by pixel divisionValues are derived by the pixel by pixel division of two images
113047 Pixel by pixel maskValues are derived by the pixel by pixel masking of one image by another
113048 Pixel by pixel MaximumValues are derived by calculating the pixel by pixel maximum of two or more images
113049 Pixel by pixel meanValues are derived by calculating the pixel by pixel mean of two or more images
113050 Metabolite Maps from spectroscopy dataValues are derived by calculating from spectroscopy data pixel values localized in two dimensional space based on the concentration of specific metabolites (i.e, at specific frequencies)
113051 Pixel by pixel MinimumValues are derived by calculating the pixel by pixel minimum of two or more images
113052 Mean Transit TimeThe time required for blood to pass through a region of tissue
113053 Pixel by pixel multiplicationValues are derived by the pixel by pixel multiplication of two images
113054 Negative Enhancement IntegralValues are derived by calculating negative enhancement integral values
113055 Regional Cerebral Blood FlowThe flow rate of blood perfusing a region of the brain as volume per mass per unit of time
113056 Regional Cerebral Blood VolumeThe volume of blood perfusing a region of brain as volume per mass
113057 R-CoefficientCorrelation Coefficient, r
113058 Proton DensityValues are derived by calculating proton density values
113059 Signal ChangeValues are derived by calculating signal change values
113060 Signal to NoiseValues are derived by calculating the signal to noise ratio
113061 Standard DeviationValues are derived by calculating the standard deviation of two or more images
113062 Pixel by pixel subtractionValues are derived by the pixel by pixel subtraction of two images
113063 T1Values are derived by calculating T1 values
113064 T2*Values are derived by calculating T2* values
113065 T2Values are derived by calculating T2 values
113066 Time Course of SignalValues are derived by calculating values based on the time course of signal
113067 Temperature encodedValues are derived by calculating values based on temperature encoding
113068 Student's T-TestValues are derived by calculating the value of the Student's T-Test statistic from multiple image samples
113069 Time To PeakThe time from the start of the contrast agent injection to the maximum enhancement value
113070 Velocity encodedValues are derived by calculating values based on velocity encoded; e.g. phase contrast
113071 Z-ScoreValues are derived by calculating the value of the Z-Score statistic from multiple image samples
113072 Multiplanar reformattingValues are derived by reformatting in a flat plane other than that originally acquired
113073 Curved multiplanar reformattingValues are derived by reformatting in a curve plane other than that originally acquired
113074 Volume renderingValues are derived by volume rendering of acquired data
113075 Surface renderingValues are derived by surface rendering of acquired data
113076 SegmentationValues are derived by segmentation (classification into tissue types) of acquired data
113077 Volume editingValues are derived by selectively editing acquired data (removing values from the volume), such as in order to remove obscuring structures or noise
113078 Maximum intensity projectionValues are derived by maximum intensity projection of acquired data
113079 Minimum intensity projectionValues are derived by minimum intensity projection of acquired data
113080 Glutamate and glutamineFor single-proton MR spectroscopy, the resonance peak corresponding to glutamate and glutamine
113081 Choline/Creatine RatioFor single-proton MR spectroscopy, the ratio between the Choline and Creatine resonance peaks
113082 N-acetylaspartate /Creatine RatioFor single-proton MR spectroscopy, the ratio between the N-acetylaspartate and Creatine resonance peaks
113083 N-acetylaspartate /Choline RatioFor single-proton MR spectroscopy, the ratio between the N-acetylaspartate and Choline resonance peaks
113085 Spatial resamplingValues are derived by spatial resampling of acquired data
113086 Edge enhancementValues are derived by edge enhancement
113087 SmoothingValues are derived by smoothing
113088 Gaussian blurValues are derived by Gaussian blurring
113089 Unsharp maskValues are derived by unsharp masking
113090 Image stitchingValues are derived by stitching two or more images together
113091 Spatially-related frames extracted from the volumeSpatially-related frames in this image are representative frames from the referenced 3D volume data set
113092 Temporally-related frames extracted from the set of volumesTemporally-related frames in this image are representative frames from the referenced 3D volume data set
113093 Polar to Rectangular Scan ConversionConversion of a polar coordinate image to rectangular (Cartesian) coordinate image
113094 Creatine and CholineFor single-proton MR spectroscopy, the resonance peak corresponding to creatine and choline
113095 Lipid and LactateFor single-proton MR spectroscopy, the resonance peak corresponding to lipid and lactate
113096 Creatine+Choline/ Citrate RatioFor single-proton MR spectroscopy, the ratio between the Choline and Creatine resonance peak and the Citrate resonance peak
113097 Multi-energy proportional weightingImage pixels created through proportional weighting of multiple acquisitions at distinct X-Ray energies
113100 Basic Application Confidentiality ProfileDe-identification using a profile defined in PS3.15 that requires removing all information related to the identity and demographic characteristics of the patient, any responsible parties or family members, any personnel involved in the procedure, the organizations involved in ordering or performing the procedure, additional information that could be used to match instances if given access to the originals, such as UIDs, dates and times, and private attributes, when that information is present in the non-Pixel Data Attributes, including graphics or overlays
113101 Clean Pixel Data OptionAdditional de-identification according to an option defined in PS3.15 that requires any information burned in to the Pixel Data corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed
113102 Clean Recognizable Visual Features OptionAdditional de-identification according to an option defined in PS3.15 that requires that sufficient removal or distortion of the Pixel Data shall be applied to prevent recognition of an individual from the instances themselves or a reconstruction of a set of instances
113103 Clean Graphics OptionAdditional de-identification according to an option defined in PS3.15 that requires that any information encoded in graphics, text annotations or overlays corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed
113104 Clean Structured Content OptionAdditional de-identification according to an option defined in PS3.15 that requires that any information encoded in SR Content Items or Acquisition Context Sequence Items corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed
113105 Clean Descriptors OptionAdditional de-identification according to an option defined in PS3.15 that requires that any information that is embedded in text or string Attributes corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed
113106 Retain Longitudinal Temporal Information Full Dates OptionRetention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any dates and times be retained,
113107 Retain Longitudinal Temporal Information Modified Dates OptionRetention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any dates and times be modified in a manner that preserves temporal relationships; e.g. Study Date and Time
113108 Retain Patient Characteristics OptionRetention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any physical characteristics of the patient, which are descriptive rather than identifying information per se, be retained; e.g. Patient's Age, Sex, Size (height) and Weight
113109 Retain Device Identity OptionRetention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any information that identifies a device be retained; e.g. Device Serial Number
113110 Retain UIDs OptionRetention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that UIDs be retained; e.g. SOP Instance UID
113111 Retain Safe Private OptionRetention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that private attributes that are known not to contain identity information be retained; e.g. private SUV scale factor
113500 Radiopharmaceutical Radiation Dose ReportThe procedure report is a Radiopharmaceutical Radiation Dose report
113502 Radiopharmaceutical AdministrationInformation pertaining to the administration of a radiopharmaceutical
113503 Radiopharmaceutical Administration Event UIDUnique identification of a single radiopharmaceutical administration event
113505 Intravenous Extravasation SymptomsInitial signs or symptoms of extravasation
113506 Estimated Extravasation ActivityThe estimated percentage of administered activity lost at the injection site. The estimation includes extravasation, paravenous administration and leakage at the injection site
113507 Administered activityThe calculated activity at the Radiopharmaceutical Start Time when the radiopharmaceutical is administered to the patient. The residual activity (i.e. radiopharmaceutical not administered) , if measured, is reflected in the calculated value. The estimated extravasation is not reflected in the calculated value
113508 Pre-Administration Measured ActivityRadioactivity measurement of radiopharmaceutical before or during the administration
113509 Post-Administration Measured ActivityRadioactivity measurement of radiopharmaceutical after the administration
113510 Drug Product IdentifierRegistered drug establishment code for product, coding scheme example is NDC or RxNorm
113511 Radiopharmaceutical Dispense Unit IdentifierThe human readable identification of the specific radiopharmaceutical dispensed quantity or dose ("dose" as unit of medication delivery, not radiation dose measure) to be administered to the patient
113512 Radiopharmaceutical Lot IdentifierIdentifies the vial, batch or lot number from which the individual dispense radiopharmaceutical quantity (dose) is produced. The Radiopharmaceutical Dispense Unit Identifier records the identification for each individual dose
113513 Reagent Vial IdentifierIdentifies the lot or unit serial number for the reagent component for the radiopharmaceutical
113514 Radionuclide Vial IdentifierIdentifies the lot or unit serial number for the radionuclide component for the radiopharmaceutical
113516 Prescription IdentifierAdministered Product's Prescription Number
113517 Organ Dose InformationInformation pertaining to the estimated absorbed radiation dose to an organ
113518 Organ DoseThe absorbed radiation dose to organ
113520 MIRD Pamphlet 1Reference authority MIRD Pamphlet No.1 (rev) ,Society of Nuclear Medicine, 1976
113521 ICRP Publication 53Reference authority ICRP, 1988. Radiation Dose to Patients from Radiopharmaceuticals. ICRP Publication 53. Ann. ICRP 18 (1-4)
113522 ICRP Publication 80Reference authority ICRP, 1998. Radiation Dose to Patients from Radiopharmaceuticals (Addendum to ICRP Publication 53). ICRP Publication 80. Ann. ICRP 28 (3)
113523 ICRP Publication 106Reference authority ICRP, 2008. Radiation Dose to Patients from Radiopharmaceuticals - Addendum 3 to ICRP Publication 53. ICRP Publication 106. Ann. ICRP 38 (1-2)
113526 MIRDOSEReference authority Stabin MG, Sparks RB, Crowe E (1994) MIRDOSE: personal computer software for internal dose assessment in nuclear medicine [Computer program]
113527 OLINDA-EXMReference authority Stabin MG, Sparks RB, Crowe E (2005) OLINDA/EXM: The Second-Generation Personal Computer Software for Internal Dose Assessment in Nuclear Medicine [Computer program]
113528 Package InsertReference authority The reported organ dose is based on radiopharmaceutical's package insert
113529 Institutionally Approved EstimatesReference authority The reported organ dose is based on Institutionally approved estimates from the Radioactive Drug Research Committee (RDRC) of the institution itself
113530 Investigational New DrugReference authority The reported organ dose is based on an Investigation new drug
113540 Activity Measurement DeviceThe type of device that performed the activity measurement
113541 Dose CalibratorThe device that measures the radiation activity of the radiopharmaceutical
113542 Infusion SystemRadiopharmaceutical Infusion System
113543 GeneratorRadioisotope Generator
113550 Fasting DurationThe number hours the patient has gone without food
113551 Hydration VolumeThe amount of fluids the patient has consumed before the procedure
113552 Recent Physical ActivityA description of physical activity the patient performed before the start of the procedure, such as that which may affect imaging agent biodistribution
113560 Acute unilateral renal blockageBlockage in one of the tubes (ureters) that drain urine from the kidneys
113561 Low Thyroid Uptake5% or less Thyroid Uptake of Iodine
113562 High Thyroid Uptake25% or higher Thyroid Uptake of Iodine
113563 Severely JaundicedThe patient exhibits symptoms severe of jaundice and/or has a Bilirubin >10 mg/dL
113568 Extravasation visible in imageExtravasation or paravenous administration of the product is visible in the images
113570 Cockroft-Gault Formula estimation of GFRThe measurement method of the Glomerular Filtration Rate is Cockroft-Gault Formula
113571 CKD-EPI Formula estimation of GFRThe measurement method of the Glomerular Filtration Rate is CKD-EPI Formula
113572 Glomerular Filtration Rate (MDRD)The measurement method of the Glomerular Filtration Rate is MDRD
113573 Glomerular Filtration Rate non-black (MDRD)The measurement method of the Glomerular Filtration Rate is non-black MDRD
113574 Glomerular Filtration Rate black (MDRD)The measurement method of the Glomerular Filtration Rate is black (MDRD)
113575 Glomerular Filtration Rate female (MDRD)The measurement method of the Glomerular Filtration Rate is female (MDRD)
113576 Glomerular Filtration Rate Cystatin-based formulaThe measurement method of the Glomerular Filtration Rate is Cystatin-based formula
113577 Glomerular Filtration Rate Creatinine-based formula (Schwartz)The measurement method of the Glomerular Filtration Rate is Creatinine-based formula (Schwartz)
113601 Small: < 32.0 cm lateral thicknessSmall body thickness for calcium scoring adjustment. Lateral thickness is measured from skin-to-skin, at the level of the proximal ascending aorta, from an A/P localizer image
113602 Medium: 32.0-38.0 cm lateral thicknessMedium body thickness for calcium scoring adjustment. Lateral thickness is measured from skin-to-skin, at the level of the proximal ascending aorta, from an A/P localizer image
113603 Large: > 38.0 cm lateral thicknessLarge body thickness for calcium scoring adjustment. Lateral thickness is measured from skin-to-skin, at the level of the proximal ascending aorta, from an A/P localizer image
113605 Irradiation Event LabelA human-readable label identifying an irradiation event
113606 Label TypeThe type of a human-readable label
113607 Series NumberA number that identifies a Series. Corresponds to (0020,0011) in PS3.3
113608 Acquisition NumberA number that identifies an Acquisition. Corresponds to (0020,0012) in PS3.3
113609 Instance NumberA number that identifies an Instance. Corresponds to (0020,0013) in PS3.3
113611 Stationary AcquisitionAcquisition where the X-Ray source does not move in relation to the patient
113612 Stepping AcquisitionAcquisition where the X-Ray source moves laterally in relation to the patient
113613 Rotational AcquisitionAcquisition where the X-Ray source moves angularly in relation to the patient
113620 Plane APrimary plane of a Biplane acquisition equipment
113621 Plane BSecondary plane of a Biplane acquisition equipment
113622 Single PlaneSingle plane acquisition equipment
113630 ContinuousContinuous X-Ray radiation is applied during an irradiation event
113631 PulsedPulsed X-Ray radiation is applied during an irradiation event
113650 Strip filterFilter with uniform thickness
113651 Wedge filterFilter with variation in thickness from one edge to the opposite edge
113652 Butterfly filterFilter with two triangular sections
113653 Flat filterFilter with uniform thickness that is for spectral filtering only; e.g. filter out low energy portion of the X-Ray that would only contribute to skin dose, but not to image
113661 Outline of lobulationsA polyline defining the outline of a lobulated finding
113662 Inner limits of fuzzy marginA polyline defining the inner limits of a finding with fuzzy margin
113663 Outer limits of fuzzy marginA polyline defining the outer limits of a finding with fuzzy margin
113664 Outline of spiculationsA polyline defining the outline of the spiculations of a finding
113665 Linear spiculationA polyline segment graphically indicating the location and direction of a spiculation of a finding
113666 Pixelated spiculationsA collection of points indicating the pixel locations of the spiculations of a finding
113669 Orthogonal location arcConnected line segments indicating the center of location of a finding on an orthogonal view
113670 Orthogonal location arc inner marginConnected line segments indicating the inner margin of the location of a finding on an orthogonal view
113671 Orthogonal location arc outer marginConnected line segments indicating the outer location of a finding on an orthogonal view
113680 Quality Control IntentThis procedure is intended to gather data that is used for calibration or other quality control purposes
113681 PhantomAn artificial subject of an imaging study
113682 ACR Accreditation Phantom - CTA phantom acceptable for the ACR Computed Tomography Accreditation program
113683 ACR Accreditation Phantom - MRA phantom acceptable for the ACR Magnetic Resonance Imaging Accreditation program
113684 ACR Accreditation Phantom - MammographyA phantom acceptable for the ACR Mammography Accreditation program
113685 ACR Accreditation Phantom - Stereotactic Breast BiopsyA phantom acceptable for the ACR Stereotactic Breast Biopsy Accreditation program
113686 ACR Accreditation Phantom - ECTA phantom acceptable for the ACR SPECT Accreditation program (but not for PET)
113687 ACR Accreditation Phantom - PETA phantom acceptable for the ACR PET Accreditation program (but not for SPECT)
113688 ACR Accreditation Phantom - ECT/PETA SPECT phantom with a PET faceplate acceptable for both the ACR SPECT and PET Accreditation programs
113689 ACR Accreditation Phantom - PET FaceplateA PET faceplate (made to fit an existing flangeless or flanged ECT phantom) acceptable for the ACR PET Accreditation program
113690 IEC Head Dosimetry PhantomA phantom used for CTDI measurement in head modes according to IEC 60601-2-44, Ed.2.1 (Head 16 cm diameter Polymethyl methacrylate PMMA)
113691 IEC Body Dosimetry PhantomA phantom used for CTDI measurement in body modes according to IEC 60601-2-44, Ed.2.1 (Body 32cm diameter Polymethyl methacrylate PMMA)
113692 NEMA XR21-2000 PhantomA phantom in accordance with NEMA standard XR-21-2000
113701 X-Ray Radiation Dose ReportX-Ray Radiation Dose Report
113702 Accumulated X-Ray Dose DataX-Ray dose data accumulated over multiple irradiation events; e.g. for a study or a performed procedure step
113704 Projection X-RayImaging using a point X-Ray source with a diverging beam projected onto a 2 dimensional detector
113705 Scope of AccumulationEntity over which dose accumulation values are integrated
113706 Irradiation Event X-Ray DataX-Ray dose data for a single Irradiation Event
113710 Niobium or Niobium compoundMaterial containing Niobium or a Niobium compoundDeprecated
113711 Europium or Europium compoundMaterial containing Europium or a Europium compoundDeprecated
113720 Calibration ProtocolDescribes the method used to derive the calibration factor
113721 Irradiation Event TypeDenotes the type of irradiation event recorded
113722 Dose Area Product TotalTotal calculated Dose Area Product (in the scope of the including report)
113723 Calibration DateLast calibration Date for the integrated dose meter or dose calculation
113724 Calibration Responsible PartyIndividual or organization responsible for calibration
113725 Dose (RP) TotalTotal Dose related to Reference Point (RP). (in the scope of the including report)
113726 Fluoro Dose Area Product TotalTotal calculated Dose Area Product applied in Fluoroscopy Modes (in the scope of the including report)
113727 Acquisition Dose Area Product TotalTotal calculated Dose Area Product applied in Acquisition Modes (in the scope of the including report)
113728 Fluoro Dose (RP) TotalDose applied in Fluoroscopy Modes, related to Reference Point (RP). (in the scope of the including report)
113729 Acquisition Dose (RP) TotalDose applied in Acquisition Modes, related to Reference Point (RP). (in the scope of the including report)
113730 Total Fluoro TimeTotal accumulated clock time of Fluoroscopy in the scope of the including report (i.e., the sum of the Irradiation Duration values for accumulated fluoroscopy irradiation events)
113731 Total Number of Radiographic FramesAccumulated Count of exposure pulses (single or multi-frame encoded) created from irradiation events performed with high dose (acquisition)
113732 Fluoro ModeMode of application of X-Rays during Fluoroscopy
113733 KVPApplied X-Ray Tube voltage at peak of X-Ray generation, in kilovolts; Mean value if measured over multiple peaks (pulses)
113734 X-Ray Tube CurrentMean value of applied Tube Current
113735 Exposure TimeCumulative time the patient has received X-Ray exposure during the irradiation eventDeprecated
113736 ExposureMean value of X-Ray Current Time product
113737 Distance Source to Reference PointDistance to the Reference Point (RP) defined according to IEC 60601-2-43 or equipment defined
113738 Dose (RP)Dose applied at the Reference Point (RP)
113739 Positioner Primary End AnglePositioner Primary Angle at the end of an irradiation event. For further definition see (112011, DCM, "Positioner Primary Angle")
113740 Positioner Secondary End AnglePositioner Secondary Angle at the end of an irradiation event. For further definition see (112012, DCM, "Positioner Secondary Angle")
113742 Irradiation DurationClock time from the start of loading time of the first pulse until the loading time trailing edge of the final pulse in the same irradiation event. Note Loading time is defined in IEC 60601-1-3:2008, 3.37, and described in IEC 60601-2-54:2009, 203.4.101.3
113743 Patient OrientationOrientation of the Patient with respect to Gravity
113744 Patient Orientation ModifierEnhances or modifies the Patient orientation specified in Patient Orientation
113745 Patient Table RelationshipOrientation of the Patient with respect to the Head of the Table
113748 Distance Source to IsocenterDistance from the X-Ray Source to the Equipment C-Arm Isocenter.(Center of Rotation)
113750 Distance Source to DetectorMeasured or calculated distance from the X-Ray source to the detector plane in the center of the beam
113751 Table Longitudinal PositionTable Longitudinal Position with respect to an arbitrary chosen reference by the equipment. Table motion towards LAO is positive assuming that the patient is positioned supine and its head is in normal position
113752 Table Lateral PositionTable Lateral Position with respect to an arbitrary chosen reference by the equipment. Table motion towards CRA is positive assuming that the patient is positioned supine and its head is in normal position
113753 Table Height PositionTable Height Position with respect to an arbitrary chosen reference by the equipment in (mm). Table motion downwards is positive
113754 Table Head Tilt AngleAngle of the head-feet axis of the table in degrees relative to the horizontal plane. Positive values indicate that the head of the table is upwards
113755 Table Horizontal Rotation AngleRotation of the table in the horizontal plane (clockwise when looking from above the table)
113756 Table Cradle Tilt AngleAngle of the left-right axis of the table in degrees relative to the horizontal plane. Positive values indicate that the left of the table is upwards
113757 X-Ray Filter MaterialX-Ray absorbing material used in the filter
113758 X-Ray Filter Thickness MinimumThe minimum thickness of the X-Ray absorbing material used in the filters
113759 Table Longitudinal End PositionTable Longitudinal Position at the end of an irradiation event; see (113751, DCM, "Table Longitudinal Position")
113760 Table Lateral End PositionTable Lateral Position at the end of an irradiation event; see (113752, DCM, "Table Lateral Position")
113761 Table Height End PositionTable Height Position at the end of an irradiation event; see (113753, DCM, "Table Height Position")
113763 Calibration UncertaintyUncertainty of the 'actual' value
113764 Acquisition PlaneIdentification of Acquisition Plane with Biplane systems
113766 Focal Spot SizeNominal Size of Focal Spot of X-Ray Tube
113767 Average X-Ray Tube CurrentAverage X-Ray Tube Current averaged over time for pulse or for continuous Fluoroscopy
113768 Number of PulsesNumber of pulses applied by X-Ray systems during an irradiation event (acquisition run or pulsed fluoro)
113769 Irradiation Event UIDUnique identification of a single irradiation event
113770 Column AngulationAngle of the X-Ray beam in degree relative to an orthogonal axis to the detector plane
113771 X-Ray FiltersDevices used to modify the energy or energy distribution of X-Rays
113772 X-Ray Filter TypeType of filter(s) inserted into the X-Ray beam; e.g. wedges
113773 X-Ray Filter Thickness MaximumThe maximum thickness of the X-Ray absorbing material used in the filters
113780 Reference Point DefinitionSystem provided definition of the Reference Point used for Dose calculations
113788 Collimated Field HeightDistance between the collimator blades in pixel column direction as projected at the detector plane
113789 Collimated Field WidthDistance between the collimator blades in pixel row direction as projected at the detector plane
113790 Collimated Field AreaCollimated field area at image receptor. Area for compatibility with IEC 60601-2-43
113791 Pulse RatePulse rate applied by equipment during Fluoroscopy
113792 Distance Source to Table PlaneMeasured or calculated distance from the X-Ray source to the table plane in the center of the beam
113793 Pulse Width(Average) X-Ray pulse width
113794 Dose Measurement DeviceCalibrated device to perform dose measurements
113795 Acquired ImageImage acquired during a specified event
113800 DLP to E conversion via MC computationEffective Dose evaluation from the product of Dose Length Product (DLP) and the Effective Dose Conversion Factor (E/DLP in units of mSv/mGy-cm), where the ratio is derived by means of Monte Carlo computations
113801 CTDIfreeair to E conversion via MC computationEffective Dose evaluation from the product of the Mean CTDIfreeair and the ratio E/CTDIfreeair (mSv/mGy), where the ratio is derived by means of Monte Carlo computations
113802 DLP to E conversion via measurementEffective Dose evaluation from the product of Dose Length Product (DLP) and the Effective Dose Conversion Factor (E/DLP in units of mSv/mGy-cm), where the ratio is derived by means of dosimetric measurements with an anthropomorphic phantom
113803 CTDIfreeair to E conversion via measurementEffective Dose evaluation from the product of the Mean CTDIfreeair and the ratio E/CTDIfreeair (mSv/mGy), where the ratio is derived by means of dosimetric measurements with an anthropomorphic phantom
113804 Sequenced AcquisitionThe CT acquisition was performed by acquiring single or multi detector data while rotating the source about the gantry while the table is not moving. Additional slices are acquired by incrementing the table position and again rotating the source about the gantry while the table is not moving
113805 Constant Angle AcquisitionThe CT acquisition was performed by holding the source at a constant angle and moving the table to obtain a projection image; e.g. localizer
113806 Stationary AcquisitionThe CT acquisition was performed by holding the table at a constant position and acquiring multiple slices over time at the same location
113807 Free AcquisitionThe CT acquisition was performed while rotating the source about the gantry while the table movement is under direct control of a human operator or under the control of an analysis application; e.g. fluoro
113808 ICRP Pub 60Reference authority 1990 Recommendations of the International Commission on Radiological Protection (ICRP Publication 60, published as the Annals of the ICRP Vol. 21, No. 1-3, Pergamon Press,1991)
113809 Start of X-Ray IrradiationStart, DateTime of the first X-Ray Irradiation Event of the accumulation within a Study
113810 End of X-Ray IrradiationEnd, DateTime of the last X-Ray Irradiation Event of the accumulation within a Study
113811 CT Accumulated Dose DataX-Ray dose accumulated over multiple CT irradiation events; e.g. for a study or a performed procedure step
113812 Total Number of Irradiation EventsTotal number of events during the defined scope of accumulation
113813 CT Dose Length Product TotalThe total dose length product defined scope of accumulation
113814 CT Effective Dose TotalThe total Effective Dose at the defined scope of accumulation
113815 Patient ModelIdentification of the reference-patient model used when Effective Dose is evaluated via Monte Carlo calculations or from a Dose Length Product conversion factor based on Monte Carlo calculations
113816 Condition Effective Dose measuredReferences the physical phantom and the type of dosimeter used when measurements are done to establish Effective Dose Conversion Factors (E/DLP) or ratios E/CTDIfreeair
113817 Effective Dose Phantom TypeType of Effective Dose phantom used
113818 Dosimeter TypeType of dosimeter used
113819 CT AcquisitionGeneral description of the CT Irradiation event
113820 CT Acquisition TypeMethod of the CT acquisition
113821 X-Ray Filter Aluminum EquivalentThickness of an equivalent filter in mm in Aluminum
113822 CT Acquisition ParametersGeneral description of the acquisition parameters
113823 Number of X-Ray SourcesNumber of X-Ray sources
113824 Exposure TimeTotal time the patient has received X-Ray exposure during the irradiation event
113825 Scanning LengthLength of the table travel during the entire tube loading, according to IEC 60601-2-44 Note Scanning Length might be longer than the programmed acquisition length (Length of Reconstructable Volume)
113826 Nominal Single Collimation WidthThe value of the nominal width referenced to the location of the isocenter along the z axis of a single row of acquired data in mm
113827 Nominal Total Collimation WidthThe value of the nominal width referenced to the location of the isocenter along the z axis of the total collimation in mm over the area of active X-Ray detection
113828 Pitch FactorFor Spiral scanning: Pitch Factor = (Table Feed per Rotation (mm)) /(Nominal Total Collimation Width (mm)) For Sequenced scanning: Pitch Factor = (Table Feed per single Sequenced scan (mm)) /(Nominal Total Collimation Width (mm))
113829 CT DoseGeneral description of CT dose values
113830 Mean CTDIvol"Mean CTDIvol" refers to the average value of the CTDIvol associated with this acquisition
113831 CT X-Ray Source ParametersIdentification, tube-potential, tube-current, and exposure-time parameters associated with an X-Ray source during an acquisition
113832 Identification of the X-Ray SourceIdentifies the particular X-Ray source (in a multi-source CT system) for which the set of X-Ray source parameter values is reported
113833 Maximum X-Ray Tube CurrentMaximum X-Ray tube current
113834 Exposure Time per RotationThe exposure time for one rotation of the source around the object in s
113835 CTDIw Phantom TypeA label describing the type of phantom used for CTDIW measurement according to IEC 60601-2-44 (Head 16 cm diameter PMMA, Body 32 cm diameter PMMA)
113836 CTDIfreeair Calculation FactorThe CTDIfreeair Calculation Factor is the CTDIfreeair per mAs, expressed in units of mGy/mAs. The CTDIfreeair Calculation Factor may be used in one method calculating Dose
113837 Mean CTDIfreeairThe average value of the free-in-air CTDI associated with this acquisition
113838 DLPDose Length Product (DLP), expressed in mGy-cm, is an index characterizing the product of the CTDIvol and the length scanned. For Spiral scanning, DLP = CTDIvol x Scanning Length. For Sequenced scanning, DLP = CTDIvol x Nominal Total Collimation Width x Cumulative Exposure Time / Exposure Time per Rotation. For Stationary and Free scanning, DLP = CTDIvol x Nominal Total Collimation Width
113839 Effective DoseEffective dose in mSv
113840 Effective Dose Conversion FactorEffective Dose per DLP, reference value for Effective Dose calculation, expressed in mSv/mGY.cm
113841 ICRP Pub 103Effective Dose Reference authority 2007 Recommendations of the International Commission on Radiological Protection (ICRP Publication 103, published as the Annals of the ICRP Vol. 37, No. 2-4, Elsevier, 2007)
113842 X-Ray Modulation TypeThe type of exposure modulation used for the purpose of limiting the dose
113845 Exposure IndexMeasure of the detector response to radiation in the relevant image region of an image acquired with a digital X-Ray imaging system as defined in IEC 62494-1; see PS3.3 definition of Exposure Index Macro
113846 Target Exposure IndexThe target value used to calculate the Deviation Index as defined in IEC 62494-1; see PS3.3 definition of Exposure Index Macro
113847 Deviation IndexA scaled representation of the accuracy of the Exposure Index compared to the Target Exposure Index as defined in IEC 62494-1; see PS3.3 definition of Exposure Index Macro
113850 Irradiation AuthorizingThe clinician responsible for determining that the irradiating procedure was appropriate for the indications
113851 Irradiation AdministeringThe person responsible for the administration of radiation
113852 Irradiation EventAn irradiation event is the loading of X-Ray equipment caused by a single continuous actuation of the equipment's irradiation switch, from the start of the loading time of the first pulse until the loading time trailing edge of the final pulse. Any automatic on-off switching of the irradiation source during the event is not treated as separate events, rather the event includes the time between start and stop of irradiation as triggered by the user; e.g. a pulsed fluoro X-Ray acquisition shall be treated as a single irradiation event
113853 Irradiation Event UIDUnique Identifier of an Irradiation Event
113854 Source of Dose InformationMethod by which dose-related details of an Irradiation Event were obtained
113855 Total Acquisition TimeTotal accumulated acquisition clock time in the scope of the including report (i.e., the sum of the Irradiation Duration values for accumulated acquisition irradiation events)
113856 Automated Data CollectionDirect recording of data by a relevant system
113857 Manual EntryRecording of data by a human operator, including manual transcription of electronic data
113858 MPPS ContentThe data is taken from an MPPS SOP Instance
113859 Irradiating DeviceA device exposing a patient to ionizing radiation
113860 15cm from Isocenter toward Source15cm from the isocenter towards the X-Ray source; See IEC 60601-2-43
113861 30cm in Front of Image Input Surface30cm in front (towards the tube) of the input surface of the image receptor; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d) (7)
113862 1cm above Tabletop1cm above the patient tabletop or cradle; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d) (7)
113863 30cm above Tabletop30cm above the patient tabletop of cradle; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d) (7)
113864 15cm from Table Centerline15cm from the centerline of the X-Ray table and in the direction of the X-Ray source; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d) (7)
113865 Entrance exposure to a 4.2 cm breast thicknessStandard breast means a 4.2 centimeter (cm) thick compressed breast consisting of 50 percent glandular and 50 percent adipose tissue. See Department of Health and Human Services, Food and Drug Administration. Mammography quality standards; final rule. Federal Register. Oct. 28, 1997; 68(208):55852-55994; see 900.2(uu)
113866 Copied From Image AttributesThe data is copied from information present in the image attributes; e.g. dose attributes such as CTDIvol (0018,9345)
113867 Computed From Image AttributesThe data is computed from information present in the image attributes; e.g. by using dosimetry information for the specific irradiating device make and model, applied to technique information such as KVP and mAs
113868 Derived From Human-Readable ReportsThe data is derived from human-readable reports; e.g. by natural language parsing of text reports, or optical character recognition from reports saved as images by the irradiating device
113870 Person NameThe name of a specific person
113871 Person IDAn identification number or code for a specific person
113872 Person ID IssuerThe organization that issued a Person ID
113873 Organization NameThe name of an organization
113874 Person Role in OrganizationThe role played by a person in an organization
113875 Person Role in ProcedureThe role played by a person in a procedure
113876 Device Role in ProcedureThe role played by a device in a procedure
113877 Device NameThe name used to refer to a device; usually locally unique
113878 Device ManufacturerManufacturer of a device
113879 Device Model NameModel Name of a device
113880 Device Serial NumberSerial Number of a device
113890 All PlanesAll planes of a multi-plane acquisition equipment
113893 Length of Reconstructable VolumeThe length from which images may be reconstructed (i.e., excluding any overranging performed in a spiral acquisition that is required for data interpolation). Value is distinct from (1113825, DCM, "Scanning Length"), which is the actual length of the table travel during the entire tube loading, according to IEC 60601-2-44, and includes overranging. Also distinct from any actual Reconstructed Volume, which may depend on the slice thickness chosen for a particular reconstruction
113895 Top Z Location of Reconstructable VolumeThe Z location that is the top (highest Z value) of the Reconstructable Volume. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference
113896 Bottom Z Location of Reconstructable VolumeThe Z location that is the bottom (lowest Z value) of the Reconstructable Volume. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference
113897 Top Z Location of Scanning LengthThe Z location that is the top (highest Z value) of the scanning length. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference
113898 Bottom Z Location of Scanning LengthThe Z location that is the bottom (lowest Z value) of the scanning length. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference
113899 Exposed RangeThe range along the z axis of the total volume irradiated, per IEC 60601-2-44, Ed. 3, 203.115(b). The start and stop of loading corresponding to the outer edge of the full width half maximum of the free-in-air dose profile for the beam collimation used
113900 Dose Check Alert DetailsReport section about cumulative dose alerts during an examination
113901 DLP Alert Value ConfiguredFlag denoting whether a DLP Alert Value was configured
113902 CTDIvol Alert Value ConfiguredFlag denoting whether a CTDIvol Alert Value was configured
113903 DLP Alert ValueCumulative Dose Length Product value configured to trigger an alert; see NEMA XR 25-2010 Dose Check Standard
113904 CTDIvol Alert ValueCumulative CTDIvol value configured to trigger an alert; see NEMA XR 25-2010 Dose Check Standard
113905 Accumulated DLP Forward EstimateA forward estimate of the accumulated DLP plus the estimated DLP for the next Protocol Element Group; see NEMA XR 25-2010 Dose Check Standard
113906 Accumulated CTDIvol Forward EstimateA forward estimate at a given location of the accumulated CTDIvol plus the estimated CTDIvol for the next Protocol Element Group; see NEMA XR 25-2010 Dose Check Standard
113907 Reason for ProceedingReason provided for proceeding with a procedure that is projected to exceed a configured dose value
113908 Dose Check Notification DetailsReport section about dose notifications during a protocol element
113909 DLP Notification Value ConfiguredFlag denoting whether a DLP Notification Value was configured
113910 CTDIvol Notification Value ConfiguredFlag denoting whether a CTDIvol Notification Value was configured
113911 DLP Notification ValueDose Length Product value configured to trigger a notification for a given protocol element
113912 CTDIvol Notification ValueCTDIvol value configured to trigger a notification for a given protocol element
113913 DLP Forward EstimateA forward estimate of the DLP for the next Protocol Element Group; see NEMA XR 25-2010 Dose Check Standard
113914 CTDIvol Forward EstimateA forward estimate of the CTDIvol for the next Protocol Element Group; see NEMA XR 25-2010 Dose Check Standard
113921 Radiation ExposureThe amount of ionizing radiation to which the patient was exposed
113922 Radioactive Substance AdministeredType, amount and route of radioactive substance administered
113923 Radiation Exposure and Protection InformationExposure to ionizing radiation and associated preventive measures used to reduce the exposure of parts of the body like lead apron or eye, thyroid gland or gonad protectionDeprecated
113930 Size Specific Dose EstimationThe Size-Specific Dose Estimate is a patient dose estimate that takes into account the size of the patient, such as described in AAPM Report 204 by using linear dimensions measured on the patient or patient images or estimated from patient age
113931 Measured Lateral DimensionThe side-to-side (left to right) dimension of the body part being scanned (per AAPM Report 204)
113932 Measured AP DimensionThe thickness of the body part being scanned, in the antero-posterior dimension (per AAPM Report 204)
113933 Derived Effective DiameterThe diameter of the patient at a given location along the Z-axis of the patient, assuming that the patient has a circular cross-section (per AAPM Report 204)
113934 AAPM 204 Lateral DimensionThe Size Specific Dose Estimation is computed using Table 1B (32cm phantom) or Table 2B (16cm phantom) of AAPM Report 204
113935 AAPM 204 AP DimensionThe Size Specific Dose Estimation is computed using Table 1C (32cm phantom) or Table 2C (16cm phantom) of AAPM Report 204
113936 AAPM 204 Sum of Lateral and AP DimensionThe Size Specific Dose Estimation is computed using Table 1A (32cm phantom) or Table 2A (16cm phantom) of AAPM Report 204
113937 AAPM 204 Effective Diameter Estimated From Patient AgeThe Size Specific Dose Estimation is computed using Table 1D (32cm phantom) or Table 2D (16cm phantom) using an effective diameter estimated from the patient's age using Table 3 of AAPM Report 204
113940 System CalculatedValues calculated from other existing parameters
113941 In Detector PlaneA segmented region of the detector surface within the irradiated area (but might not be near the center of the detector)
113942 X-Ray Reading DeviceA device that creates digital images from X-Ray detectors (Direct, Indirect or Storage)
113943 X-Ray Source Data AvailableParameters related to the X-Ray source (generator, tube, etc.) are available to the recording application
113944 X-Ray Mechanical Data AvailableParameters related to the X-Ray Mechanical System (Stand, Table) are available to the recording application
113945 X-Ray Detector Data AvailableParameters related to the X-Ray Detector are available to the recording application
113946 Projection Eponymous NameDescribes the radiographic method of patient, tube and detector positioning to achieve a well described projection or view
113947 Detector TypeType of Detector used to acquire data; e.g. Images
113948 Direct DetectorDetector that directly transforms the input signal to pixel values
113949 Indirect DetectorDetector that transforms an intermediate signal into pixel values; e.g. a scintillator-based detector
113950 Storage DetectorStorage detector that stores a signal that is later transformed by a reader into pixel values; e.g. a phosphor-based detector
113951 FilmFilm that is scanned to create pixel values
113952 Table MountThe cassette/detector is mounted in the patient table
113953 Unmounted DetectorThe cassette/detector is not mounted.; e.g. a cassette placed underneath the patient
113954 Upright Stand MountThe cassette/detector is mounted in an upright stand
113955 C-Arm MountThe cassette/detector is mounted on a c-arm
113956 CR/DR Mechanical ConfigurationMethod of mounting or positioning a CR/DR cassette or detector
113957 Fluoroscopy-Guided Projection Radiography SystemAn integrated projection radiography system capable of fluoroscopy
113958 Integrated Projection Radiography SystemA projection radiography system where the X-Ray detector, X-Ray Source and gantry components are integrated and the managing system is able to access details of each component
113959 Cassette-based Projection Radiography SystemA projection radiography system where the X-Ray detector, X-Ray Source and gantry components are not integrated; e.g. cassette-based CR and DR systems
113961 Reconstruction AlgorithmDescription of the algorithm used when reconstructing the image from the data acquired during the acquisition process
113962 Filtered Back ProjectionAn algorithm for reconstructing an image from multiple projections by back-projecting the measured values along the line of the projection and filtering the result to reduce blurring
113963 Iterative ReconstructionAn algorithm for reconstructing an image from multiple projections by starting with an assumed reconstructed image, computing projections from the image, comparing the original projection data and updating the reconstructed image based upon the difference between the calculated and the actual projections
113970 Procedure Step To This PointThe period of time from the start of a Procedure Step until the time point established by the context of the reference
114000 Not a numberMeasurement not available: Not a number (per IEEE 754)
114001 Negative InfinityMeasurement not available: Negative Infinity (per IEEE 754)
114002 Positive InfinityMeasurement not available: Positive Infinity (per IEEE 754)
114003 Divide by zeroMeasurement not available: Divide by zero (per IEEE 754)
114004 UnderflowMeasurement not available: Underflow (per IEEE 754)
114005 OverflowMeasurement not available: Overflow (per IEEE 754)
114006 Measurement failureMeasurement not available: Measurement failure
114007 Measurement not attemptedMeasurement not available: Measurement not attempted
114008 Calculation failureMeasurement not available: Calculation failure
114009 Value out of rangeMeasurement not available: Value out of range
114010 Value unknownMeasurement not available: Value unknown
114011 Value indeterminateMeasurement not available: Value indeterminate
114201 Time of flightMeasures the time-of-flight of a light signal between the camera and the subject for each point of the image
114202 InterferometryInterferometry is a family of techniques in which waves are superimposed in order to extract depth information about the scanned object
114203 Laser scanningLaser scanning describes the general method to sample or scan a surface using laser technology
114204 Pattern projectionProjecting a narrow band of light onto a three-dimensionally shaped surface produces a line of illumination that appears distorted from other perspectives than that of the projector. It can be used for an exact geometric reconstruction of the surface shape
114205 Shape from shadingA technique for estimating the surface normal of an object by observing that object under different lighting conditions
114206 Shape from motionA technique for estimating the surface normal of an object by observing that object under different motions
114207 Confocal imagingAn optical imaging technique used to increase optical resolution and contrast of a micrograph by using point illumination and a spatial pinhole to eliminate out-of-focus light in specimens that are thicker than the focal plane. It enables the reconstruction of 3D structures from the obtained images
114208 Point Cloud AlgorithmicPoint cloud that was calculated by an algorithm
114209 Turntable Scan MethodScanning the object from different views by placing it on a rotating table
114210 High resolutionHigher resolution with a longer acquisition time
114211 Fast modeLower resolution with a shorter acquisition time
114213 Iterative Closest PointAn algorithm employed to minimize the difference between two clouds of points. It iteratively revises the transformation (translation, rotation) needed to minimize the distance between the points of two point clouds
114215 FreehandHuman controlled minimization of the distance between the points of two point clouds
114216 CheckerboardScanning the object from different views by placing it in front of a checkerboard pattern
121001 Quotation ModeType of source for observations quoted from an external source
121002 Quoted SourceReference to external source of quoted observations
121003 DocumentDocumentary source of quoted observations
121004 VerbalVerbal source of quoted observations
121005 Observer TypeType of observer that created the observations
121006 PersonHuman observer created the observations
121007 DeviceAutomated device created the observations
121008 Person Observer NameName of human observer that created the observations
121009 Person Observer's Organization NameOrganization or institution with which the human observer is affiliated for the context of the current observation
121010 Person Observer's Role in the OrganizationOrganizational role of human observer for the context of the current observation
121011 Person Observer's Role in this ProcedureProcedural role of human observer for the context of the current observation
121012 Device Observer UIDUnique identifier of automated device that created the observations
121013 Device Observer NameInstitution-provided identifier of automated device that created the observations
121014 Device Observer ManufacturerManufacturer of automated device that created the observations
121015 Device Observer Model NameManufacturer-provided model name of automated device that created the observations
121016 Device Observer Serial NumberManufacturer-provided serial number of automated device that created the observations
121017 Device Observer Physical Location During ObservationLocation of automated device that created the observations whilst the observations were being made
121018 Procedure Study Instance UIDUnique identifier for the Study or Requested Procedure
121019 Procedure Study Component UIDUnique identifier for the Performed Procedure Step
121020 Placer NumberIdentifier for the Order (or Service Request) assigned by the order placer system
121021 Filler NumberIdentifier for the Order (or Service Request) assigned by the order filler system
121022 Accession NumberIdentifier for the Order (or Service Request) assigned by the department information system
121023 Procedure CodeType of procedure scheduled or performed
121024 Subject ClassType of observation subject
121025 PatientA patient is the subject of observations
121026 FetusFetus of patient is the subject of observations
121027 SpecimenSpecimen is the subject of observations
121028 Subject UIDUnique Identifier of patient or fetus who is the subject of observations
121029 Subject NameName of patient who is the subject of observations
121030 Subject IDIdentifier of patient or fetus who is the subject of observations
121031 Subject Birth DateBirth Date of patient who is the subject of observations
121032 Subject SexSex of patient who is the subject of observations
121033 Subject AgeAge of patient who is the subject of observations
121034 Subject SpeciesSpecies of patient who is the subject of observations
121035 Subject BreedThe breed of the subject
121036 Mother of fetusName of mother of fetus that is the subject of observations
121037 Fetus numberDeprecated
121038 Number of FetusesDeprecated
121039 Specimen UIDUnique Identifier of specimen that is the subject of observations
121040 Specimen Accession NumberAccession Number of specimen that is the subject of observationsDeprecated
121041 Specimen IdentifierIdentifier of specimen that is the subject of observations
121042 Specimen TypeCoded category of specimen that is the subject of observationsDeprecated
121043 Slide IdentifierIdentifier of specimen microscope slide that is the subject of observationsDeprecated
121044 Slide UIDUnique Identifier of specimen microscope slide that is the subject of observationsDeprecated
121045 LanguageThe language of the content, being a language that is primarily used for human communication; e.g. English, French
121046 Country of LanguageThe country-specific variant of language; e.g. Canada for Candadian French
121047 Language of ValueThe language of the value component of a name-value pair
121048 Language of Name and ValueThe language of both the name component and the value component of a name-value pair
121049 Language of Content Item and DescendantsThe language of the current content item (node in a tree of content) and all its descendants
121050 Equivalent Meaning of Concept NameThe human readable meaning of the name component of a name-value pair that is equivalent to the post-coordinated meaning conveyed by the coded name and its concept modifier children
121051 Equivalent Meaning of ValueThe human readable meaning of the value component of a name-value pair that is equivalent to the post-coordinated meaning conveyed by the coded value and its concept modifier children
121052 Presence of propertyWhether or not the property concept being modified is present or absent
121053 PresentDeprecated
121054 AbsentDeprecated
121055 PathA set of points on an image, that when connected by line segments, provide a polyline from which a linear measurement was inferred
121056 Area outlineA set of points on an image, that when connected by line segments, provide a closed polyline that is the border of a defined region from which an area, or two-dimensional measurement, was inferred
121057 Perimeter outlineA set of points on an image, that when connected by line segments, provide a closed polyline that is a two-dimensional border of a three-dimensional region's intersection with, or projection into the image
121058 Procedure reportedThe imaging procedure whose results are reported
121059 Presence UndeterminedPresence or absence of a property is undeterminedDeprecated
121060 HistoryDeprecated
121062 RequestDeprecated
121064 Current Procedure DescriptionsDeprecated
121065 Procedure DescriptionA description of the imaging procedure
121066 Prior Procedure DescriptionsDeprecated
121068 Previous FindingsDeprecated
121069 Previous FindingAn observation found on a prior imaging study
121070 FindingsDeprecated
121071 FindingAn observation found on an imaging study
121072 ImpressionsDeprecated
121073 ImpressionAn interpretation in the clinical context of the finding(s) on an imaging study
121074 RecommendationsDeprecated
121075 RecommendationA recommendation for management or investigation based on the findings and impressions of an imaging study
121076 ConclusionsDeprecated
121077 ConclusionAn interpretation in the clinical context of the finding(s) on an imaging study
121078 AddendumDeprecated
121079 BaselineInitial images used to esyablish a beginning condition that is used for comparison over time to look for changes. [Paraphrases NCI-PT (C1442488, UMLS, "Baseline"), which is defined as "An initial measurement that is taken at an early time point to represent a beginning condition, and is used for comparison over time to look for changes. For example, the size of a tumor will be measured before treatment (baseline) and then afterwards to see if the treatment had an effect. A starting point to which things may be compared."]
121080 Best illustration of findingA selection of composite instances that best illustrates a particular finding; e.g. an image slice at the location of the largest extent of a tumor
121081 PhysicianDeprecated
121082 NurseDeprecated
121083 TechnologistDeprecated
121084 RadiographerDeprecated
121085 InternDeprecated
121086 ResidentDeprecated
121087 RegistrarDeprecated
121088 FellowA medical practitioner undergoing sub-specialty training; e.g. during the period after specialty training (residency)
121089 Attending [Consultant]Deprecated
121090 Scrub nurseDeprecated
121091 SurgeonDeprecated
121092 SonologistA medical practitioner with sub-specialty training in Ultrasound
121093 SonographerDeprecated
121094 PerformingThe person responsible for performing the procedure
121095 ReferringThe person responsible for referring the patient for the procedureDeprecated
121096 RequestingThe person responsible for requesting the procedure
121097 RecordingThe person responsible for recording the procedure or observation
121098 VerifyingThe person responsible for verifying the recorded procedure or observation
121099 AssistingThe person responsible for assisting with the procedure
121100 CirculatingThe person responsible for making preparations for and monitoring the procedureDeprecated
121101 StandbyThe person responsible for standing by to assist with the precedure if required
121102 Other sexOther sex
121103 Undetermined sexSex of subject undetermined at time of encoding
121104 Ambiguous sexAmbiguous sex
121105 Radiation PhysicistRadiation PhysicistDeprecated
121106 CommentComment
121109 Indications for ProcedureIndications for ProcedureDeprecated
121110 Patient PresentationPatient condition at the beginning of a healthcare encounterDeprecated
121111 SummarySummary of a procedure, including most significant findingsDeprecated
121112 Source of MeasurementImage or waveform used as source for measurement
121113 ComplicationsComplications from a procedureDeprecated
121114 Performing PhysicianPhysician who performed a procedure
121115 Discharge SummarySummary of patient condition upon Discharge from a healthcare facility
121116 Proximal Finding SiteProximal Anatomic Location for a differential measurement; may be considered subtype of term (G-C0E3, SRT, "Finding Site"); e.g. distance or pressure gradient
121117 Distal Finding SiteDistal Anatomic Location for a differential measurement; may be considered subtype of term (G-C0E3, SRT, "Finding Site"); e.g. distance or pressure gradient
121118 Patient CharacteristicsPatient Characteristics (findings)
121120 Cath Lab Procedure LogTime-stamped record of events that occur during a catheterization procedure
121121 Room identificationRoom identification
121122 Equipment IdentificationEquipment identification
121123 Patient Status or EventA recorded Patient Status or an event involving a patient
121124 Procedure Action Item IDIdentification of a step, action, or phase of a procedure
121125 DateTime of Recording of Log EntryDateTime of Recording of an Entry in an Event Log
121126 Performed Procedure Step SOP Instance UIDSOP Instance UID of a Performed Procedure Step
121127 Performed Procedure Step SOP Class UIDSOP Class UID of a Performed Procedure Step
121128 Procedure Action DurationDuration of a step, action, or phase of a procedure
121130 Start Procedure Action ItemBeginning of a step, action, or phase of a procedure
121131 End Procedure Action ItemEnd of a step, action, or phase of a procedure
121132 Suspend Procedure Action ItemSuspension of a step, action, or phase of a procedure
121133 Resume Procedure Action ItemResumption of a step, action, or phase of a procedure
121135 Observation DateTime QualifierConcept modifier for the DateTime of Recording of an Entry in an Event Log
121136 DateTime UnsynchronizedRecorded DateTime had its source in a system clock not synchronized to other recorded DateTimes
121137 DateTime EstimatedRecorded DateTime is estimated
121138 Image AcquiredEvent of the acquisition of an image
121139 ModalityType of data acquisition device
121140 Number of FramesNumber of Frames in a multi-frame image
121141 Image TypeDescriptor of an Image
121142 Acquisition DurationDuration of the acquisition of an image or a waveform
121143 Waveform AcquiredEvent of the acquisition of an image
121144 Document TitleDocument Title
121145 Description of MaterialDescription of Material used in a procedure
121146 Quantity of MaterialQuantity of Material used in a procedure
121147 Billing CodeBilling Code for materials used in a procedure
121148 Unit Serial IdentifierUnit or Device Serial Identifier
121149 Lot IdentifierLot Identifier
121150 Device CodeVendor or local coded value identifying a device
121151 Lesion IdentifierIdentification of a Lesion observed during an imaging procedure
121152 Person administering drug/contrastPerson administering drug/contrast
121153 Lesion RiskAssessment of the risk a coronary lesion presents to the health of a patient
121154 Intervention attempt identifierIdentifier for an attempted Intervention
121155 DeploymentUse of a device to deploy another device
121156 Percutaneous Entry ActionAction of a clinical professional at the site of percutaneous access to a patient's cardiovascular system
121157 Begin Circulatory SupportThe action or event of beginning circulatory support for a patient
121158 End Circulatory SupportThe action or event of ending circulatory support for a patient
121160 Oxygen Administration RateRate of Oxygen Administration
121161 Begin Oxygen AdministrationThe action or event of beginning administration of oxygen to a patient
121162 End oxygen administrationThe action or event of ending administration of oxygen to a patient
121163 By ventilatorMethod of administration of oxygen to a patient by ventilator
121165 Patient Assessment PerformedThe action or event of assessing the clinical status of a patient
121166 Begin PacingThe action or event of beginning pacing support for a patient
121167 End PacingThe action or event of ending pacing support for a patient
121168 Begin VentilationThe action or event of beginning ventilation support for a patient
121169 End VentilationThe action or event of ending ventilation support for a patient
121171 Tech NoteProcedural note originated by a technologist
121172 Nursing NoteProcedural note originated by a nurse
121173 Physician NoteProcedural note originated by a Physician
121174 Procedure NoteGeneral procedural note
121180 Key ImagesList of references to images considered significantDeprecated
121181 DICOM Object CatalogList of references to DICOM SOP Instances
121190 Referenced FramesIndividual frames selected as a subset of a multi-frame image
121191 Referenced SegmentSegment selected as a subset of a segmentation image, specifically the pixels/voxels identified as belonging to the classification of the identified segment
121192 Device SubjectA device is the subject of observations
121193 Device Subject NameName or other identifier of a device that is the subject of observations
121194 Device Subject ManufacturerManufacturer of a device that is the subject of observations
121195 Device Subject Model NameModel Name of a device that is the subject of observations
121196 Device Subject Serial NumberSerial Number of a device that is the subject of observations
121197 Device Subject Physical Location during observationPhysical Location of a device that is the subject of observations during those observations
121198 Device Subject UIDUnique Identifier of a device that is the subject of observations
121200 Illustration of ROIIllustration of a region of interest
121201 Area OutlineDeprecated
121202 Area of Defined RegionDeprecated
121206 DistanceA one dimensional, or linear, numeric measurement
121207 HeightVertical measurement value
121208 Inter-Marker DistanceDistance between marks on a device of calibrated size; e.g. a ruler
121210 PathDeprecated
121211 Path lengthA one dimensional, or linear, numeric measurement along a polyline
121213 Perimeter OutlineDeprecated
121214 Referenced Segmentation FrameFrame selected from a segmentation image, specifically the pixels/voxels identified as belonging to the classification of the segment encompassing the identified frame
121216 Volume estimated from single 2D regionA three-dimensional numeric measurement that is approximate, based on a two-dimensional region in a single image
121217 Volume estimated from three or more non-coplanar 2D regionsA three-dimensional numeric measurement that is approximate, based on three or more non-coplanar two-dimensional image regions
121218 Volume estimated from two non-coplanar 2D regionsA three-dimensional numeric measurement that is approximate, based on two non-coplanar two-dimensional image regions
121219 Volume of bounding three dimensional regionA three-dimensional numeric measurement of the bounding region of a three-dimensional region of interest in an image set
121220 Volume of circumscribed sphereA three-dimensional numeric measurement of the bounding sphere of a three-dimensional region of interest in an image set
121221 Volume of ellipsoidA three-dimensional numeric measurement of an ellipsoid shaped three-dimensional region of interest in an image set
121222 Volume of sphereA three-dimensional numeric measurement of a sphere shaped three-dimensional region of interest in an image set
121230 Path VertexCoordinates of a point on a defined path
121231 Volume SurfaceSurface of an identified or measured volume
121232 Source series for segmentationSeries of image instances used as source data for a segmentation
121233 Source image for segmentationImage instances used as source data for a segmentation
121242 Distance from nippleIndicates the location of the area of interest as measured from the nipple of the breast
121243 Distance from skinIndicates the location of the area of interest as measured from the most direct skin point of the breast
121244 Distance from chest wallIndicates the location of the area of interest as measured from the chest wall
121290 Patient exposure to ionizing radiationPatient exposure to ionizing radiation (procedure)
121291 Results communicatedThe act of communicating actionable findings to a responsible receiver
121301 Simultaneous DopplerReference is to a Doppler waveform acquired simultaneously with an image
121302 Simultaneous HemodynamicReference is to a Hemodynamic waveform acquired simultaneously with an image
121303 Simultaneous ECGReference is to a ECG waveform acquired simultaneously with an image
121304 Simultaneous Voice NarrativeReference is to a voice narrative recording acquired simultaneously with an image
121305 Simultaneous Respiratory WaveformA waveform representing chest expansion and contraction due to respiratory activity, measured simultaneously with the acquisition of this Image
121306 Simultaneous Arterial Pulse WaveformArterial pulse waveform obtained simultaneously with acquisition of a referencing image
121307 Simultaneous Phonocardiographic WaveformPhonocardiographic waveform obtained simultaneously with acquisition of a referencing image
121311 LocalizerImage providing an anatomical reference on the patient under examination, for the purpose of defining the location of the ensuing imaging
121312 Biopsy localizerImage providing an anatomical reference on the patient under examination, for the purpose of planning or documenting a biopsy
121313 Other partial viewsImage providing a partial view of the target anatomy, when the target anatomy is too large for a single image
121314 Other image of biplane pairImage providing a view of the target anatomy in a different imaging plane, typically from a near perpendicular angle
121315 Other image of stereoscopic pairImage providing a view of the target anatomy in a different imaging plane, typically with a small angular difference
121316 Images related to standalone objectImage related to a non-image information object
121317 SpectroscopyImage where signals are identified and separated according to their frequencies; e.g. to identify individual chemicals, or individual nuclei in a chemical compound
121318 Spectroscopy Data for Water Phase CorrectionMR spectroscopy data acquired to correct the phase of the diagnostic data for the phase signal of the Water
121320 Uncompressed predecessorAn image that has not already been lossy compressed that is used as the source for creation of a lossy compressed image
121321 Mask image for image processing operationImage used as the mask for an image processing operation, such as subtraction
121322 Source image for image processing operationImage used as the source for an image processing operation
121323 Source series for image processing operationSeries used as the source for an image processing operation
121324 Source ImageImage used as the source for a derived or compressed image
121325 Lossy compressed imageImage encoded with a lossy compression transfer syntax
121326 Alternate SOP Class instanceSOP Instance encoded with a different SOP Class but otherwise equivalent data
121327 Full fidelity imageFull fidelity image, uncompressed or lossless compressed
121328 Alternate Photometric Interpretation imageImage encoded with a different photometric interpretation
121329 Source image for montageImage used as a source for a montage (stitched) image
121330 Lossy compressed predecessorAn image that has previously been lossy compressed that is used as the source for creation of another lossy compressed image
121331 Equivalent CDA DocumentHL7 Document Architecture (CDA) Document that contains clinical content equivalent to the referencing Instance
121332 Complete Rendering for PresentationInstance that contains a displayable complete rendering of the referencing Instance
121333 Partial Rendering for PresentationInstance that contains a displayable partial rendering of the referencing Instance
121334 Extended Rendering for PresentationInstance that contains a displayable complete rendering of the referencing Instance, plus additional content such as inline rendering of referenced images
121335 Source DocumentDocument whose content has been wholly or partially transformed to create the referencing document
121338 Anatomic imageImage showing structural anatomic features
121339 Functional imageImage showing physical or chemical activity
121340 Spectral filtered imageImage providing the same view of the target anatomy acquired using only a specific imaging wavelength, frequency or energy
121341 Device localizerImage providing an anatomical reference on the patient under examination, for the purpose of documenting the location of device such as a diagnostic or therapeutic catheter
121342 Dose ImageImage providing a graphic view of the distribution of radiation dose
121346 Acquisition frames corresponding to volumeThe referenced image is the source of spatially-related frames from which the referencing 3D volume data set was derived
121347 Volume corresponding to spatially-related acquisition frames3D Volume containing the spatially-related frames in the referencing instance
121348 Temporal PredecessorInstance acquired prior to the referencing instance in a set of consecutively acquired instances
121349 Temporal SuccessorInstance acquired subsequent to the referencing instance in a set of consecutively acquired instances
121350 Same acquisition at lower resolutionImage of the same target area at lower resolution acquired in the same acquisition process
121351 Same acquisition at higher resolutionImage of the same target area at higher resolution acquired in the same acquisition process
121352 Same acquisition at different focal depthImage of the same target area at different focal depth (Z-plane) acquired in the same acquisition process
121353 Same acquisition at different spectral bandImage of the same target area at different spectral band acquired in the same acquisition process
121354 Imaged container labelImage specifically targeting the container label
121358 For Processing predecessorSource image from which FOR PRESENTATION images were created
121360 Replaced reportThe reference is to a predecessor report that has been replaced by the current report
121361 Addended reportThe reference is to a predecessor report to which the current report provides and addendum
121362 Preliminary reportA report that precedes the final report and may contain only limited information; it may be time sensitive, and it is not expected to contain all the reportable findings
121363 Partial reportA report that is not complete
121370 Composed from prior dosesThe dose object created was calculated by summation of existing, previously calculated, RT Dose instances
121371 Composed from prior doses and current planThe dose object created was calculated by summation of existing, previously calculated, RT Dose instances and dose newly calculated by the application. The newly calculated dose may or may not exist as an independent object
121372 Source dose for composing current doseRT Dose Instances used as source for calculated dose
121380 Active Ingredient Undiluted ConcentrationConcentration of the chemically or physically interesting (active) ingredient of a drug or contrast agent as delivered in product form from the manufacturer, typically in mg/ml
121381 Contrast/Bolus Ingredient OpaqueX-Ray absorption of the active ingredient of a contrast agent ingredient is greater than the absorption of water (tissue)
121382 Quantity administeredNumber of units of substance administered to a patient; e.g. tablets
121383 Mass administeredMass of substance administered to a patient
121401 DerivationMethod of deriving or calculating a measured value; e.g. mean, or maximum of set
121402 NormalityAssessment of a measurement relative to a normal range of values; may be considered subtype of term (G-C0F2, SRT, "has interpretation")
121403 Level of SignificanceSignificance of a measurement
121404 Selection StatusStatus of selection of a measurement for further processing or use
121405 Population descriptionDescription of a population of measurements
121406 Reference AuthorityBibliographic or clinical reference for a Description of a population of measurements
121407 Normal Range descriptionDescription of a normal range of values for a measurement concept
121408 Normal Range AuthorityBibliographic or clinical reference for a Description of a normal range of values
121410 User chosen valueObservation value selected by user for further processing or use, or as most representative
121411 Most recent value chosenObservation value is the recently obtained, and has been selected for further processing or use
121412 Mean value chosenObservation value is the mean of several measurements, and has been selected for further processing or use
121414 Standard deviation of populationStandard deviation of a measurement in a reference population
121415 Percentile Ranking of measurementPercentile Ranking of an observation value with respect a reference population
121416 Z-Score of measurementZ-score of an observation value with respect a reference population, expressed as the dimensionless quantity (x-m) /s, where (x-m) is the deviation of the observation value (x) from the population mean (m), and s is the standard deviation of the population
121417 2 Sigma deviation of population2 Sigma deviation of a measurement in a reference population
121420 EquationFormula used to compute a derived measurement
121421 Equation CitationBibliographic reference to a formula used to compute a derived measurement; reference may be to a specific equation in a journal article
121422 Table of Values CitationBibliographic reference to a Table of Values used to look up a derived measurement
121423 Method CitationBibliographic reference to a method used to compute a derived measurement
121424 Table of ValuesA Table of Values used to look up a derived measurement
121425 IndexFactor (divisor or multiplicand) for normalizing a measurement; e.g. body surface area used for normalizing hemodynamic measurements
121427 EstimatedMeasurement obtained by observer estimation, rather than with a measurement tool or by calculationDeprecated
121428 CalculatedMeasurement obtained by calculationDeprecated
121430 ConcernIdentified issue about a state or process that has the potential to require intervention or management
121431 DateTime Concern NotedDateTime concern noted (noted by whom is determined by context of use)
121432 DateTime Concern ResolvedDateTime the concern was resolved
121433 DateTime Problem ResolvedDateTime the problem was resolved
121434 Service Delivery LocationPlace at which healthcare services may be provided
121435 Service PerformerIdentification of a healthcare provider who performed a healthcare service; may be either a person or an organization
121436 Medical Device UsedType or identifier of a medical device used on, in, or by a patient
121437 Pharmacologic and exercise stress testCardiac stress test using pharmacologic and exercise stressorsDeprecated
121438 Paced stress testCardiac stress test using an implanted or external cardiac pacing deviceDeprecated
121439 Correction of congenital cardiovascular deformityProcedure for correction of congenital cardiovascular deformityDeprecated
121701 RT Patient SetupProcess of placing patient in the anticipated treatment position, including specification and location of positioning aids, and other treatment delivery accessories
121702 RT Patient Position Acquisition, single plane MVAcquisition of patient positioning information prior to treatment delivery, using single-plane megavoltage imaging
121703 RT Patient Position Acquisition, dual plane MVAcquisition of patient positioning information prior to treatment delivery, using dual-plane megavoltage imaging
121704 RT Patient Position Acquisition, single plane kVAcquisition of patient positioning information prior to treatment delivery, using single-plane kilovoltage imaging
121705 RT Patient Position Acquisition, dual plane kVAcquisition of patient positioning information prior to treatment delivery, using dual-plane kilovoltage imaging
121706 RT Patient Position Acquisition, dual plane kV/MVAcquisition of patient positioning information prior to treatment delivery, using dual-plane combination kilovoltage and megavoltage imaging
121707 RT Patient Position Acquisition, CT kVAcquisition of patient positioning information prior to treatment delivery, using kilovoltage CT imaging
121708 RT Patient Position Acquisition, CT MVAcquisition of patient positioning information prior to treatment delivery, using megavoltage CT imaging
121709 RT Patient Position Acquisition, OpticalAcquisition of patient positioning information prior to treatment delivery, using optical imaging
121710 RT Patient Position Acquisition, UltrasoundAcquisition of patient positioning information prior to treatment delivery, using ultrasound imaging
121711 RT Patient Position Acquisition, Spatial FiducialsAcquisition of patient positioning information prior to treatment delivery, using spatial fiducials
121712 RT Patient Position Registration, single planeRegistration of intended and actual patient position prior to treatment delivery, using single-plane images
121713 RT Patient Position Registration, dual planeRegistration of intended and actual patient position prior to treatment delivery, using dual-plane images
121714 RT Patient Position Registration, 3D CT generalRegistration of intended and actual patient position prior to treatment delivery, using 3D CT images and an unspecified registration approach
121715 RT Patient Position Registration, 3D CT marker-basedRegistration of intended and actual patient position prior to treatment delivery, using 3D CT images and a marker-based registration approach
121716 RT Patient Position Registration, 3D CT volume-basedRegistration of intended and actual patient position prior to treatment delivery, using 3D CT images and a volume-based registration approach
121717 RT Patient Position Registration, 3D on 2D referenceRegistration of intended and actual patient position prior to treatment delivery, using 3D verification images and 2D reference images
121718 RT Patient Position Registration, 2D on 3D referenceRegistration of intended and actual patient position prior to treatment delivery, using 2D verification images and 3D reference images
121719 RT Patient Position Registration, OpticalRegistration of intended and actual patient position prior to treatment delivery, using optical images
121720 RT Patient Position Registration, UltrasoundRegistration of intended and actual patient position prior to treatment delivery, using ultrasound images
121721 RT Patient Position Registration, Spatial FiducialsRegistration of intended and actual patient position prior to treatment delivery, using spatial fiducials
121722 RT Patient Position AdjustmentAdjustment of patient position such that the patient is correctly positioned for treatment
121723 RT Patient Position In-treatment-session ReviewReview of patient positioning information in the process of delivering a treatment session
121724 RT Treatment Simulation with Internal VerificationSimulated radiotherapy treatment delivery using verification integral to the Treatment Delivery System
121725 RT Treatment Simulation with External VerificationSimulated radiotherapy treatment delivery using verification by a external Machine Parameter Verifier
121726 RT Treatment with Internal VerificationRadiotherapy treatment delivery using verification integral to the Treatment Delivery System
121727 RT Treatment with External VerificationRadiotherapy treatment delivery using verification by an external Machine Parameter Verifier
121728 RT Treatment QA with Internal VerificationQuality assurance of a radiotherapy treatment delivery using verification integral to the Treatment Delivery System
121729 RT Treatment QA with External VerificationQuality assurance of a radiotherapy treatment delivery using verification by an external Machine Parameter Verifier
121730 RT Machine QAQuality assurance of a Treatment Delivery Device
121731 RT Treatment QA by RT Plan Dose CheckPerform Quality Assurance on an RT Plan by evaluating dosimetric content of the current RT Plan
121732 RT Treatment QA by RT Plan Difference CheckPerform Quality Assurance on an RT Plan by comparing the content of previously quality-assessed RT Plans with the current RT Plan
121733 RT Treatment QA by RT Ion Plan Dose CheckPerform Quality Assurance on an RT Ion Plan by evaluating dosimetric content of the current RT Ion Plan
121734 RT Treatment QA with RT Ion Plan Difference CheckPerform Quality Assurance on an RT Ion Plan by comparing the content of previously quality-assessed RT Ion Plans with the current RT Ion Plan
121740 Treatment Delivery TypeIndicates whether the treatment to be delivered is a complete fraction or a continuation of previous incompletely treated fraction
122001 Patient called to procedure roomPatient called to procedure room
122002 Patient admitted to procedure roomPatient admitted to procedure room
122003 Patient given pre-procedure instructionPatient given pre-procedure instruction
122004 Patient informed consent givenPatient informed consent given
122005 Patient advance directive givenPatient advance directive given
122006 Nil Per Os (NPO) status confirmedNil Per Os (NPO) status confirmed
122007 Patient assisted to tablePatient assisted to table
122008 Patient prepped and drapedPatient prepped and draped
122009 Patient connected to continuous monitoringPatient connected to continuous monitoring
122010 Patient transferred to holding areaPatient transferred to holding area
122011 Patient transferred to surgeryPatient transferred to surgery
122012 Patient transferred to CCUPatient transferred to CCU
122020 Patient disorientedPatient disoriented
122021 Patient reports nauseaPatient reports nausea
122022 Patient reports discomfortPatient reports discomfort
122023 Patient reports chest painPatient reports chest pain
122024 Patient reports no painPatient reports no pain
122025 Patient alertPatient alert
122026 Patient restlessPatient restless
122027 Patient sedatedPatient sedated
122028 Patient asleepPatient asleep
122029 Patient unresponsivePatient unresponsive
122030 Patient has respiratory difficultyPatient has respiratory difficulty
122031 Patient coughedPatient coughed
122032 Patient disconnected from continuous monitoringPatient disconnected from continuous monitoring
122033 Hemostasis achievedHemostasis achieved
122034 Hemostasis not achieved - oozingHemostasis not achieved - oozing
122035 Hemostasis not achieved - actively bleedingHemostasis not achieved - actively bleeding
122036 Patient given post-procedure instructionPatient given post-procedure instruction
122037 Patient discharged from departmentPatient discharged from department or laboratory
122038 Patient pronounced deadPatient pronounced dead
122039 Patient transferred to morguePatient transferred to morgue
122041 Personnel ArrivedIdentified personnel or staff arrived in procedure room
122042 Personnel DepartedIdentified personnel or staff departed procedure room
122043 Page Sent ToPage sent to identified personnel or staff
122044 Consultation WithConsultation with identified personnel or staff
122045 Office calledOffice of identified personnel or staff was called
122046 Equipment failureEquipment failureDeprecated
122047 Equipment brought to procedure roomEquipment brought to procedure room
122048 Equipment readyEquipment ready for procedure
122049 Equipment removedEquipment removed from procedure room
122052 BioptomeDevice for obtaining biopsy sample
122053 Valvular InterventionValvular Intervention
122054 Aortic InterventionAortic Intervention
122055 Septal Defect InterventionSeptal Defect Intervention
122056 Vascular InterventionVascular Intervention
122057 Myocardial biopsyMyocardial biopsy
122058 Arterial conduit angiographyArterial conduit angiography
122059 Single plane AngiographySingle plane Angiography
122060 Bi-plane AngiographyBi-plane Angiography
122061 Percutaneous Coronary InterventionPercutaneous Coronary Intervention
122062 15-Lead ECG15-Lead electrocardiographyDeprecated
122072 Pre-procedure logLog of events occurring prior to the current procedure
122073 Current procedure evidenceAnalysis or measurements for current procedure (purpose of reference to evidence document)
122075 Prior report for current patientPrior report for current patient
122076 Consumable taken from inventoryIdentifier of Consumable taken from inventory
122077 Consumable returned to inventoryIdentifier of Consumable returned to inventory
122078 Remaining consumable disposedIdentifier of consumable whose remaining content has been disposed
122079 Consumable unusableIdentifier of Consumable determined to be unusable
122081 Drug startIdentifier of Drug whose administration has started
122082 Drug endIdentifier of Drug whose administration has ended
122083 Drug administeredIdentifier of Drug administered as part of procedure
122084 Contrast startIdentifier of Contrast agent whose administration has started
122085 Contrast endIdentifier of Contrast agent whose administration has ended
122086 Contrast administeredIdentifier of Contrast agent administered
122087 Infusate startIdentifier of Infusate whose administration has started
122088 Infusate endIdentifier of Infusate whose administration has ended
122089 Device crossed lesionAction of a device traversing a vascular lesion
122090 Intervention ActionAction of a clinical professional performed on a patient for therapeutic purpose
122091 Volume administeredVolume of Drug, Contrast agent, or Infusate administered
122092 Undiluted dose administeredUndiluted dose of Drug, Contrast agent, or Infusate administered
122093 ConcentrationConcentration of Drug, Contrast agent, or Infusate administered
122094 Rate of administrationRate of Drug, Contrast agent, or Infusate administration
122095 Duration of administrationDuration of Drug, Contrast agent, or Infusate administration
122096 Volume unadministered or discardedVolume of Drug, Contrast agent, or Infusate unadministered or discarded
122097 Catheter CurveNumeric parameter of Curvature of Catheter
122098 Transmit FrequencyTransmit Frequency
122099 ST change from baselineMeasured change of patient electrocardiographic ST level relative to baseline measurement
122101 Aneurysm on cited vesselAnatomic term modifier indicating aneurysm on cited vessel is the subject of the finding
122102 Graft to cited segment, proximal sectionAnatomic term modifier indicating proximal section of graft to cited vessel is the subject of the finding
122103 Graft to cited segment, mid sectionAnatomic term modifier indicating mid section of graft to cited vessel is the subject of the finding
122104 Graft to cited segment, distal sectionAnatomic term modifier indicating distal section of graft to cited vessel is the subject of the finding
122105 DateTime of InterventionDateTime of Intervention
122106 Duration of InterventionDuration of Intervention
122107 Baseline Stenosis MeasurementLesion stenosis measured prior to any interventional procedureDeprecated
122108 Post-Intervention Stenosis MeasurementLesion stenosis measured after an interventional procedureDeprecated
122109 Baseline TIMI FlowAssessment of perfusion across a coronary lesion measured prior to any interventional procedure
122110 Post-Intervention TIMI FlowAssessment of perfusion across a coronary lesion measured after an interventional procedure
122111 Primary Intervention DeviceIndication that device is the primary (first and/or most significant) device used for interventional therapy of a particular pathology; e.g. lesion
122112 Normal MyocardiumNormal Myocardium
122113 Sacrred MyocardialSacrred Myocardial
122114 Thinning MyocardiumThinning Myocardium
122120 Hemodynamics ReportHemodynamics Report
122121 Atrial pressure measurementsAtrial pressure measurements, report section
122122 Ventricular pressure measurementsVentricular pressure measurements, report section
122123 Gradient assessmentGradient assessment, report section
122124 Blood velocity measurementsBlood velocity measurements, report section
122125 Blood lab measurementsBlood lab measurements, report section
122126 Derived Hemodynamic MeasurementsDerived Hemodynamic Measurements, report section
122127 Clinical ContextClinical Context, report section
122128 Patient Transferred FromLocation from which the patient was transferred
122129 PCI during this procedureIndication that the procedure includes a percutaneous coronary intervention
122130 Dose Area ProductRadiation dose times area of exposure
122131 Degree of ThrombusFinding of probability and/or severity of thrombus
122132 Severity of CalcificationSeverity of Calcification, property of lesion
122133 Lesion MorphologyLesion Morphology; form and/or structural properties of lesion
122134 Vessel MorphologyVessel Morphology; form and/or structural properties of vessel
122138 Circulatory SupportTechnique (device or procedure) of support for patient circulatory system; hemodynamic support
122139 Reason for ExamReason for Exam
122140 Comparison with Prior Exam DoneIndication that the current exam data has been compared with prior exam data
122141 Electrode PlacementElectrocardiographic electrode placement technique
122142 Acquisition Device TypeAcquisition Device Type
122143 Acquisition Device IDAcquisition Device ID
122144 Quantitative AnalysisQuantitative Analysis, report section
122145 Qualitative AnalysisQualitative Analysis, report section
122146 Procedure DateTimeThe date and time on which a procedure was performed on a patient
122147 Clinical InterpretationClinical Interpretation, report section
122148 Lead IDECG Lead Identifier
122149 Beat NumberBeat Number; ordinal of cardiac cycle within an acquisition
122150 Compound StatementComplex coded semantic unit, consisting of several coded components
122151 TrendTrend (temporal progression) of a clinical condition, finding, or disease
122152 StatementCoded semantic unit
122153 Statement ModifierCoded modifier for a semantic unit
122154 Conjunctive TermConjunctive term between semantic units
122157 ProbabilityProbability
122158 ECG Global MeasurementsECG Global Measurements, report section
122159 ECG Lead MeasurementsECG Lead Measurements, report section
122160 Derived Area, Non-ValveDerived cross-sectional area of a vessel or anatomic feature, other than a cardiac valve
122161 Pulmonary FlowRate of blood flow through Pulmonary artery
122162 Systemic FlowRate of blood flow through the aorta
122163 Discharge DateTimeDateTime of patient discharge from hospital admission
122164 Coronary Artery Bypass During This AdmissionIndication that a Coronary Artery Bypass operation was performed during the current hospital admission
122165 Date of DeathDate of Death
122166 Death During This AdmissionIndication that the patient died during the current hospital admission
122167 Death During CatheterizationIndication that the patient died during the current Catheterization procedure
122170 Type of Myocardial InfarctionFinding of type of Myocardial Infarction
122171 Coronary lesion > = 50% stenosisFinding of Coronary lesion with greater than 50% stenosis
122172 Acute MI PresentFinding of Acute Myocardial Infarction Presence as indication for interventional procedure
122173 ST Elevation Onset DateTimeDateTime of first determination of elevated ECG ST segment, as indication of Myocardial Infarction
122175 Number of lesion interventions attemptedNumber of lesion interventions attempted during current procedure
122176 Number of lesion interventions successfulNumber of lesion interventions successful during current procedure, where the residual post intervention stenosis is less than or equal to 50% of the arterial luminal diameter, TIMI Flow is 3 and the minimal decrease in stenosis was 20%
122177 Procedure ResultOverall success of interventional procedure
122178 Lesion Intervention InformationLesion Intervention Information, report section
122179 Peri-procedural MI occurredIndication that Myocardial Infarction occurred during current procedure
122180 CK-MB baselineCreatine Kinase-MB value at baseline (start of procedure)
122181 CK-MB peakCreatine Kinase-MB highest value measured during procedure
122182 R-R intervalTime interval between ECG R-wave peaks in subsequent cardiac cycles
122183 Blood temperatureBlood temperature
122185 Blood Oxygen contentBlood Oxygen content
122187 Blood Carbon dioxide saturationBlood Carbon dioxide saturation
122188 Pulmonary Arterial Content (FCpa)Pulmonary Arterial Content (FCpa)
122189 Pulmonary Venous Content (FCpv)Pulmonary Venous Content (FCpv)
122190 Max dp/dt/PMax dp/dt/P
122191 Ventricular End Diastolic pressureVentricular End Diastolic pressure
122192 Indicator appearance timeElapsed time from injection of an indicator bolus until it is observed at another location
122193 Maximum pressure accelerationMaximum pressure acceleration
122194 Ventricular Systolic blood pressureVentricular Systolic blood pressure
122195 Pulse StrengthPulse Strength; palpable strength of systolic flow
122196 C wave pressureThe secondary peak pressure in the atrium during atrial contraction
122197 Gradient pressure, averageGradient pressure, average
122198 Gradient pressure, peakGradient pressure, peak
122199 Pressure at dp/dt maxPressure at dp/dt max
122201 Diastolic blood velocity, meanDiastolic blood velocity, mean
122202 Diastolic blood velocity, peakDiastolic blood velocity, peak
122203 Systolic blood velocity, meanSystolic blood velocity, mean
122204 Systolic blood velocity, peakSystolic blood velocity, peak
122205 Blood velocity, meanBlood velocity, mean
122206 Blood velocity, minimumBlood velocity, minimum
122207 Blood velocity, peakBlood velocity, peak
122208 x-descent pressureVenous or atrial pressure minimum during ventricular systole, after A-wave
122209 y-descent pressureVenous or atrial pressure minimum when tricuspid valve opens during diastole, after V-wave
122210 z-point pressureAtrial pressure upon closure of tricuspid and mitral valves
122211 Left Ventricular ejection timeLeft Ventricular ejection time
122212 Left Ventricular filling timeLeft Ventricular filling time
122213 Right Ventricular ejection timeRight Ventricular ejection time
122214 Right Ventricular filling timeRight Ventricular filling time
122215 Total Pulmonary ResistanceTotal Pulmonary Resistance
122216 Total Vascular ResistanceTotal Vascular Resistance
122217 Coronary Flow reserveCoronary Flow reserve
122218 Diastolic/Systolic velocity ratioDiastolic/Systolic velocity ratio
122219 Hyperemic ratioHyperemic ratio
122220 Hemodynamic Resistance IndexHemodynamic Resistance Index
122221 Thorax diameter, sagittalThorax diameter, sagittal
122222 Procedure Environmental CharacteristicsEnvironmental characteristics in the procedure room
122223 Room oxygen concentrationOxygen concentration in the procedure room
122224 Room temperatureTemperature in the procedure room
122225 Room Barometric pressureBarometric pressure in the procedure room
122227 Left to Right FlowLeft to Right Flow
122228 Right to Left FlowRight to Left Flow
122229 Arteriovenous differenceArteriovenous oxygen content difference
122230 10 Year CHD RiskFramingham Study 10 Year CHD Risk
122231 Comparative Average10 Year CHD RiskFramingham Study Comparative Average10 Year CHD Risk
122232 Comparative Low10 Year CHD RiskFramingham Study Comparative Low10 Year CHD Risk
122233 LDL Cholesterol Score Sheet for MenFramingham Study LDL Cholesterol Score Sheet for Men
122234 LDL Cholesterol Score Sheet for WomenFramingham Study LDL Cholesterol Score Sheet for Women
122235 Total Cholesterol Score Sheet for MenFramingham Study Total Cholesterol Score Sheet for Men
122236 Total Cholesterol Score Sheet for WomenFramingham Study Total Cholesterol Score Sheet for Women
122237 Corrected Sinus Node Recovery TimeCorrected Sinus Node Recovery Time
122238 Max volume normalized to 50mmHg pulse pressureMax volume normalized to 50mmHg pulse pressure
122239 Oxygen ConsumptionOxygen Consumption
122240 BSA = 3.207*WT^(0.7285-0.0188 log (WT)) *HT^0.3Body Surface Area computed from patient height and weight: BSA = 3.207*WT[g]^(0.7285-0.0188 log (WT[g])) *HT[cm] ^ 0.3 [Boyd E, The growth of the surface area of the human body. Minneapolis: University of Minnesota Press, 1935, eq. (36) ]
122241 BSA = 0.007184*WT^ 0.425*HT^0.725Body Surface Area computed from patient height and weight: BSA = 0.007184* WT[kg] ^ 0.425*HT[cm] ^ 0.725 [Dubois and Dubois, Arch Int Med 1916 17:863-71]
122242 BSA = 0.0235*WT^0.51456*HT^ 0.42246Body Surface Area computed from patient height and weight: BSA = 0.0235* WT[kg] ^0.51456*HT[cm]^ 0.42246 [Gehan EA, George SL, 'Estimation of human body surface area from height and weight', Cancer Chemother Rep 1970 54:225-35]
122243 BSA = 0.024265*WT^0.5378*HT^0.3964Body Surface Area computed from patient height and weight: BSA = 0.024265 * WT[kg] ^ 0.5378 * HT[cm] ^ 0.3964 [Haycock G.B., Schwartz G.J., Wisotsky D.H. 'Geometric method for measuring body surface area: A height weight formula validated in infants, children and adults.' The Journal of Pediatrics 1978 93:1:62-66]
122244 BSA = (HT * WT/36) ^0.5Body Surface Area computed from patient height and weight: BSA = (HT[m] * WT[kg] / 36) ^ 0.5 [Mosteller, R.D. 'Simplified Calculation of Body Surface Area.' N Engl J Med 1987 Oct 22;317(17):1098]
122245 BSA = 1321+0.3433*WTBody Surface Area computed from patient weight:BSA = 1321 + 0.3433 * WT[kg] (for pediatrics 3-30 kg) [Current, J.D. 'A Linear Equation For Estimating The Body Surface Area In Infants And Children', The Internet Journal of Anesthesiology. 1998. 2:2]
122246 BSA = 0.0004688 * WT ^ (0.8168 - 0.0154 * log(WT))BSA = 0.0004688 * (1000 * WT) ^ (0.8168 - 0.0154 * log(1000 * WT)) Where (WT is weight in kilogram) Units = m2 Boyd, Edith. The Growth of the Surface Area of the Human Body(originally published in 1935 by the University of Minnesota Press), Greenwood Press, Westport, Connecticut, 1975, p. 102.Equation (35)
122247 VO2male = BSA (138.1 - 11.49 * loge(age) + 0.378 * HRf)Equation for estimated oxygen consumption: VO2male = BSA (138.1 - 11.49 * loge(age) + 0.378 * HRf)
122248 VO2female = BSA (138.1 - 17.04 * loge(age) + 0.378 * HRf)Equation for estimated oxygen consumption: VO2female = BSA (138.1 - 17.04 * loge(age) + 0.378 * HRf)
122249 VO2 = VeSTPD * 10 * (FIO2 - FE02)Equation for estimated oxygen consumption: VO2 = VeSTPD * 10 * (FIO2 - FE02)
122250 VO2 = 152 * BSAEquation for estimated oxygen consumption: VO2 = 152 * BSA
122251 VO2 = 175 * BSAEquation for estimated oxygen consumption: VO2 = 175 * BSA
122252 VO2 = 176 * BSAEquation for estimated oxygen consumption: VO2 = 176 * BSA
122253 Robertson & Reid tableRobertson & Reid Table for estimated oxygen consumption
122254 Fleisch tableFleisch table for estimated oxygen consumption
122255 Boothby tableBoothby table for estimated oxygen consumption
122256 if (prem age< 3days) P50 = 19.9Estimate of Oxygen partial pressure at 50% saturation for premature infants less than 3 days old: P50 = 19.9
122257 if (age < 1day) P50 = 21.6Estimate of Oxygen partial pressure at 50% saturation for infants less than 1 day old: P50 = 21.6
122258 if (age < 30day) P50 = 24.6Estimate of Oxygen partial pressure at 50% saturation for infants less than 30 days old: P50 = 24.6
122259 if (age < 18y) P50 = 27.2Estimate of Oxygen partial pressure at 50% saturation for patients less than 18 years old: P50 = 27.2
122260 if (age < 40y) P50 = 27.4Estimate of Oxygen partial pressure at 50% saturation for patients less than 40 years old: P50 = 27.4
122261 if (age > 60y) P50 = 29.3Estimate of Oxygen partial pressure at 50% saturation for patients more than 60 years old: P50 = 29.3
122262 Area = Flow / 44.5 * sqrt(Gradient[mmHg])Cardiac valve area computed from flow and pressure gradient: Area = Flow / 44.5 * sqrt(Gradient[mmHg]) [Gorlin and Gorlin, Am Heart J, 1951]
122263 MVA = Flow / 38.0 * sqrt(Gradient[mmHg])Mitral valve area computed from flow and pressure gradient: Mitral valve Area = Flow / 38.0 * sqrt(Gradient[mmHg]) [Gorlin and Gorlin, Am Heart J, 1951]
122265 BMI = Wt / Ht ^ 2Body Mass Index computed from weight and height: BMI = Wt/Ht^2
122266 BSA = 0.007358 * WT ^ 0.425 * HT ^ 0.725Body Surface Area computed from patient height and weight: BSA = 0.007358 * WT[kg] ^ 0.425 * HT[cm] ^ 0.725 (for East Asian adult, aged 15+ years) [Kanai Izumi, Masamitsu Kanai, 'Clinical examination method summary']
122267 BSA = 0.010265 * WT ^ 0.423 * HT ^ 0.651Body Surface Area computed from patient height and weight: BSA = 0.010265 * WT[kg] ^ 0.423 * HT[cm] ^ 0.651 (For East Asian child aged 12-14 years)
122268 BSA = 0.008883 * WT ^ 0.444 * HT ^ 0.663Body Surface Area computed from patient height and weight: BSA = 0.008883* WT[kg] ^ 0.444 * HT[cm] ^ 0.663 (For East Asian child aged 6-11 years)
122269 BSA = 0.038189 * WT ^ 0.423 * HT ^ 0.362Body Surface Area computed from patient height and weight: BSA = 0.038189 * WT[kg] ^ 0.423 * HT[cm] ^ 0.362 (For East Asian child aged 1-5 years)
122270 BSA = 0.009568 * WT ^ 0.473 * HT ^ 0.655Body Surface Area computed from patient height and weight: BSA = 0.009568* WT[kg] ^ 0.473 * HT[cm] ^ 0.655 (For East Asian child aged 0-12 months)
122271 Skin Condition WarmSkin Condition Warm
122272 Skin Condition CoolSkin Condition Cool
122273 Skin Condition ColdSkin Condition Cold
122274 Skin Condition DrySkin Condition Dry
122275 Skin Condition ClammySkin Condition Clammy
122276 Skin Condition DiaphoreticSkin Condition Diaphoretic
122277 Skin Condition FlushSkin Condition Flush
122278 Skin Condition MottledSkin Condition Mottled
122279 Skin Condition PaleSkin Condition Pale
122281 Airway unobstructedAirway unobstructed
122282 Airway partially obstructedAirway partially obstructed
122283 Airway severely obstructedAirway severely obstructed
122288 Not VisualizedAnatomy could not be visualized for the purpose of evaluation
122291 Quantitative Arteriography ReportQuantitative Arteriography Report
122292 Quantitative Ventriculography ReportQuantitative Ventriculography Report
122301 Guidewire crossing lesion unsuccessfulGuidewire crossing lesion unsuccessful
122302 Guidewire crossing lesion successfulGuidewire crossing lesion successful
122303 Angioplasty balloon inflatedAngioplasty balloon inflated
122304 Angioplasty balloon deflatedAngioplasty balloon deflated
122305 Device deployedDevice deployed
122306 Stent re-expandedStent re-expanded
122307 Object removedObject removed
122308 Radiation appliedRadiation applied
122309 Radiation removedRadiation removed
122310 Interventional device placement unsuccessfulInterventional device placement unsuccessful
122311 Interventional device placedInterventional device placed
122312 Intervention performedIntervention performed
122313 Interventional device withdrawnInterventional device withdrawn
122319 Catheter SizeCatheter Size
122320 Injectate TemperatureInjectate Temperature
122321 Injectate VolumeInjectate Volume
122322 Calibration FactorFactor by which a measured or calculated value is multiplied to obtain the estimated real-world value
122325 IVUS ReportIntravascular Ultrasound Report
122330 EEM DiameterExternal Elastic Membrane (EEM) diameter measured through the center point of the vessel. Center point of the vessel is defined as the center of gravity of the EEM area. The EEM is a discrete interface at the border between the media and the adventitia
122331 Plaque Plus Media ThicknessThe distance from intimal leading edge to the external elastic membrane along any line passing through the luminal center, which is defined as the center of gravity of the lumen area
122332 Lumen PerimeterPlanimetered perimeter of the lumen
122333 EEM Cross-Sectional AreaVessel area measured at the External Elastic Membrane (EEM), a discrete interface at the border between the media and the adventitia
122334 Plaque plus Media Cross-Sectional AreaArea within the EEM occupied by atheroma, regardless of lumen compromise. Plaque plus Media Area = EEM cross-sectional area - vessel lumen cross-sectional area
122335 In-Stent Neointimal Cross-Sectional AreaMeasurement of in-stent restenosis. In-Stent Intimal Area = Stent cross-sectional area - vessel lumen cross-sectional area
122336 Vascular Volume measurement lengthLongitudinal extent of the Vascular Volume Measurement. This is the distance from the distal edge to the proximal edge of the Volume measurement
122337 Relative positionLongitudinal distance from the closest edge of a fiducial feature or reference location to the start of the vascular measurement. This value will be a positive if the measurement is distal to the fiducial feature or reference location, or negative if the measurement is proximal to the fiducial feature or reference location
122339 Stent Volume ObstructionIn-Stent Neointimal Volume / Stent Volume
122340 Fiducial featureReference, normally anatomical, which is used for locating the position of a measurement
122341 Calcium LengthLongitudinal calcium length measurement
122343 Lumen Eccentricity IndexMeasurement of vessel lumen eccentricity. Lumen Eccentricity Index = (maximum vessel lumen diameter - minimum vessel lumen diameter) / maximum vessel lumen diameter. Lumen diameters are measured through the center point of the lumen, which is defined as the center of gravity of the lumen area
122344 Plaque plus Media Eccentricity IndexPlaque plus Media Eccentricity Index = (maximum Plaque plus media thickness - minimum Plaque plus media thickness) / maximum Plaque plus media thickness
122345 Remodeling IndexMeasurement of increase or decrease in EEM area that occurs during the development of atherosclerosis. Remodeling Index = Lesion EEM area / reference EEM area
122346 Stent Symmetry IndexMeasurement of stent circularity. Stent Symmetry Index = (maximum stent diameter - minimum stent diameter) / maximum stent diameter
122347 Stent Expansion IndexMeasurement of stent area relative to the reference lumen area. Stent Expansion Index = Minimum stent area / reference vessel lumen cross-sectional area
122348 Lumen Shape IndexMeasurement of vessel lumen eccentricity. Lumen Shape Index = (2p * sqrt(Vessel lumen cross-sectional area / p) / Lumen Perimeter) 2 Reference: Tobis & Yock, "Intravascular Ultrasound Imaging", Chapter 7
122350 Lumen Diameter RatioLumen diameter ratio = minimum vessel lumen diameter / maximum vessel lumen diameter, measured at the same cross section in the vessel. Lumen diameters are measured through the center point of the lumen, which is defined as the center of gravity of the lumen area
122351 Stent Diameter RatioStent diameter ratio = Minimum stent diameter / Maximum stent diameter, measured at the same cross section in the vessel. Stent diameters are measured through the center point of the stent, which is defined as the center of gravity of the stent area
122352 EEM Diameter RatioEEM diameter ratio = minimum EEM diameter / maximum EEM diameter. Measured at the same cross section in the vessel
122354 Plaque BurdenFractional area within the External Elastic Membrane (EEM) occupied by atheroma. Plaque Burden = (EEM area - vessel lumen cross-sectional area) / EEM area
122355 Arc of CalciumAngular measurement of a Calcium deposit with the apex located at the center of the lumen, which is defined as the center of gravity of the lumen area
122356 Soft plaquePlaque characterized by low density or echogenicity
122357 In-Stent NeointimaAbnormal thickening of the intima within the stented segment
122360 True LumenLumen surrounded by all three layers of the vessel-intima, media, and adventitia
122361 False LumenA channel, usually parallel to the true lumen, which does not communicate with the true lumen over a portion of its length
122363 Plaque RupturePlaque ulceration with a tear detected in a fibrous cap
122364 Stent GapLength of gap between two consecutive stents
122367 T-1 WorstWorst stenosis - the stenosis with the smallest lumen size within a vessel segment
122368 T-2 Secondary2nd most severe stenosis within a vessel segment
122369 T-3 Secondary3rd most severe stenosis within a vessel segment
122370 T-4 Secondary4th most severe stenosis within a vessel segment
122371 EEM VolumeExternal Elastic Membrane (EEM) volume measured within a specified region. The EEM is a discrete interface at the border between the media and the Adventitia
122372 Lumen VolumeLumen volume measured within a specified region
122374 In-Stent Neointimal VolumeThe amount of plaque between the lumen and stent, within the stent region; In-stent restenosis. In-Stent Neointimal Volume = Stent Volume - Lumen Volume
122375 Native Plaque VolumeThe amount of plaque between the stent and the EEM, within the stent region. Native Plaque Volume = EEM Volume - Stent Volume
122376 Total Plaque VolumeTotal amount of plaque between the EEM and the Lumen, over the entire region that is measured. Total Plaque Volume = EEM Volume - Lumen Volume
122380 Proximal ReferenceProximal reference segment measurement site. Typically the site with the largest lumen proximal to a stenosis but within the same segment (usually within 10 mm of the stenosis with no major intervening branches)
122381 Distal ReferenceDistal reference segment measurement site. Typically the site with the largest lumen distal to a stenosis but within the same segment (usually within 10 mm of the stenosis with no major intervening branches)
122382 Site of Lumen MinimumSite of the smallest lumen in a vessel; e.g. due to a stenotic lesion
122383 Entire PullbackMeasurement region that encompasses the entire vessel imaged in a single pullback acquisition
122384 Stented RegionMeasurement region occupied by the stent
122385 Proximal Stent MarginRegion starting at the proximal edge of the Stent and extending several millimeters (usually 5 mm) proximal to the Stent edge
122386 Distal Stent MarginRegion starting at the distal edge of the Stent and extending several millimeters (usually 5 mm) distal to the Stent edge
122387 Dissection ClassificationClassification of dissections in a vessel
122388 Intra-stent DissectionSeparation of neointimal hyperplasia from stent struts, usually seen only after treatment of in-stent restenosis
122389 Vulnerable PlaquePlaque with a thin cap fibrous atheroma that is at increased risk of rupture and thrombosis (or re-thrombosis) and rapid stenosis progression
122390 Eroded PlaquePlaque erosions with no structural defect (beyond endothelial injury) or gap in the plaque
122391 Relative Stenosis SeverityStenosis severity classifications of multiple lesions in a vessel
122393 Restenotic LesionA finding of a previously treated lesion in which stenosis has reoccurred
122394 Fibro-Lipidic PlaqueLoosely packed bundles of collagen fibers with regions of lipid deposition present. Region is cellular and no cholesterol clefts or necrosis are present. Some macrophage infiltration. Increase in extra cellular matrix
122395 Necrotic-Lipidic PlaqueArea within the plaque with very low echogenicity separated from the lumen and surrounded by more echogenic structures (fibrous cap). Highly lipidic necrotic region with remnants of foam cells and dead lymphocytes present. No collagen fibers are visible and mechanical integrity is poor. Cholesterol clefts and micro calcifications are visible
122398 Intimal DissectionDissection limited to the intima or atheroma, and not extending to the media
122399 Medial DissectionDissection in the arterial Media, extending into the media
122400 Simultaneously AcquiredThe referenced information was acquired simultaneously with the information in the object in which the reference occurs
122401 Same AnatomyInformation acquired for the same anatomic region
122402 Same IndicationInformation acquired for the same indication; e.g. to elucidate the same diagnostic question
122403 For Attenuation CorrectionThe referenced information was used to correct the data for differential attenuation through different anatomic tissue
122404 ReconstructedValue estimated for a vessel in the absence of a stenosis
122405 Algorithm ManufacturerManufacturer of application used
122406 Left Atrial Ejection Fraction by AngiographyLeft Atrial Ejection Fraction by Angiography
122407 Left Atrial ED VolumeLeft Atrial End Diastolic Volume
122408 Left Atrial ES VolumeLeft Atrial End Systolic Volume
122410 Contour RealignmentContour repositioning of End Diastolic relative to End Systolic contour
122411 Threshold ValueThe minimum standard deviation to define the hypokinesis and hyperkinesis
122417 Regional Abnormal Wall MotionReport of differentiation of wall motion compared to normal
122421 Calibration ObjectObject used for Calibration
122422 Calibration MethodMethod used for Calibration
122423 Calibration Object SizeSize of calibration object
122428 Area Length MethodMethod how long axis is positioned
122429 Volume MethodModel for cardiac chamber volume calculation
122430 Reference MethodMethod to define original diameter of the artery
122431 Regression Slope EDRelation between calculated End Diastolic volume and ventricular End Diastolic volume. The specific meaning is dependent on volume method used
122432 Regression Offset EDCorrection factor for the calculated End Diastolic volume and ventricular End Diastolic volume. The specific meaning is dependent on volume method used
122433 Regression Slope ESRelation between calculated End Systolic volume and ventricular End Systolic volume. The specific meaning is dependent on volume method used
122434 Regression Offset ESCorrection factor for the calculated End Systolic volume and ventricular End Systolic volume. The specific meaning is dependent on volume method used
122435 Regression Volume ExponentExponent of volume in regression formula
122438 Reference PointsContainer for spatial locations or coordinates used for calculation
122445 Wall ThicknessAverage thickness of the chamber wall in the current view
122446 Wall VolumeVolume of the chamber wall estimated from the current view
122447 Wall MassMass of the chamber wall (myocardium)
122448 Wall StressPeak systolic stress of chamber wall
122449 Centerline Wall Motion AnalysisMethod to calculate wall motion [example: Sheehan, 1986]
122450 Normalized Chord LengthThe length between End Diastolic and End Systolic contour perpendicular on the centerline normalized by a method dependent ventricular perimeter length. The centerline is the line equidistant between the End Diastolic and End Systolic contour [example: Sheehan, 1986]
122451 Abnormal RegionThe report of the boundaries of the abnormal (hyperkinetic, hypokinetic, a-kinetic) regions associated with the territory of the artery [example: Sheehan, 1986]
122452 First Chord of Abnormal RegionThe chord number specifying the begin of abnormal region [example: Sheehan, 1986]
122453 Last Chord of Abnormal RegionThe chord number specifying the end of abnormal region [example: Sheehan, 1986]
122459 Territory Region SeveritySeverity at the regional abnormality extent [example: Sheehan, 1986]
122461 Opposite Region SeveritySeverity at the opposite regional abnormality extent [example: Sheehan, 1986]
122464 LAD Region in RAO ProjectionBased on a total number of chords of 100 and RAO project the range of chords belonging to this circumferential extent lies between 5 - 85. [Sheehan, 1986]
122465 RCA Region in ROA ProjectionBased on a total number of chords of 100 and RAO project the range of chords belonging to this circumferential extent lies between 25 - 85. [Sheehan, 1986]
122466 Single LAD Region in RAO ProjectionBased on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 10 - 66 (hypokinetic) and 67 - 80 (hyperkinetic). [Sheehan, 1986]
122467 Single RCA Region in RAO ProjectionBased on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 51 - 80 (hypokinetic) and 10 - 50 (hyperkinetic). [Sheehan, 1986]
122468 Multiple LAD Region in RAO ProjectionBased on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 10 - 58 (hypokinetic) and 59 -80 (hyperkinetic). [Sheehan, 1986]
122469 Multiple RCA Region in RAO ProjectionBased on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 59 - 80 (hypokinetic) and 10 - 58 (hyperkinetic). [Sheehan, 1986]
122470 LAD Region in LAO ProjectionBased on a total number of chords of 100 and LAO projection the range of chords belonging to this regional extent lies between 50 -100 (hypokinetic) and 20 - 49 (hyperkinetic). [Sheehan, 1986]
122471 RCA Region in LAO ProjectionBased on a total number of chords of 100 and LAO projection the range of chords belonging to this regional extent lies between 19 - 67 (hypokinetic) and 68 - 100 (hyperkinetic). [Sheehan, 1986]
122472 CFX Region in LAO ProjectionBased on a total number of chords of 100 and LAO projection the range of chords belonging to this regional extent lies between 38 -74 (hypokinetic) and 75 - 100 (hyperkinetic). [Sheehan, 1986]
122473 Circular MethodMethod based on assumption that the image object is circular
122474 Densitometric MethodMethod based on the gray value distribution of the image
122475 Center of GravityEnd Systolic contour realigned to End Diastolic contour based on the center of gravity
122476 Long Axis BasedEnd Systolic contour realigned to End Diastolic contour based on the mid point of the long axis. The long axis end-points are defined as the posterior and apex
122477 No RealignmentNo Contour Realignment applied
122480 Vessel Lumen Cross-Sectional AreaCalculated Vessel Lumen Cross-Sectional Area based on the referenced method
122481 Contour StartLocation of the beginning of a contour
122482 Contour EndLocation of the end of a contour
122485 SphereSphere is used as calibration object
122486 Geometric IsocenterObject of interest in isocenter of image and pixel separation is calculated from geometric data
122487 Geometric Non-IsocenterObject of interest not in isocenter of image and pixel separation is calculated from geometric data and out of isocenter distances
122488 Calibration Object UsedObject used for calibration; e.g. sphere
122489 Curve Fitted ReferenceApplication dependent method to calculate the reference diameter based on the multiple diameter values
122490 Interpolated Local ReferenceApplication dependent method to calculate reference by interpolation, based on the diameter of two or more user defined reference positions
122491 Mean Local ReferenceApplication dependent method to calculate by averaging the reference, based on the diameter of one or more user defined reference positions
122493 Radial Based Wall Motion AnalysisMethod to calculate wall motion based on the lengths of the radials in the predefined regions [Ingels]
122495 Regional Contribution to Ejection FractionContribution of Region to global Ejection factor based on radial or landmark based wall motion method
122496 Radial ShorteningThe reduction of area between End Systolic and End Diastolic based on radial wall motion analysis
122497 Landmark Based Wall Motion AnalysisMethod to calculate wall motion based on the move of landmarks on the wall [Slager]
122498 Slice Contribution to Ejection FractionContribution to the ejection fraction of a specific slice region [Slager]
122499 Frame to Frame AnalysisMethod to calculate volumes of heart chambers for every image in a range
122501 Area of closed irregular polygonThe area is derived by considering a set of coordinates as a closed irregular polygon, accounting for inner angles. The exact method, such as by decomposition into triangles or quadrilaterals, is not specified, since it does not affect the numeric result, apart from the effect of numeric precision during computation of intermediate results
122502 Area of a closed NURBSThe area is derived by using a set of coordinates as control points for a Non Uniform Rational B-Spline (NURBS)
122503 Integration of sum of closed areas on contiguous slicesThe volume derived by integrating the sum of the areas on adjacent slices across the slice interval; each area is defined by a regular planar shape or by considering a set of coordinates as a closed irregular polygon, accounting for inner angles
122505 CalibrationProcedure used to calibrate measurements or measurement devices
122507 Left ContourLeft contour of lumen (direction proximal to distal)
122508 Right ContourRight contour of lumen (direction proximal to distal)
122509 Diameter GraphOrdered set of diameters values derived from contours (direction proximal to distal)
122510 Length Luminal SegmentLength Luminal Segment
122511 Graph IncrementIncrement value along X-axis in Diameter Graph
122516 Site of Maximum LuminalLocation of the maximum lumen area in a lesion or vessel
122517 Densitometric Luminal Cross-sectional Area GraphOrdered set of cross-sectional Vessel Lumen Cross-Sectional Area values derived from contours (direction proximal to distal) based on densitometric method
122528 Position of Proximal BorderPosition of proximal border of segment relative to the contour start (proximal end of analysis area)
122529 Position of Distal BorderPosition of distal border of segment relative to the contour start (proximal end of analysis area)
122542 Plaque AreaLongitudinal cross sectional area of plaque
122544 Diameter SymmetrySymmetry of stenosis (0 = complete asymmetry, 1 = complete symmetry); see Section T.2 "Definition of Diameter Symmetry with Arterial Plaques" in PS3.17
122545 Area SymmetrySymmetry of plaque (0 = complete asymmetry, 1 = complete symmetry); see Section T.2 "Definition of Diameter Symmetry with Arterial Plaques" in PS3.17
122546 Inflow AngleThe average slope of the diameter function between the position of the minimum luminal diameter and the position of the proximal border of the segment
122547 Outflow AngleThe average slope of the diameter function between the position of the minimum luminal diameter and the position of the distal border of the segment
122548 Stenotic Flow ReserveThe relation between coronary pressure and coronary flow
122549 Poiseuille ResistancePoiseuille Resistance at the location of the stenosis
122550 Turbulence ResistanceTurbulence Resistance at the location of the stenosis
122551 Pressure Drop at SFRPressure drop over the stenosis at maximum heart output
122554 Segmentation MethodMethod for selection of vessel sub-segments
122555 Estimated Normal FlowEstimate of the volume of blood flow in the absence of stenosis
122558 Area Length KennedyArea Length method defined by Kennedy [Kennedy, 1970]
122559 Area Length DodgeArea Length method defined by Dodge [Dodge, 1960]
122560 Area Length WynneArea Length method defined by Wynne [Wynne]
122562 Multiple SlicesVolume method based on multiple slice
122563 BoakVolume method defined by Boak [Boak]
122564 TS PyramidVolume method defined by Ferlinz [Ferlinz]
122565 Two ChamberVolume method defined by Graham [Graham]
122566 ParallelepipedVolume method defined by Arcilla [Arcilla]
122572 BSA^1.219Corrected Body Surface area for indexing the hemodynamic measurements for a pediatric patient
122574 Equidistant methodMethod for selecting sub-segments that are all of the same length
122575 User selected methodManually selected start and end of sub-segment
122582 Left ventricular posterobasal segmentLeft ventricular posterobasal segment
122600 Cardiovascular Analysis ReportReport of a Cardiovascular Analysis, typically from a CT or MR study
122601 Ventricular AnalysisVentricular Analysis
122602 Myocardial Perfusion AnalysisMyocardial Perfusion Analysis
122603 Calcium Scoring AnalysisCalcium Scoring Analysis
122604 Flow QuantificationFlow Quantification Analysis
122605 Vascular Morphological AnalysisVascular Morphological Analysis
122606 Vascular Functional AnalysisVascular Functional Analysis
122607 Thickening AnalysisAnalysis of myocardial wall thickening
122608 Absolute Values Of Ventricular MeasurementsSection Heading for absolute values of ventricular measurements
122609 Normalized Values Of Ventricular MeasurementsResults of normalizing ventricular measurements
122611 Reference PointReference Point of a measurement
122612 Central breathing positionCentral breathing position between inspiration and expiration
122616 Peak Ejection RatePeak of the ventricular ejection rate
122617 Peak Ejection TimeTime of the peak of ventricular ejection
122618 Peak Filling RatePeak of the fluid filling rate
122619 Peak Filling TimeTime interval until time of peak filling from a given reference point; e.g. end systole
122620 Papillary Muscle ExcludedPapillary muscle was excluded from the measurement
122621 Papillary Muscle IncludedPapillary muscle was included in the measurement
122624 Wall Thickness Ratio end-systolic to end-diastolicThe ratio of the end-systolic wall thickness compared to the end-diastolic wall thickness
122627 Curve Fit MethodThe method to smooth a ventricular volume as a function of time
122628 Baseline Result CorrectionBaseline correction used in the calculation of the results
122631 Signal Earliest Peak TimeThe time in a dynamic set of images at which the first peak of the signal is observed for the analyzed myocardial wall segments
122633 Signal Increase Start TimeThis is the time at which the signal begins to increase
122634 Signal Time to PeakTime interval between the beginning of the signal increase to the time at which the signal intensity reaches its first maximum in a dynamic set of images
122635 MR Perfusion PeakPeak of the MR perfusion signal
122636 MR Perfusion SlopeSignal intensity as a function of time. It is the change in the signal intensity divided by the change in the time
122637 MR Perfusion Time IntegralMR perfusion time integral from baseline (foot time) to earliest peak
122638 Signal Baseline StartFirst time point in a dynamic set of images used in the calculation of the baseline signal intensity for each myocardial wall segment
122639 Signal Baseline EndLast time point in a dynamic set of images used in the calculation of the baseline signal intensity for each myocardial wall segment
122640 Image IntervalThe time delta between images in a dynamic set of images
122642 Velocity Encoding Minimum ValueThe minimum velocity encoded by the phase encoding gradient
122643 Velocity Encoding Maximum ValueThe maximum velocity encoded by the phase encoding gradient
122645 Net Forward VolumeForward volume-reverse volume
122650 Area Based MethodArea Based Method for estimating volume or area
122651 Diameter Based MethodDiameter Based Method for estimating volume, area or diameter
122652 Volume Based MethodVolume Based Method for estimating volume
122655 NASCETA method of diameter measurements according to NASCET (North American Symptomatic Carotid Endarterectomy Trial)
122656 ECSTA method of diameter measurements according to ECST (European Carotid Surgery Trial)
122657 Agatston Score ThresholdAgatston Score Threshold
122658 Calcium Mass ThresholdCalcium Mass Threshold
122659 Calcium Scoring CalibrationCalcium Scoring Calibration
122660 Calcium VolumeCalcium Volume
122661 Calcium MassCalcium Mass
122664 Late Contrast EnhancementDelayed hyperenhancement of a tissue observed in an image acquired after injection of contrast media
122665 Time interval since injection of contrast mediaTime interval since injection of contrast media
122666 Time relative to R-wave peakTime relative to R-wave peak
122667 Blood velocity vs. time of cardiac cycleRelationship between blood velocity and time relative to R-wave peak
122668 Time interval since detection of contrast bolusTime interval since detection of contrast bolus
122670 Papillary Muscle Included/ExcludedIndicates if the papillary muscle was included or excluded in the measurement
122675 Anterior-PosteriorAnterior to Posterior direction
122680 endoleakPersistent flow of blood into the stent-grafting
122683 Stent FractureFracture of a stent
122684 Stent DisintegrationDisintegration of a stent
122685 Stent CompositionMaterial that a stent consists of
122686 Parent Vessel FindingFinding about the characteristics of the parent vessel of a vessel
122687 Site of Lumen MaximumSite of Maximal lumen diameter of a vessel
122698 X-ConceptThe physical domain (time, space, etc.) to the horizontal axis of the graphical presentation
122699 Y-ConceptThe physical domain (time, space, etc.) to the vertical axis of the graphical presentation
122700 Indications for Pharmacological StressIndications for Pharmacological Stress
122701 Procedure time baseReference time for measurement of elapsed time in a procedure
122702 Treadmill speedTreadmill speed
122703 Treadmill gradientTreadmill gradient
122704 Ergometer powerErgometer power
122705 Pharmacological Stress Agent Dose RatePharmacological Stress Agent Dose Rate
122706 Rating of Perceived ExertionRating of Perceived Exertion
122707 Number of Ectopic BeatsNumber of ectopic beats during a period of collection
122708 Double ProductHeart rate times systolic blood pressure
122709 Activity workloadPhysical activity workload (intensity) measurement
122710 Time since start of stageElapsed time at stage
122711 Exercise duration after stress agent injectionExercise duration after stress agent injection
122712 Imaging Start TimeImaging Start Time
122713 Attenuation correction methodAttenuation correction method
122715 Pharmacological Stress Agent DosePharmacological Stress Agent Dose
122716 Maximum Power Output AchievedMaximum power output achieved during course of procedure
122717 Peak activity workloadPeak physical activity intensity measurement during course of procedure
122718 Peak Double ProductPeak Double Product measurement during course of procedure
122720 OSEM algorithmOrdered subsets expectation maximization reconstruction algorithm
122721 Chang methodChang attenuation correction method
122726 Algorithmic attenuation correctionAttenuation correction not based on image-based attenuation maps
122727 NM transmission attenuation correctionNM transmission attenuation correction
122728 CT-based attenuation correctionCT-based attenuation correction
122729 No Attenuation CorrectionNo attenuation correction
122730 Bazett QTc AlgorithmBazett QT Correction Algorithm; QT/(RR ^ 0.5); Bazett HC. "An analysis of the time-relations of electrocardiograms" Heart7:353-370 (1920)
122731 Hodges QTc AlgorithmHodges QT Correction Algorithm; QT + 1.75 (heart rate-60); Hodges M, Salerno Q, Erlien D. "Bazett's QT correction reviewed. Evidence that a linear QT correction for heart rate is better." J Am Coll Cardiol1:694 (1983)
122732 Fridericia QTc AlgorithmFridericia QT Correction Algorithm; QT/(RR ^ 0.333); Fridericia LS. "The duration of systole in the electrocardiogram of normal subjects and of patients with heart disease" Acta Med Scand53:469-486 (1920)
122733 Framingham QTc AlgorithmFramingham QT Correction Algorithm; QT + 0.154 (1- RR); Sagie A, Larson MG, Goldberg RJ, et al. "An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)." Am J Cardiol70:797-801(1992)
122734 Borg RPE ScaleBorg Rating of Perceived Exertion Scale, range 6:20
122735 Borg CR10 ScaleBorg category ratio scale, open ended range with nominal range 0:10
122739 Overall study qualityOverall study quality
122740 Excellent image qualityExcellent image quality
122741 Good image qualityGood image quality
122742 Poor image qualityPoor image quality
122743 Body habitus attenuationImage attenuation due to body physique (overweight)
122744 Breast attenuationImage attenuation due to breast tissue
122745 Diaphragmatic attenuationImage attenuation due to diaphragm
122748 False positive defect findingFinding of a defect is incorrect; e.g. from automated analysis
122750 Non-diagnostic - low heart rateECG is non-diagnostic due to low heart rate
122751 Non-diagnostic - resting ST abnormalitiesECG is non-diagnostic due to resting ST abnormalities
122752 Non-diagnostic - ventricular pacing or LBBBECG is non-diagnostic due to ventricular pacing or Left Bundle Branch Block
122753 Non-diagnostic ECGECG is non-diagnostic for presence of acute coronary syndrome
122755 Strongly positiveStrongly positive finding
122756 Strongly positive - ST elevationStrongly positive finding - ST elevation
122757 ST Depression - HorizontalFinding of ST segment depression with no slope
122758 ST Depression - UpslopingFinding of ST segment depression with upslope
122759 ST Depression - DownslopingFinding of ST segment depression with downslope
122760 Stress test scoreStress test score
122762 Number of diseased vessel territoriesNumber of diseased vessel territories
122764 Weight exceeds equipment limitPatient weight exceeds equipment limit
122768 Difference in Ejection FractionDifference in Ejection Fraction
122769 Difference in ED LV VolumeDifference in End Diastolic Left Ventricular Volume
122770 Ratio of achieved to predicted maximal oxygen consumptionRatio of achieved to predicted maximal oxygen consumption
122771 Ratio of achieved to predicted functional capacityRatio of achieved to predicted functional capacity
122772 Aerobic indexWorkload (Watts) at target heart rate divided by body weight
122773 ST/HR IndexST depression at peak exercise divided by the exercise-induced increase in heart rate [Kligfield P, Ameisen O, Okin PM. "Heart rate adjustment of ST segment depression for improved detection of coronary artery disease." Circulation 1989;79:245-55.]
122775 Agreement with prior findingsAgreement with prior findings
122776 Disagreement with prior findingsDisagreement with prior findings
122781 Rest thallium/stress technetium procedureNuclear Medicine Rest thallium/stress technetium procedure
122782 Rest technetium/stress technetium 1 day procedureNuclear Medicine Rest technetium/stress technetium 1 day procedure
122783 Rest technetium/stress technetium 2 day procedureNuclear Medicine Rest technetium/stress technetium 2 day procedure
122784 Stress technetium/rest technetium 1 day procedureNuclear Medicine Stress technetium/rest technetium 1 day procedure
122785 NM Myocardial Viability procedureNuclear Medicine Myocardial Viability procedure
122791 PET Myocardial Perfusion, Rest onlyPositron Emission Tomography Perfusion Imaging procedure, rest only
122792 PET Myocardial Perfusion, Stress onlyPositron Emission Tomography Perfusion Imaging procedure, stress only
122793 PET Myocardial Perfusion, Rest and StressPositron Emission Tomography Perfusion Imaging procedure, rest and stress
122795 PET Myocardial Viability, Rest onlyPositron Emission Tomography Myocardial Viability procedure, rest only
122796 PET Myocardial Viability, Stress onlyPositron Emission Tomography Myocardial Viability procedure, stress only
122797 PET Myocardial Viability, Rest and StressPositron Emission Tomography Myocardial Viability procedure, rest and stress
122799 Anginal EquivalentGroup of symptoms heralding angina pectoris that does not include chest pain (dyspnea, diaphoresis, profuse vomiting in a diabetic patient, or arm or jaw pain)
123001 RadiopharmaceuticalActive ingredient (molecular) used for radioactive tracingDeprecated
123003 Radiopharmaceutical Start TimeTime of radiopharmaceutical administration to the patient for imaging purposes
123004 Radiopharmaceutical Stop TimeEnding time of radiopharmaceutical administration to the patient for imaging purposes
123005 Radiopharmaceutical VolumeVolume of radiopharmaceutical administered to the patient
123006 Radionuclide Total DoseTotal amount of radionuclide administered to the patient at Radiopharmaceutical Start Time
123007 Radiopharmaceutical Specific ActivityActivity per unit mass of the radiopharmaceutical at Radiopharmaceutical Start Time
123009 Radionuclide Syringe CountsPre-injection syringe acquisition count rate
123010 Radionuclide Residual Syringe CountsSyringe acquisition count rate following patient injection
123011 Contrast/Bolus AgentContrast or bolus agent
123012 Pre-MedicationMedication to be administered at the beginning of the Scheduled Procedure Step
123014 Target RegionAnatomic Region to be imaged
123015 Imaging DirectionDirection of imaging (includes view, transducer orientation, patient orientation, and/or projection)
123016 Imaging ConditionsImaging condition for refinement of protocol (includes secondary posture, instruction, X-Ray / electron beam energy or nuclide, and ultrasound modes), as used in JJ1017 v3.0
123019 Caudal 10 degree distal-cranioproximal obliqueCaudal 10 degree distal-cranioproximal oblique radiographic projection, defined per Smallwood et al
123101 Neighborhood AnalysisSurface processing utilizing predefined weighting factors (i.e., kernels) applied to different data values depending on their location relative to other data values within the data domain. Includes Low Pass, High Pass, Gaussian, Laplacian, etc.
123102 Adaptive FilteringSurface processing applied non-uniformly utilizing a priori knowledge of the system and/or relative locations of the data values within the data domain. Example: Neighborhood analysis where weighting factors are modified continuously based on predefined criteria
123103 Edge DetectionSurface processing through the exploitation of discontinuities in the data values within their domain. Includes Gradient filters
123104 Morphological OperationsSurface processing based on the connectivity of values based on the shape or structure of the data values within their domain. Includes erode, dilate, etc.
123105 Histogram AnalysisSurface processing applied to the distribution of the data values. Includes thresholding, Bayesian Classification, etc.
123106 Multi-Scale/Resolution FilteringSurface processing accomplished through varying the data domain size. Include deformable models
123107 Cluster AnalysisSurface processing accomplished by combining data values based on their relative location within their domain or value distribution. Includes K- and C-means, Fuzzy Analysis, Watershed, Seed Growing, etc.
123108 Multispectral ProcessingSurface processing accomplished through the weighted combination of multiple data sets. Includes Principle Component Analysis, linear and non-linear weighed combinations, etc.
123109 Manual ProcessingSurface processing accomplished through human interaction. Region drawing
123110 Artificial IntelligenceSurface processing using Artificial Intelligence techniques, such as Machine Learning, Neural Networks, etc.
123111 Deformable ModelsSurface processing using Deformable Model techniques, such as Point Distribution Models, Level Sets, Simplex Meshes, etc.
125000 OB-GYN Ultrasound Procedure ReportDocument Title of OB-GYN procedure report
125001 Fetal Biometry RatiosReport section for assessment of fetal growth using ratios and indexes
125002 Fetal BiometryReport section for assessment of fetal growth
125003 Fetal Long BonesReport section for assessment of fetal growth by long bone measurements
125004 Fetal CraniumReport section for assessment of fetal cranium growth
125005 Biometry GroupBiometric assessment of
125006 Biophysical ProfileReport section for assessment of biophysical observations that evaluate fetal well-being according to Manning, Antepartum Fetal Evaluation: Development of a Fetal Biophysical Profile Score, Am. J Obstet Gynecol, 1980;136:787
125007 Measurement GroupA grouping of related measurements and calculations that share a common context
125008 Fetus SummaryReport section for fetus specific procedure summary observations
125009 Early GestationReport section for assessment of early gestation fetus
125010 IdentifierA name to differentiate between multiple instances of some item
125011 Pelvis and UterusReport section for assessment of pelvis and uterus
125012 Growth Percentile rankThe rank of a measured growth indicator relative to a normal distribution expressed as a percentage
125013 Growth Z-scoreThe rank of a measured growth indicator relative to a normal distribution expressed as the dimensionless quantity z = (x-m) /s where (x-m) is the deviation of the value x, from the distribution mean, m, and s is the standard deviation of the distribution
125015 Fetus CharacteristicsFetus characteristics (findings section title)
125016 Fetal MeasurementsFetal Measurements (findings section title)
125021 Frame of Reference IdentityThere is a defined equivalence between the Frame of Reference of the Registration SOP instance and the Frame of Reference of the referenced images
125022 Fiducial AlignmentThe registration is based on fiducials that represent patient or specimen features identified in each data set
125023 Acquisition Equipment AlignmentRegistration based on a-priori knowledge of the acquisition geometry. This is not an object registration as in fiducial registration. Rather, it specifies a known spatial relationship
125024 Image Content-based AlignmentComputed registration based on global image information
125025 Visual AlignmentRegistration by visually guided manipulation
125030 Inter-Hemispheric PlaneA plane fiducial that specifies the location of the plane separating the two hemispheres of the brain
125031 Right Hemisphere Most AnteriorA point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the anterior limit of the right brain hemisphere
125032 Right Hemisphere Most PosteriorA point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the posterior limit of the right brain hemisphere
125033 Right Hemisphere Most SuperiorA point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the superior limit of the right brain hemisphere
125034 Right Hemisphere Most InferiorA point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the inferior limit of the Right brain hemisphere
125035 Left Hemisphere Most AnteriorA point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the anterior limit of the left brain hemisphere
125036 Left Hemisphere Most PosteriorA point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the posterior limit of the left brain hemisphere
125037 Left Hemisphere Most SuperiorA point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the superior limit of the left brain hemisphere
125038 Left Hemisphere Most InferiorA point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the inferior limit of the left brain hemisphere
125040 BackgroundThat which is not part of an object
125041 Registration InputA segment for use as an input to an image registration process; e.g. to specify the bounding region for determining a Frame of Reference Transformation Matrix
125100 Vascular Ultrasound Procedure ReportRoot Document Title for ultrasound vascular evidence reports (worksheets)
125101 Vessel BranchThe particular vessel branch, such as the inferior, medial or lateral
125102 Graft TypeA descriptor or elaboration of the type of graft
125105 Measurement OrientationA modifier to a 2D distance measurement to describe its orientation; e.g. a vascular distance measurement for a vessel plague could have a modifier Transverse or Longitudinal
125106 Doppler AngleThe angle formed between the Doppler beam line and the direction of blood flow within a region of interest in the body defined by the sample volume
125107 Sample Volume DepthThe depth of the center of the Doppler sample volume measured from skin line along the Doppler line
125195 Pediatric Cardiac Ultrasound ReportPediatric Cardiac Ultrasound Report (document title)
125196 Fetal Cardiac Ultrasound ReportFetal Cardiac Ultrasound Report (document title)
125197 Adult Congenital Cardiac Ultrasound ReportAdult Congenital Cardiac Ultrasound Report (document title)
125200 Adult Echocardiography Procedure ReportDocument title of adult echocardiography procedure (evidence) report
125201 Illustration of FindingAn image that is a pictorial representation of findings. The concept is typically used as a purpose of reference to an image, such as a depiction of myocardium segments depicting wall motion function
125202 LV Wall Motion Score IndexThe average of all scored (non-zero) Left Ventricle segment wall motion scores
125203 Acquisition ProtocolA type of clinical acquisition protocol for creating images or image-derived measurements. Acquisition protocols may be specific to a manufacturer's product
125204 Area-length biplaneMethod for calculating left ventricular volume from two orthogonal views containing the true long axis (usually the apical 4 and 2 chamber views). Volume = [pL1 / 6] * [(4A1) ÷ (pL1) ] * [(4A2) ÷ (pL2) ]
125205 Area-Length Single PlaneMethod for calculating left ventricular volume from a view containing the true long axis (usually the apical 4-chamber view). Volume = [8(A)2]÷[3pL]
125206 CubeMethod (formula) for calculating left ventricle volumes and function derivatives (EF, SV, SI, etc.) that estimates the volume as the cube of diameter
125207 Method of Disks, BiplaneMethod of calculating volume based on the summation of disk volumes. The disk axis is parallel to the left ventricular long axis and using a disk diameter averaged from the two chamber and four chamber views
125208 Method of Disks, Single PlaneMethod of calculating volume based on the summation of disk volumes. The disk axis is parallel to the left ventricular long axis with disk diameter taken from the four-chamber view
125209 TeichholzMethod (formula) for calculating left ventricle volumes and function derivatives (EF, SV, SI, etc.) Volume = [7.0/(2.4+D) ]*D3
125210 Area by Pressure Half-TimeMitral valve area (cm2) by Pressure Half-time = 220 (cm2.ms) / PHT (ms)
125211 Biplane EllipseArea = P/4 X d1 X d2 d1 = anterior/posterior axis d2 = medial/lateral axis Hagen-Ansert, Sandra L., Textbook of Diagnostic Ultrasound, ed. 3, The C.V.Mosby Co., 1989, p. 73.
125212 Continuity EquationFor conduits in series ("in continuity"), volume flow is equal: A1*V1 = A2*V2. where V is the velocity
125213 Continuity Equation by Mean VelocityFor conduits in series ("in continuity"), volume flow is equal: A1*V1 = A2*V2. where V is the mean velocity
125214 Continuity Equation by Peak VelocityFor conduits in series ("in continuity"), volume flow is equal: A1*V1 = A2*V2. where V is the peak velocity
125215 Continuity Equation by Velocity Time IntegralFor conduits in series ("in continuity"), volume flow is equal: A1*V1 = A2*V2. where V is the velocity time integral
125216 Proximal Isovelocity Surface AreaUtilizes aliasing velocity (by color Doppler) of flow into an orifice (often regurgitant or stenotic) to measure instantaneous flow rate, orifice area, and flow volume. The instantaneous flow rate = (2πr2vav ) * (α / π) where vav is the constant velocity known as aliasing velocity at radius r, vp is the peak velocity at the orifice, and α is the angle in radians of the constant velocity surface. Estimated Orifice area = Flow rate / vp , where vp is the peak velocity at the orifice and the flow rate is the PISA peak flow rate. The volume flow is then the product of the orifice area and Velocity Time Integral
125217 Full BernoulliΔP = 4*(V12 - V22)
125218 Simplified BernoulliΔP = 4*V2
125219 Doppler Volume FlowVolume flow = Conduit CSA * (Velocity Time Integral)
125220 PlanimetryDirect measurement of an area by tracing an irregular perimeter
125221 Left Ventricle Mass by M-modeMass = 1.04 * [(ST+LVID+PWT)3 - LVID3] * 0.8+ 0.6. Mass unit is grams and length in cm
125222 Left Ventricle Mass by Truncated EllipseMass = 1.05P ((b + t)2 X (2/3 (a + t) + d - d3 /3(a + t)2) - b2 (2/3a + d - d3 /3a2)) a = Semi-major axis from widest minor axis radius to apex. b = Short axis radius calculated from short axis cavity area t = Myocardial thickness calculated from short axis epicardial and cavity areas d = Truncated semi-major axis from widest short axis diameter to plane of mitral annulus. Mass unit is grams and length in cm. Schiller NB et al: Recommendations for quantification of the left ventricle by two-dimensional echocardiography, American Society of Echocardiography 2:364, 1989.
125223 4 Point Segment Finding ScaleA four point, echocardiographic numeric scoring scheme of myocardium segments based on evaluation of wall motion and ventricle morphology. Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography, Journal of the American Society of Echocardiography, 2:358-367, 1989
125224 5 Point Segment Finding ScaleA five point, echocardiographic numeric scoring scheme of myocardium segments based on evaluation of wall motion and ventricle morphology. Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography, Journal of the American Society of Echocardiography, 2:358-367, 1989
125225 5 Point Segment Finding Scale With Graded HypokinesisA five point, echocardiographic numeric scoring scheme of myocardium segments based on evaluation of wall motion and ventricle morphology, with severity of hypokinesis graded. Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography, Journal of the American Society of Echocardiography, 2:358-367, 1989
125226 Single Plane EllipseMethod of estimating volume from a planar ellipse. Equivalent to Biplane Ellipse with an assumption that the ellipse in the orthogonal plane has identical major and minor diameters
125227 Modified SimpsonModified Simpson's Method of estimating ventricular volume, based on the method of disks with paired apical views. Schiller NB, et al. "Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms". J Am Soc Echocardiogr.1989 2(5):358-367. Sep-Oct
125228 Bullet MethodBullet method of estimating ventricular volume. Volume = 5/6 * L * S L: Left ventricle long axis length S: Left ventricle area, SAX view at level of Mitral Valve
125230 Power DopplerColor coded ultrasound images of blood flow, which depict the amplitude, or power, of Doppler signalsDeprecated
125231 3D modeVolumetric ultrasound imagingDeprecated
125233 Start of drug dose administrationOnset of administration of dose of a drug
125234 Start of contrast agent administrationOnset of contrast agent administration
125235 Destruction of microbubblesDestruction of ultrasonic contrast microbubbles by a high-energy ultrasound pulse
125236 Onset of exerciseInstant at which exercise begins
125237 Cessation of exerciseInstant at which exercise ends
125238 Onset of stimulationInstant at which stimulation begins
125239 Cessation of stimulationInstant at which stimulation ends
125240 Line scan patternUltrasound transducer scan pattern in which information is gathered along a line
125241 Plane scan patternUltrasound transducer scan pattern in which information is gathered within a plane
125242 Volume scan patternUltrasound transducer scan pattern in which information is gathered within a volume
125251 Non-imaging Doppler ultrasound transducer geometryUltrasound transducer geometry characterized by a single scan line used for PW or CW Doppler scanning
125252 Linear ultrasound transducer geometryUltrasonic transducer geometry characterized by parallel lines
125253 Curved linear ultrasound transducer geometryUltrasonic transducer geometry characterized by radial lines normal to the outside of a curved surface
125254 Sector ultrasound transducer geometryUltrasonic transducer geometry characterized by lines originating from a common apex
125255 Radial ultrasound transducer geometryUltrasonic transducer geometry characterized by lines emanating radially from a single point
125256 Ring ultrasound transducer geometryUltrasonic transducer geometry characterized by a circular ring of transducer elements
125257 Fixed beam directionUltrasonic steering technique consisting of a single beam normal to the transducer face steered by the orientation of the probe
125258 Mechanical beam steeringUltrasonic steering technique consisting of mechanically directing the beam
125259 Phased beam steeringUltrasonic steering technique consisting of electronically-steered beams
125261 External TransducerTransducer is designed to be placed onto the surface of the subject
125262 Transesophageal TransducerTransducer is designed for insertion into the esophagus
125263 Endovaginal TransducerTransducer is designed for insertion into the vagina
125264 Endorectal TransducerTransducer is designed for insertion into the rectum
125265 Intravascular TransducerTransducer is designed for insertion via a catheter
125270 Left Ventricle Mass by Area Lengthmethod to measure the mass of the Left Ventricle via the ASE area-length method at end diastole. LV Mass = 1.05*(5/6*(A1*(L+t)) - 5/6*(A2*L)) A1 = Left Ventricle epicardial SAX area at the level of the papillary muscle tips at end diastole. A2 = Left Ventricle endocardial SAX area cavity area at the level of the papillary muscle tips at end diastole. L = Left Ventricle apical view long axis length at end diastole. t = Myocardial thickness can be computed as: t = sqrt (A1/3.14) - sqrt (A2/3.14) Reference: 1) Schiller, N.B., et al. "Recommendations for Quantification of the LV by Two-dimensional Echocardiography." J Am Soc Echo, Vol. 2, No. 5: 358-367, Sep-Oct 1989. 2) Reichek, N., et al. "Anatomic Validation of Left Ventricular Mass Estimates from Clinical Two-dimensional Echocardiography: Initial Results." Circulation, Vol. 67, No. 2: 348-52, February 1983
125271 Left Ventricle Mass by M-mode - adjusted by HeightEquation = Left Ventricle Mass by M-mode (in gram) / (Height (in meter)) ^2.7 Reference: Giovanni De Simone, et al. "Effect of Growth on Variability of Left Ventricular Mass: Assessment of Allometric Signals in Adults and Children and Their Capacity to Predict Cardiovascular Risk". New York, New York and Cincinnati, Ohio
125272 Left Ventricle Mass by Truncated Ellipse - adjusted by HeightEquation = Left Ventricle Mass by Truncated Ellipse / Height^2.7 Reference: Giovanni De Simone, et al. "Effect of Growth on Variability of Left Ventricular Mass: Assessment of Allometric Signals in Adults and Children and Their Capacity to Predict Cardiovascular Risk". New York, New York and Cincinnati, Ohio
125273 Left Ventricle Mass by Area Length - adjusted by HeightEquation = Left Ventricle Mass by Area Length / Height^2.7 Reference: Giovanni De Simone, et al. "Effect of Growth on Variability of Left Ventricular Mass: Assessment of Allometric Signals in Adults and Children and Their Capacity to Predict Cardiovascular Risk". New York, New York and Cincinnati, Ohio
125901 CARDIOsphereCARDIOsphere™ ultrasonic contrast agent produced by POINT Biomedical
125902 EchovistEchovist® ultrasonic contrast agent produced by Schering AG
125903 ImagifyImagify™ ultrasonic contrast agent produced by Accusphere Inc
125904 LevovistLevovist® ultrasonic contrast agent produced by Schering AG
125905 SonazoidSonazoid™ ultrasonic contrast agent produced by Daiichi Pharmaceutical / General Electric
125906 SonoVueSonoVue™ ultrasonic contrast agent produced by Bracco Diagnostics
125907 Targestar-BTargestar™-B ultrasonic contrast agent produced by Targeson LLC
125908 Targestar-PTargestar™-P ultrasonic contrast agent produced by Targeson LLC
126000 Imaging Measurement ReportA structured report containing the quantitative results of human or machine analysis of images
126001 Oncology Measurement ReportA structured report containing the quantitative results of human or machine analysis of images for oncology evaluation
126002 Dynamic Contrast MR Measurement ReportA structured report containing the quantitative results of human or machine analysis of DCE-MR
126003 PET Measurement ReportA structured report containing the quantitative results of human or machine analysis of PET images
126010 Imaging MeasurementsMeasurements made on images
126011 Derived Imaging MeasurementsMeasurements derived from measurements made on images
126020 Multiparametric MRIAn MRI procedure in which multiple parameters including diffusion, dynamic contrast and T2 are measured
126021 Multiparametric MRI of prostateAn MRI procedure of the prostate in which multiple parameters including diffusion, dynamic contrast and T2 are measured
126022 Multiparametric MRI of whole bodyAn MRI procedure of the whole body in which multiple parameters including diffusion, dynamic contrast and T2 are measured
126030 Sum of segmented voxel volumesThe volume derived by summing the volumes of all the voxels (and partial voxels if the segment contains partially occupied voxels) included in the segment
126031 Peak Value Within ROIMaximum average gray value that is calculated from a 1 cubic centimeter sphere placed within the region of interest. Reference Wahl et al PERCIST article
126032 Metabolic VolumeThe volume of a lesion (e.g. a tumor) ascertained through information about its metabolic activity (e.g. SUV on PET). Abbreviated "MV". Synonymous with Metabolic Tumor Volume (MTV)
126033 Total Lesion GlycolysisThe total activity of a lesion obtained as the product of its volume and its glycolytic activity (on FDG-PET). The volume may be defined on the same modality (e.g. the MV on FDG-PET by some thresholding or other technique) or on another spatially registered modality (e.g. the lesion outline segmented on CT or MR). Does not apply to other radiopharmaceuticals than those involved in glucose metabolism. Abbreviated TLG. Synonymnous with "Tumor Lesion Glycolysis"
126034 GlycolysisThe amount glycolytic activity summed across all voxels in a defined region or within a defined range of SUV (on FDG-PET)
126035 Total Lesion ProliferationThe total activity of a lesion obtained as the product of its volume and its proliferative activity (on FLT-PET). The volume may be defined on the same modality (e.g. the MV on FDG-PET by some thresholding or other technique) or on another spatially registered modality (e.g. the lesion outline segmented on CT or MR). Does not apply to other radiopharmaceuticals than those involved in cellular proliferation. Abbreviated TLP. Synonymnous with "Tumor Lesion Proliferation"
126036 Proliferative ActivityThe amount proliferative activity summed across all voxels in a defined region or within a defined range of SUV (on FLT-PET)
126037 Standardized Added Metabolic Activity (SAM)A background-corrected, partial volume independent version of TLG. SAM is calculated by drawing a volume of interest (VOI1) around the tumour and a larger VOI (VOI2) around VOI1. Subtracting the background activity in VOI2-VOI1 from VOI1 yields SAM. See Mertens et al. "Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases". Eur J Nucl Med Mol Imaging (2012) 39:1441-1448
126038 Standardized Added Metabolic Activity (SAM) BackgroundThe background value (VOI2-VOI1) used to calculate Standardized Added Metabolic Activity (SAM). SAM is calculated by drawing a volume of interest (VOI1) around the tumour and a larger VOI (VOI2) around VOI1. Subtracting the background activity in VOI2-VOI1 from VOI1 yields SAM. See Mertens et al. "Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases". Eur J Nucl Med Mol Imaging (2012) 39:1441-1448
126039 Lesion to Background SUV RatioThe ratio of the SUV within a tumor to the SUV of a pre-defined background region. Need reference(s). A more general concept than Tumor to Background Ratio (TBR)
126040 Background for Lesion to Background SUV RatioThe SUV of a pre-defined background region used to compute Lesion to Background SUV Ratio. Need reference(s)
126050 Fractal DimensionA statistical index of complexity comparing how detail in a fractal pattern changes with the scale at which it is measured; a ratio of the change in detail to the change in scale
126051 SkewnessMeasure of the asymmetry of the probability distribution of a real-valued random variable about its mean
126052 KurtosisMeasure of the peakedness of the probability distribution of a real-valued random variable
126060 Entropy of GLCMThe zero order entropy of a Gray Level Co-occurrence Matrix (GLCM). A measure of disorder. See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126061 Energy of GLCMThe energy (uniformity) (square root of the Angular Second Moment (ASM)) of a Gray Level Co-occurrence Matrix (GLCM). A measure of orderliness. See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126062 Homogeneity of GLCMThe Inverse Difference Moment of a Gray Level Co-occurrence Matrix (GLCM). See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126063 Contrast of GLCMThe sum of squares variance of a Gray Level Co-occurrence Matrix (GLCM). See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126064 Dissimilarity of GLCMThe dissimilarity of a Gray Level Co-occurrence Matrix (GLCM). See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126065 ASM of GLCMThe Angular Second Moment of a Gray Level Co-occurrence Matrix (GLCM). See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126066 Correlation of GLCMA measure of the linear dependency of grey levels on those of neighbouring pixels of a Gray Level Co-occurrence Matrix (GLCM). See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126067 Gray Level Co-occurrence Matrix (GLCM)A tabulation of how often different combinations of pixel values (grey levels) occur in an image. See http://www.fp.ucalgary.ca/mhallbey/the_glcm.htm
126070 Subject Time Point IdentifierAn identifier of a specific time point in a continuum, which is unique within an appropriate local context (such as an entire organization, system or treatment protocol), which identifies the time point for a specific patient
126071 Protocol Time Point IdentifierAn identifier of a specific time point in a continuum, which is unique within an appropriate local context (such as an entire organization, system or treatment protocol), which identifies the time point "slot" within a treatment protocol using the same value for all patients in the protocol
126072 Time Point TypeA pre-defined type of a specific time point in a continuum
126073 Time Point OrderA number indicating the order of a time point relative to other time points in the same continuum
126074 PosttreatmentThe time after the treatment of interest
126075 EligibilityFor the purpose of determining eligibility for a protocol
126080 RECIST 1.0Response Evaluation Criteria in Solid Tumors version 1.0. See [RECIST] in Normative References
126081 RECIST 1.1Response Evaluation Criteria in Solid Tumors Version 1.1. See Eisenhauer et al. "New Response Evaluation Criteria in Solid Tumours: Revised RECIST Guideline (version 1.1)." European Journal of Cancer 45, no. 2 (n.d.): 228-47. doi:10.1016/j.ejca.2008.10.026.
126100 Real World Value Map used for measurementA reference to the Real World Value Map applied to the stored image pixel values before their use for a measurement
126200 Image Library GroupA container that groups common information about a set of images used as evidence to produce a report
126201 Acquisition DateThe date the acquisition of data started
126202 Acquisition TimeThe time the acquisition of data started
126203 PET Radionuclide Incubation TimeThe time between the start of injection of the PET radionuclide and the start of acquisition of the PET data
126220 R2-CoefficientCoefficient of determination, R2. An indication of goodness of fit
126300 Perfusion analysis by Stable Xenon CT techniquePerfusion analysis by Stable Xenon CT technique
126301 Perfusion analysis by IV Iodinated Contrast CT techniquePerfusion analysis by IV Iodinated Contrast CT technique
126302 Perfusion analysis by Arterial Spin Labeling MR techniquePerfusion analysis by Arterial Spin Labeling (ASL) MR technique
126303 Perfusion analysis by Susceptibility MR techniquePerfusion analysis by Susceptibility (T2*) MR technique
126310 Least Mean Square (LMS) deconvolutionLeast Mean Square (LMS) deconvolution
126311 Singular Value Decomposition (SVD) deconvolutionSingular Value Decomposition (SVD) deconvolution
126312 KtransKtrans, the volume transfer constant of a tracer diffusion kinetic model, specifically the volume transfer constant between blood plasma and extravascular extracellular space (EES) See Tofts et al, "Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols", Journal of Magnetic Resonance Imaging, vol. 10, pp. 223-232, 1999
126313 kepkep, the rate constant between extravascular extracellular space (EES) and blood plasma See Tofts et al, "Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols", Journal of Magnetic Resonance Imaging, vol. 10, pp. 223-232, 1999
126314 veve, the fractional (not absolute) volume of extravascular extracellular space (EES) per unit volume of tissue See Tofts et al, "Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols", Journal of Magnetic Resonance Imaging, vol. 10, pp. 223-232, 1999
126320 IAUCThe intial area under the contrast agent concentration-time curve
126321 IAUC60The intial area under the contrast agent concentration-time curve at 60 seconds after the onset time
126322 IAUC90The intial area under the contrast agent concentration-time curve at 90 seconds after the onset time
126330 tau_mτm. The mean intracellular water lifetime (τi). Used in the Shutter-Speed Model (SSM) of tracer kinetics
126331 vpvp. The fractional (not absolute) blood plasma volume per unit volume of tissue. See Tofts et al, "Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols", Journal of Magnetic Resonance Imaging, vol. 10, pp. 223-232, 1999
126340 Standard Tofts ModelA tracer diffusion kinetic model in which the permeability is assumed to be isodirectional. See P. Tofts, "Modeling tracer kinetics in dynamic Gd-DTPA MR imaging", Journal of Magnetic Resonance Imaging, vol. 7, pp. 91-101, 1997
126341 Extended Tofts ModelA tracer diffusion kinetic model in which the permeability is not assumed to be isodirectional, and which includes the contribution of tracer in the blood plasma to the total tissue concentration. See P. Tofts, "Modeling tracer kinetics in dynamic Gd-DTPA MR imaging", Journal of Magnetic Resonance Imaging, vol. 7, pp. 91-101, 1997
126342 Model-free concentration-time quantitificationA semiquantitative analysis of the contrast-enhancement concentration versus time curve that avoids the use of a pharmacokinetic model; e.g. integration to compute the initial area under the curve
126343 First Pass Leakage Profile (FPLP)A tracer diffusion kinetic model that accounts for the tumor leakage profile during the first pass of contrast. See Li, Ka-Loh, Xiao Ping Zhu, John Waterton, and Alan Jackson. "Improved 3D Quantitative Mapping of Blood Volume and Endothelial Permeability in Brain Tumors." Journal of Magnetic Resonance Imaging 12, no. 2 (2000): 347-357. doi:10.1002/1522-2586(200008)12:2<347::AID-JMRI19>3.0.CO;2-7
126344 Shutter-Speed Model (SSM)A tracer diffusion kinetic model that does not assume that intercompartmental water molecule exchange is infinitely fast. See Li, Xin, Wei Huang, Thomas E. Yankeelov, Alina Tudorica, William D. Rooney, and Charles S. Springer. "Shutter-Speed Analysis of Contrast Reagent Bolus-Tracking Data: Preliminary Observations in Benign and Malignant Breast Disease." Magnetic Resonance in Medicine 53, no. 3 (2005): 724-29. doi:10.1002/mrm.20405
126350 T1 by Multiple Flip AnglesT1 measurement by Multiple Flip Angles (MFA) (variable saturation) method
126351 T1 by Inversion RecoveryT1 measurement by Inversion Recovery (IR) method
126352 T1 by Fixed ValueCalculation was performed using a fixed value of T1 rather than a measured value. The value could be encoded as the value of (126353, DCM, "T1 Used For Calculation")
126353 T1 Used For CalculationThe fixed value of T1 used for a calculation
126360 AIF IgnoredNo Arterial Input Function was used
126361 Population Averaged AIFA population-averaged Arterial Input Function
126362 User-defined AIF ROIAn Arterial Input Function computed from a user-defined Region of Interest
126363 Automatically Detected AIF ROIAn Arterial Input Function computed from an automatically detected Region of Interest
126364 Blind Estimation of AIFA data-driven blind source separation (BSS) algorithm that estimates AIF from individuals without any presumed AIF model and initialization. See Lin, Yu-Chun, Tsung-Han Chan, Chong-Yung Chi, Shu-Hang Ng, Hao-Li Liu, Kuo-Chen Wei, Yau-Yau Wai, Chun-Chieh Wang, and Jiun-Jie Wang. "Blind Estimation of the Arterial Input Function in Dynamic Contrast-Enhanced MRI Using Purity Maximization." Magnetic Resonance in Medicine 68, no. 5 (November 1, 2012): 1439-49. doi:10.1002/mrm.24144
126370 Time of Peak ConcentrationThe time at which the concentration-time curve achieves its peak for the first time. Used as a concept name for a value or as a method; e.g. used as a method of calculation for BAT. See Shpilfoygel Med Phys 2008. doi: 10.1118/1.1288669
126371 Bolus Arrival TimeThe nominal time at which arrival of a contrast bolus is detected, which is used as a reference point for subsequent calculations. Used as a concept name for a value or as a method. No specific computational method is implied by this general definition. Abbreviated BAT
126372 Time of Leading Half-Peak ConcentrationThe time at which the concentration-time curve achieves half of its peak density for the first time. Used as a concept name for a value or as a method; e.g. used as a method of calculation for BAT. See Shpilfoygel Med Phys 2008. doi: 10.1118/1.1288669
126373 Temporal Derivative Exceeds ThresholdA method of determining BAT that involves computing the temporal derivative of the concentration-time curve and selecting the time when the temporal derivative exceeds a specified threshold. See Shpilfoygel Med Phys 2008. doi: 10.1118/1.1288669
126374 Temporal Derivative ThresholdA threshold applied to the temporal derivative of the concentration-time curve; e.g. used to establish BAT. See Shpilfoygel Med Phys 2008. doi: 10.1118/1.1288669
126375 Maximum SlopeThe maximum rate of signal intensity change within a measured region of a time-activity curve. See Boonsirikamchai, Piyaporn, Harmeet Kaur, Deborah A. Kuban, Edward Jackson, Ping Hou, and Haesun Choi. "Use of Maximum Slope Images Generated From Dynamic Contrast-Enhanced MRI to Detect Locally Recurrent Prostate Carcinoma After Prostatectomy: A Practical Approach." American Journal of Roentgenology 198, no. 3 (March 1, 2012): W228-W236. doi:10.2214/AJR.10.6387
126376 Maximum DifferenceThe maximum degree of signal intensity change within a measured region of a time-activity curve. See Boonsirikamchai, Piyaporn, Harmeet Kaur, Deborah A. Kuban, Edward Jackson, Ping Hou, and Haesun Choi. "Use of Maximum Slope Images Generated From Dynamic Contrast-Enhanced MRI to Detect Locally Recurrent Prostate Carcinoma After Prostatectomy: A Practical Approach." American Journal of Roentgenology 198, no. 3 (March 1, 2012): W228-W236. doi:10.2214/AJR.10.6387
126377 Tracer ConcentrationTracer concentration in tissue; e.g. in a DCE-MR experiment, the concentration of contrast agent in mmol/l
126380 Contrast Longitudinal RelaxivityThe degree to which a paramagnetic contrast agent can enhance the proton longitudinal relaxation rate constant (R1, 1/T1), normalized to the concentration of the contrast agent. Also referred to as r1. Typically expressed in units of l/mmol/s
126390 Regional Blood FlowThe flow rate of blood perfusing a region as volume per mass per unit of time
126391 Regional Blood VolumeThe volume of blood perfusing a region as volume per mass
126392 Oxygen Extraction FractionThe percent of the oxygen removed from the blood by tissue during its passage through the capillary network. For example, as measured by blood oxygenation level dependent (BOLD) MR. See He, Xiang, and Dmitriy A. Yablonskiy. "Quantitative BOLD: Mapping of Human Cerebral Deoxygenated Blood Volume and Oxygen Extraction Fraction: Default State." Magnetic Resonance in Medicine 57, no. 1 (2007): 115-26
126393 R1The longitiudinal relaxation rate constant. The inverse of longitudinal relaxation time, i.e., R1 = 1/T1
126394 R2The transverse relaxation rate constant. The inverse of transverse relaxation time, i.e., R2 = 1/T2
126400 Standardized Uptake ValueA ratio of locally measured radioactivity concentration versus the injected radioactivity distributed evenly throughout the whole body. This general concept encompasses all specific methods of calculating the whole body volume of distribution, such as using body weight, lean body mass, body surface area, etc.
126401 SUVbwStandardized Uptake Value calculated using body weight. The patient size correction factor for males and females is body weight. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126402 SUVlbmStandardized Uptake Value calculated using lean body mass. The patient size correction factor for males is 1.10 * weight - 120 * (weight/height) ^2, and for females is 1.07 * weight - 148 * (weight/height) ^2. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126403 SUVbsaStandardized Uptake Value calculated using body surface area. The patient size correction factor for males and females is weight^ 0.425 * height^0.725 * 0.007184. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126404 SUVibwStandardized Uptake Value calculated using ideal body weight. The patient size correction factor for males is 48.0 + 1.06 * (height - 152) and for females is 45.5 + 0.91 * (height - 152). Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126410 SUV body weight calculation methodMethod of calculating Standardized Uptake Value using body weight. The patient size correction factor for males and females is body weight. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126411 SUV lean body mass calculation methodMethod of calculating Standardized Uptake Value using lean body mass. The patient size correction factor for males is 1.10 * weight - 120 * (weight/height) ^2, and for females is 1.07 * weight - 148 * (weight/height) ^2. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126412 SUV body surface area calculation methodMethod of calculating Standardized Uptake Value using body surface area. The patient size correction factor for males and females is weight^ 0.425 * height^0.725 * 0.007184. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126413 SUV ideal body weight calculation methodMethod of calculating Standardized Uptake Value using ideal body weight. The patient size correction factor for males is 48.0 + 1.06 * (height - 152) and for females is 45.5 + 0.91 * (height - 152). Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126500 Pittsburgh compound B C^11^A beta-amyloid PET radiotracer that is an analog of thioflavin T
126501 Florbetaben F^18^A beta-amyloid PET radiotracer
126502 T807 F^18^A PHF-tau PET radiotracer
126503 Flubatine F^18^A nicotinic α4β2 receptor (nAChR) PET radiotracer
126510 Monoclonal Antibody (mAb) ^64^CuA Cu 64 Monoclonal Antibody (mAb) PET Radiotracer
126511 Monoclonal Antibody (mAb) ^89^ZrA Zr 89 Monoclonal Antibody (mAb) PET Radiotracer
126512 Trastuzumab ^89^ZrA Zr 89 Trastuzumab PET Radiotracer
126513 Cetuximab ^89^ZrA Zr 89 Cetuximab PET Radiotracer
126514 J591 ^89^ZrA Zr 89 J591 PET Radiotracer
126515 cU36 ^89^ZrA Zr 89 cU36 PET Radiotracer
126516 Bevacizumab ^89^ZrA Zr 89 Bevacizumab PET Radiotracer
126517 cG250-F(ab')(2) ^89^ZrA Zr 89 cG250-F(ab')(2) PET Radiotracer
126518 R1507 ^89^ZrA Zr 89 R1507 PET Radiotracer
126519 E4G10 ^89^ZrA Zr 89 E4G10 PET Radiotracer
126520 Df-CD45 ^89^ZrA Zr 89 Df-CD45 PET Radiotracer
126600 ^44^Scandium^44^Scandium
126601 ^51^Manganese^51^Manganese
126602 ^70^Arsenic^70^Arsenic
126603 ^90^Niobium^90^Niobium
126604 ^191m^Iridium^191m^Iridium
126605 ^43^Scandium^43^Scandium
126606 ^152^Terbium^152^Terbium
126700 ATSM Cu^60^A Cu 60 ATSM PET radiotracer
126701 ATSM Cu^61^A Cu 61 ATSM PET radiotracer
126702 ATSM Cu^62^A Cu 62 ATSM PET radiotracer
126703 Choline C^11^A C 11 Choline PET radiotracer
126704 Fallypride C^11^A C 11 Fallypride PET radiotracer
126705 Fallypride F^18^An F 18 Fallypride PET radiotracer
126706 FLB 457 C^11^A C 11 FLB 457 PET radiotracer
126707 Fluorotriopride F^18^An F 18 Fluorotriopride PET radiotracer
126708 Fluoromisonidazole (FMISO) F^18^An F 18 Fluoromisonidazole PET radiotracer
126709 Glutamine C^11^A C 11 Glutamine PET radiotracer
126710 Glutamine C^14^A C 14 Glutamine PET radiotracer
126711 Glutamine F^18^An F 18 Glutamine PET radiotracer
126712 Flubatine F^18^An F 18 Flubatine PET radiotracer
126713 2FA F^18^An F 18 2FA PET radiotracer
126714 Nifene F^18^An F 18 Nifene PET radiotracer
126715 CLR1404 I^124^An I 124 cancer targeted phospholipid ether PET radiotracer
126716 CLR1404 I^131^An I 131 cancer targeted phospholipid ether PET radiotracer
126801 IEC6127 Patient Support Continuous AnglePatient Support Continuous Angle in IEC PATIENT SUPPORT Coordinate System [IEC 61217]
126802 IEC6127 Table Top Continuous Pitch AngleTable Top Continuous Pitch Angle in the direction of the IEC TABLE TOP Coordinate System [IEC 61217]
126803 IEC6127 Table Top Continuous Roll AngleTable Top Continuous Roll Angle in the direction of the IEC TABLE TOP Coordinate System [IEC 61217]
126804 IEC6127 Table Top Eccentric Axis DistanceTable Top Eccentric Axis Distance [IEC 61217]
126805 IEC6127 Table Top Continuous Eccentric AngleTable Top Continuous Eccentric Angle in the direction of the IEC TABLE TOP ECCENTRIC Coordinate System [IEC 61217]
126806 IEC6127 Table Top Lateral PositionTable Top Lateral Position IEC TABLE TOP Coordinate System [IEC 61217]
126807 IEC6127 Table Top Longitudinal PositionTable Top Longitudinal Position IEC TABLE TOP Coordinate System [IEC 61217]
126808 IEC6127 Table Top Vertical PositionTable Top Vertical Position in IEC TABLE TOP Coordinate System [IEC 61217]
126809 IEC6127 Gantry Continuous Roll AngleGantry Continuous Roll Angle in degrees of the radiation source, i.e., the rotation about the Y-axis of the IEC GANTRY coordinate system [IEC 61217]
126810 IEC6127 Gantry Continuous Pitch AngleGantry Pitch Continuous Angle in degrees of the radiation source, i.e., the rotation about the X-axis of the IEC GANTRY coordinate system [IEC 61217]
126811 IEC6127 Gantry Continuous Yaw AngleGantry Yaw Continuous Angle in degrees of the radiation source, i.e., about the Z-axis of the IEC GANTRY coordinate system [IEC 61217]

 

See the full registry of code systems defined as part of FHIR.


Explanation of the columns that may appear on this page:

LvlA few code lists that FHIR defines are hierarchical - each code is assigned a level. See Code System for further information.
SourceThe source of the definition of the code (when the value set draws in codes defined elsewhere)
CodeThe code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
DisplayThe display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
DefinitionAn explanation of the meaning of the concept
CommentsAdditional notes about how to use the code